id	sid	tid	token	lemma	pos
dpc-4910	1	1	dermatology	dermatology	NOUN
dpc-4910	1	2	:	:	PUNCT
dpc-4910	1	3	practical	practical	ADJ
dpc-4910	1	4	and	and	CCONJ
dpc-4910	1	5	conceptual	conceptual	ADJ
dpc-4910	1	6	original	original	ADJ
dpc-4910	1	7	article	article	NOUN
dpc-4910	1	8	|	|	ADV
dpc-4910	1	9	dermatol	dermatol	ADJ
dpc-4910	1	10	pract	pract	NOUN
dpc-4910	1	11	concept	concept	NOUN
dpc-4910	1	12	.	.	PUNCT
dpc-4910	2	1	2025;15(2):4910	2025;15(2):4910	NUM
dpc-4910	2	2	1	1	NUM
dpc-4910	2	3	renal	renal	ADJ
dpc-4910	2	4	implications	implication	NOUN
dpc-4910	2	5	of	of	ADP
dpc-4910	2	6	psoriasis	psoriasis	NOUN
dpc-4910	2	7	:	:	PUNCT
dpc-4910	2	8	urinary	urinary	ADJ
dpc-4910	2	9	podocyte	podocyte	NOUN
dpc-4910	2	10	markers	marker	NOUN
dpc-4910	2	11	and	and	CCONJ
dpc-4910	2	12	disease	disease	NOUN
dpc-4910	2	13	progression	progression	NOUN
dpc-4910	2	14	sule	sule	PROPN
dpc-4910	2	15	gencoglu1	gencoglu1	PROPN
dpc-4910	2	16	,	,	PUNCT
dpc-4910	2	17	meltem	meltem	NOUN
dpc-4910	2	18	yardim2	yardim2	PROPN
dpc-4910	2	19	,	,	PUNCT
dpc-4910	3	1	ramazan	ramazan	PROPN
dpc-4910	3	2	fazil	fazil	PROPN
dpc-4910	3	3	akkoc3	akkoc3	PROPN
dpc-4910	3	4	1	1	NUM
dpc-4910	3	5	department	department	NOUN
dpc-4910	3	6	of	of	ADP
dpc-4910	3	7	dermatology	dermatology	NOUN
dpc-4910	3	8	,	,	PUNCT
dpc-4910	3	9	gozde	gozde	NOUN
dpc-4910	3	10	academy	academy	NOUN
dpc-4910	3	11	hospital	hospital	PROPN
dpc-4910	3	12	,	,	PUNCT
dpc-4910	3	13	malatya	malatya	PROPN
dpc-4910	3	14	,	,	PUNCT
dpc-4910	3	15	turkey	turkey	PROPN
dpc-4910	3	16	2	2	NUM
dpc-4910	3	17	department	department	NOUN
dpc-4910	3	18	of	of	ADP
dpc-4910	3	19	medical	medical	ADJ
dpc-4910	3	20	biochemistry	biochemistry	NOUN
dpc-4910	3	21	,	,	PUNCT
dpc-4910	3	22	yerkoy	yerkoy	PROPN
dpc-4910	3	23	state	state	PROPN
dpc-4910	3	24	hospital	hospital	PROPN
dpc-4910	3	25	,	,	PUNCT
dpc-4910	3	26	yozgat	yozgat	ADJ
dpc-4910	3	27	,	,	PUNCT
dpc-4910	3	28	turkey	turkey	PROPN
dpc-4910	3	29	3	3	NUM
dpc-4910	3	30	department	department	PROPN
dpc-4910	3	31	of	of	ADP
dpc-4910	3	32	anatomy	anatomy	NOUN
dpc-4910	3	33	,	,	PUNCT
dpc-4910	3	34	faculty	faculty	NOUN
dpc-4910	3	35	of	of	ADP
dpc-4910	3	36	medicine	medicine	NOUN
dpc-4910	3	37	,	,	PUNCT
dpc-4910	3	38	firat	firat	PROPN
dpc-4910	3	39	university	university	PROPN
dpc-4910	3	40	,	,	PUNCT
dpc-4910	3	41	elazig	elazig	PROPN
dpc-4910	3	42	,	,	PUNCT
dpc-4910	3	43	turkey	turkey	PROPN
dpc-4910	3	44	key	key	ADJ
dpc-4910	3	45	words	word	NOUN
dpc-4910	3	46	:	:	PUNCT
dpc-4910	3	47	psoriasis	psoriasis	NOUN
dpc-4910	3	48	vulgaris	vulgaris	NOUN
dpc-4910	3	49	,	,	PUNCT
dpc-4910	3	50	podocytes	podocyte	NOUN
dpc-4910	3	51	,	,	PUNCT
dpc-4910	3	52	podocalyxin	podocalyxin	NOUN
dpc-4910	3	53	,	,	PUNCT
dpc-4910	3	54	nephrin	nephrin	NOUN
dpc-4910	3	55	,	,	PUNCT
dpc-4910	3	56	albuminuria	albuminuria	PROPN
dpc-4910	3	57	citation	citation	NOUN
dpc-4910	3	58	:	:	PUNCT
dpc-4910	3	59	gencoglu	gencoglu	PROPN
dpc-4910	3	60	s	s	PROPN
dpc-4910	3	61	,	,	PUNCT
dpc-4910	3	62	yardim	yardim	PROPN
dpc-4910	3	63	m	m	PROPN
dpc-4910	3	64	,	,	PUNCT
dpc-4910	3	65	akkoc	akkoc	PROPN
dpc-4910	3	66	rf	rf	PROPN
dpc-4910	3	67	.	.	PUNCT
dpc-4910	4	1	renal	renal	ADJ
dpc-4910	4	2	implications	implication	NOUN
dpc-4910	4	3	of	of	ADP
dpc-4910	4	4	psoriasis	psoriasis	NOUN
dpc-4910	4	5	:	:	PUNCT
dpc-4910	4	6	urinary	urinary	ADJ
dpc-4910	4	7	podocyte	podocyte	NOUN
dpc-4910	4	8	markers	marker	NOUN
dpc-4910	4	9	and	and	CCONJ
dpc-4910	4	10	disease	disease	NOUN
dpc-4910	4	11	progression	progression	NOUN
dpc-4910	4	12	.	.	PUNCT
dpc-4910	5	1	dermatol	dermatol	NOUN
dpc-4910	5	2	pract	pract	PROPN
dpc-4910	5	3	concept	concept	NOUN
dpc-4910	5	4	.	.	PUNCT
dpc-4910	6	1	2025;15(2):4910	2025;15(2):4910	NUM
dpc-4910	6	2	.	.	PUNCT
dpc-4910	7	1	doi	doi	NOUN
dpc-4910	7	2	:	:	PUNCT
dpc-4910	7	3	https://doi.org/10.5826/dpc.1502a4910	https://doi.org/10.5826/dpc.1502a4910	NOUN
dpc-4910	7	4	accepted	accept	VERB
dpc-4910	7	5	:	:	PUNCT
dpc-4910	7	6	january	january	PROPN
dpc-4910	7	7	7	7	NUM
dpc-4910	7	8	,	,	PUNCT
dpc-4910	7	9	2025	2025	NUM
dpc-4910	7	10	;	;	PUNCT
dpc-4910	7	11	published	publish	VERB
dpc-4910	7	12	:	:	PUNCT
dpc-4910	8	1	april	april	PROPN
dpc-4910	8	2	2025	2025	NUM
dpc-4910	8	3	copyright	copyright	NOUN
dpc-4910	8	4	:	:	PUNCT
dpc-4910	8	5	©	©	PROPN
dpc-4910	8	6	2025	2025	NUM
dpc-4910	8	7	gencoglu	gencoglu	NOUN
dpc-4910	8	8	et	et	PROPN
dpc-4910	8	9	al	al	PROPN
dpc-4910	8	10	.	.	PUNCT
dpc-4910	9	1	this	this	PRON
dpc-4910	9	2	is	be	AUX
dpc-4910	9	3	an	an	DET
dpc-4910	9	4	open	open	ADJ
dpc-4910	9	5	-	-	PUNCT
dpc-4910	9	6	access	access	NOUN
dpc-4910	9	7	article	article	NOUN
dpc-4910	9	8	distributed	distribute	VERB
dpc-4910	9	9	under	under	ADP
dpc-4910	9	10	the	the	DET
dpc-4910	9	11	terms	term	NOUN
dpc-4910	9	12	of	of	ADP
dpc-4910	9	13	the	the	DET
dpc-4910	9	14	creative	creative	ADJ
dpc-4910	9	15	commons	common	NOUN
dpc-4910	9	16	attributionnoncommercial	attributionnoncommercial	ADJ
dpc-4910	9	17	license	license	NOUN
dpc-4910	9	18	(	(	PUNCT
dpc-4910	9	19	by	by	ADP
dpc-4910	9	20	-	-	PUNCT
dpc-4910	9	21	nc-4.0	nc-4.0	NOUN
dpc-4910	9	22	)	)	PUNCT
dpc-4910	9	23	,	,	PUNCT
dpc-4910	9	24	https://creativecommons.org/licenses/by-nc/4.0/	https://creativecommons.org/licenses/by-nc/4.0/	PROPN
dpc-4910	9	25	,	,	PUNCT
dpc-4910	9	26	which	which	PRON
dpc-4910	9	27	permits	permit	VERB
dpc-4910	9	28	unrestricted	unrestricted	ADJ
dpc-4910	9	29	noncommercial	noncommercial	ADJ
dpc-4910	9	30	use	use	NOUN
dpc-4910	9	31	,	,	PUNCT
dpc-4910	9	32	distribution	distribution	NOUN
dpc-4910	9	33	,	,	PUNCT
dpc-4910	9	34	and	and	CCONJ
dpc-4910	9	35	reproduction	reproduction	NOUN
dpc-4910	9	36	in	in	ADP
dpc-4910	9	37	any	any	DET
dpc-4910	9	38	medium	medium	NOUN
dpc-4910	9	39	,	,	PUNCT
dpc-4910	9	40	provided	provide	VERB
dpc-4910	9	41	the	the	DET
dpc-4910	9	42	original	original	ADJ
dpc-4910	9	43	authors	author	NOUN
dpc-4910	9	44	and	and	CCONJ
dpc-4910	9	45	source	source	NOUN
dpc-4910	9	46	are	be	AUX
dpc-4910	9	47	credited	credit	VERB
dpc-4910	9	48	.	.	PUNCT
dpc-4910	10	1	funding	funding	NOUN
dpc-4910	10	2	:	:	PUNCT
dpc-4910	10	3	none	none	NOUN
dpc-4910	10	4	.	.	PUNCT
dpc-4910	11	1	competing	compete	VERB
dpc-4910	11	2	interests	interest	NOUN
dpc-4910	11	3	:	:	PUNCT
dpc-4910	11	4	none	none	NOUN
dpc-4910	11	5	.	.	PUNCT
dpc-4910	12	1	authorship	authorship	NOUN
dpc-4910	12	2	:	:	PUNCT
dpc-4910	12	3	all	all	DET
dpc-4910	12	4	the	the	DET
dpc-4910	12	5	authors	author	NOUN
dpc-4910	12	6	contributed	contribute	VERB
dpc-4910	12	7	to	to	ADP
dpc-4910	12	8	the	the	DET
dpc-4910	12	9	conception	conception	NOUN
dpc-4910	12	10	of	of	ADP
dpc-4910	12	11	the	the	DET
dpc-4910	12	12	work	work	NOUN
dpc-4910	12	13	:	:	PUNCT
dpc-4910	12	14	the	the	DET
dpc-4910	12	15	acquisition	acquisition	NOUN
dpc-4910	12	16	,	,	PUNCT
dpc-4910	12	17	analysis	analysis	NOUN
dpc-4910	12	18	,	,	PUNCT
dpc-4910	12	19	and	and	CCONJ
dpc-4910	12	20	interpretation	interpretation	NOUN
dpc-4910	12	21	of	of	ADP
dpc-4910	12	22	data	datum	NOUN
dpc-4910	12	23	;	;	PUNCT
dpc-4910	12	24	drafting	draft	VERB
dpc-4910	12	25	;	;	PUNCT
dpc-4910	12	26	and	and	CCONJ
dpc-4910	12	27	revision	revision	NOUN
dpc-4910	12	28	of	of	ADP
dpc-4910	12	29	the	the	DET
dpc-4910	12	30	work	work	NOUN
dpc-4910	12	31	.	.	PUNCT
dpc-4910	13	1	they	they	PRON
dpc-4910	13	2	have	have	AUX
dpc-4910	13	3	read	read	VERB
dpc-4910	13	4	and	and	CCONJ
dpc-4910	13	5	approved	approve	VERB
dpc-4910	13	6	the	the	DET
dpc-4910	13	7	final	final	ADJ
dpc-4910	13	8	version	version	NOUN
dpc-4910	13	9	for	for	ADP
dpc-4910	13	10	submission	submission	NOUN
dpc-4910	13	11	and	and	CCONJ
dpc-4910	13	12	agree	agree	VERB
dpc-4910	13	13	to	to	PART
dpc-4910	13	14	be	be	AUX
dpc-4910	13	15	personally	personally	ADV
dpc-4910	13	16	accountable	accountable	ADJ
dpc-4910	13	17	for	for	ADP
dpc-4910	13	18	their	their	PRON
dpc-4910	13	19	contributions	contribution	NOUN
dpc-4910	13	20	and	and	CCONJ
dpc-4910	13	21	to	to	PART
dpc-4910	13	22	ensure	ensure	VERB
dpc-4910	13	23	that	that	SCONJ
dpc-4910	13	24	questions	question	NOUN
dpc-4910	13	25	related	relate	VERB
dpc-4910	13	26	to	to	ADP
dpc-4910	13	27	the	the	DET
dpc-4910	13	28	accuracy	accuracy	NOUN
dpc-4910	13	29	or	or	CCONJ
dpc-4910	13	30	integrity	integrity	NOUN
dpc-4910	13	31	of	of	ADP
dpc-4910	13	32	any	any	DET
dpc-4910	13	33	part	part	NOUN
dpc-4910	13	34	of	of	ADP
dpc-4910	13	35	the	the	DET
dpc-4910	13	36	work	work	NOUN
dpc-4910	13	37	are	be	AUX
dpc-4910	13	38	appropriately	appropriately	ADV
dpc-4910	13	39	investigated	investigate	VERB
dpc-4910	13	40	,	,	PUNCT
dpc-4910	13	41	resolved	resolve	VERB
dpc-4910	13	42	,	,	PUNCT
dpc-4910	13	43	and	and	CCONJ
dpc-4910	13	44	documented	document	VERB
dpc-4910	13	45	in	in	ADP
dpc-4910	13	46	the	the	DET
dpc-4910	13	47	literature	literature	NOUN
dpc-4910	13	48	.	.	PUNCT
dpc-4910	14	1	corresponding	correspond	VERB
dpc-4910	14	2	author	author	NOUN
dpc-4910	14	3	:	:	PUNCT
dpc-4910	14	4	meltem	meltem	PROPN
dpc-4910	14	5	yardim	yardim	PROPN
dpc-4910	14	6	,	,	PUNCT
dpc-4910	14	7	md	md	PROPN
dpc-4910	14	8	,	,	PUNCT
dpc-4910	14	9	department	department	PROPN
dpc-4910	14	10	of	of	ADP
dpc-4910	14	11	medical	medical	ADJ
dpc-4910	14	12	biochemistry	biochemistry	NOUN
dpc-4910	14	13	,	,	PUNCT
dpc-4910	14	14	yozgat	yozgat	ADJ
dpc-4910	14	15	yerkoy	yerkoy	PROPN
dpc-4910	14	16	state	state	NOUN
dpc-4910	14	17	hospital	hospital	NOUN
dpc-4910	14	18	,	,	PUNCT
dpc-4910	14	19	yozgat	yozgat	ADJ
dpc-4910	14	20	,	,	PUNCT
dpc-4910	14	21	selcuk	selcuk	NOUN
dpc-4910	14	22	mah	mah	NOUN
dpc-4910	14	23	,	,	PUNCT
dpc-4910	14	24	namik	namik	ADJ
dpc-4910	14	25	kemal	kemal	PROPN
dpc-4910	14	26	cd	cd	PROPN
dpc-4910	14	27	.	.	PUNCT
dpc-4910	15	1	no:2	no:2	PROPN
dpc-4910	15	2	,	,	PUNCT
dpc-4910	15	3	66900	66900	NUM
dpc-4910	15	4	yerkoy	yerkoy	NOUN
dpc-4910	15	5	/	/	SYM
dpc-4910	15	6	yozgat	yozgat	ADJ
dpc-4910	15	7	,	,	PUNCT
dpc-4910	15	8	turkey	turkey	NOUN
dpc-4910	15	9	.	.	PUNCT
dpc-4910	16	1	orcid	orcid	NOUN
dpc-4910	17	1	i	i	PRON
dpc-4910	17	2	d	d	NOUN
dpc-4910	17	3	:	:	PUNCT
dpc-4910	17	4	0000	0000	NUM
dpc-4910	17	5	-	-	PUNCT
dpc-4910	17	6	0002	0002	NUM
dpc-4910	17	7	-	-	PUNCT
dpc-4910	17	8	0348	0348	NUM
dpc-4910	17	9	-	-	PUNCT
dpc-4910	17	10	6312	6312	NUM
dpc-4910	17	11	.	.	PUNCT
dpc-4910	18	1	e	e	X
dpc-4910	18	2	-	-	NOUN
dpc-4910	18	3	mail	mail	NOUN
dpc-4910	18	4	:	:	PUNCT
dpc-4910	18	5	meltem_yardim@hotmail.com	meltem_yardim@hotmail.com	PROPN
dpc-4910	18	6	introduction	introduction	NOUN
dpc-4910	18	7	:	:	PUNCT
dpc-4910	18	8	psoriasis	psoriasis	NOUN
dpc-4910	18	9	may	may	AUX
dpc-4910	18	10	lead	lead	VERB
dpc-4910	18	11	to	to	ADP
dpc-4910	18	12	glomerular	glomerular	ADJ
dpc-4910	18	13	inflammatory	inflammatory	ADJ
dpc-4910	18	14	damage	damage	NOUN
dpc-4910	18	15	and	and	CCONJ
dpc-4910	18	16	disruption	disruption	NOUN
dpc-4910	18	17	of	of	ADP
dpc-4910	18	18	the	the	DET
dpc-4910	18	19	podocyte	podocyte	NOUN
dpc-4910	18	20	barrier	barrier	NOUN
dpc-4910	18	21	,	,	PUNCT
dpc-4910	18	22	allowing	allow	VERB
dpc-4910	18	23	podocyte	podocyte	NOUN
dpc-4910	18	24	degradation	degradation	NOUN
dpc-4910	18	25	products	product	NOUN
dpc-4910	18	26	to	to	PART
dpc-4910	18	27	leak	leak	VERB
dpc-4910	18	28	into	into	ADP
dpc-4910	18	29	the	the	DET
dpc-4910	18	30	urine	urine	NOUN
dpc-4910	18	31	.	.	PUNCT
dpc-4910	19	1	objectives	objective	NOUN
dpc-4910	19	2	:	:	PUNCT
dpc-4910	19	3	we	we	PRON
dpc-4910	19	4	aimed	aim	VERB
dpc-4910	19	5	to	to	PART
dpc-4910	19	6	analyze	analyze	VERB
dpc-4910	19	7	the	the	DET
dpc-4910	19	8	concentrations	concentration	NOUN
dpc-4910	19	9	of	of	ADP
dpc-4910	19	10	podocyte	podocyte	NOUN
dpc-4910	19	11	surface	surface	NOUN
dpc-4910	19	12	glycoprotein	glycoprotein	NOUN
dpc-4910	19	13	podocalyxin	podocalyxin	NOUN
dpc-4910	19	14	(	(	PUNCT
dpc-4910	19	15	pdx	pdx	PROPN
dpc-4910	19	16	)	)	PUNCT
dpc-4910	19	17	and	and	CCONJ
dpc-4910	19	18	podocyte	podocyte	NOUN
dpc-4910	19	19	slit	slit	ADJ
dpc-4910	19	20	protein	protein	NOUN
dpc-4910	19	21	nephrin	nephrin	NOUN
dpc-4910	19	22	in	in	ADP
dpc-4910	19	23	spot	spot	NOUN
dpc-4910	19	24	urine	urine	NOUN
dpc-4910	19	25	samples	sample	NOUN
dpc-4910	19	26	from	from	ADP
dpc-4910	19	27	patients	patient	NOUN
dpc-4910	19	28	with	with	ADP
dpc-4910	19	29	mild	mild	ADJ
dpc-4910	19	30	,	,	PUNCT
dpc-4910	19	31	moderate	moderate	ADJ
dpc-4910	19	32	,	,	PUNCT
dpc-4910	19	33	or	or	CCONJ
dpc-4910	19	34	severe	severe	ADJ
dpc-4910	19	35	psoriasis	psoriasis	NOUN
dpc-4910	19	36	vulgaris	vulgaris	NOUN
dpc-4910	19	37	.	.	PUNCT
dpc-4910	20	1	methods	method	NOUN
dpc-4910	20	2	:	:	PUNCT
dpc-4910	20	3	a	a	DET
dpc-4910	20	4	total	total	NOUN
dpc-4910	20	5	of	of	ADP
dpc-4910	20	6	78	78	NUM
dpc-4910	20	7	participants	participant	NOUN
dpc-4910	20	8	,	,	PUNCT
dpc-4910	20	9	including	include	VERB
dpc-4910	20	10	58	58	NUM
dpc-4910	20	11	patients	patient	NOUN
dpc-4910	20	12	diagnosed	diagnose	VERB
dpc-4910	20	13	with	with	ADP
dpc-4910	20	14	mild	mild	ADJ
dpc-4910	20	15	,	,	PUNCT
dpc-4910	20	16	moderate	moderate	ADJ
dpc-4910	20	17	,	,	PUNCT
dpc-4910	20	18	or	or	CCONJ
dpc-4910	20	19	severe	severe	ADJ
dpc-4910	20	20	psoriasis	psoriasis	NOUN
dpc-4910	20	21	vulgaris	vulgaris	NOUN
dpc-4910	20	22	and	and	CCONJ
dpc-4910	20	23	20	20	NUM
dpc-4910	20	24	healthy	healthy	ADJ
dpc-4910	20	25	controls	control	NOUN
dpc-4910	20	26	,	,	PUNCT
dpc-4910	20	27	were	be	AUX
dpc-4910	20	28	included	include	VERB
dpc-4910	20	29	in	in	ADP
dpc-4910	20	30	the	the	DET
dpc-4910	20	31	study	study	NOUN
dpc-4910	20	32	.	.	PUNCT
dpc-4910	21	1	psoriasis	psoriasis	NOUN
dpc-4910	21	2	was	be	AUX
dpc-4910	21	3	diagnosed	diagnose	VERB
dpc-4910	21	4	based	base	VERB
dpc-4910	21	5	on	on	ADP
dpc-4910	21	6	the	the	DET
dpc-4910	21	7	typical	typical	ADJ
dpc-4910	21	8	morphological	morphological	ADJ
dpc-4910	21	9	characteristics	characteristic	NOUN
dpc-4910	21	10	of	of	ADP
dpc-4910	21	11	the	the	DET
dpc-4910	21	12	lesions	lesion	NOUN
dpc-4910	21	13	.	.	PUNCT
dpc-4910	22	1	morning	morning	NOUN
dpc-4910	22	2	urine	urine	NOUN
dpc-4910	22	3	samples	sample	NOUN
dpc-4910	22	4	were	be	AUX
dpc-4910	22	5	used	use	VERB
dpc-4910	22	6	to	to	PART
dpc-4910	22	7	evaluate	evaluate	VERB
dpc-4910	22	8	urine	urine	NOUN
dpc-4910	22	9	pdx	pdx	NOUN
dpc-4910	22	10	and	and	CCONJ
dpc-4910	22	11	nephrin	nephrin	PROPN
dpc-4910	22	12	levels	level	NOUN
dpc-4910	22	13	.	.	PUNCT
dpc-4910	23	1	albuminuria	albuminuria	PROPN
dpc-4910	23	2	was	be	AUX
dpc-4910	23	3	evaluated	evaluate	VERB
dpc-4910	23	4	by	by	ADP
dpc-4910	23	5	calculating	calculate	VERB
dpc-4910	23	6	the	the	DET
dpc-4910	23	7	urine	urine	NOUN
dpc-4910	23	8	albumin	albumin	NOUN
dpc-4910	23	9	-	-	PUNCT
dpc-4910	23	10	to	to	ADP
dpc-4910	23	11	creatinine	creatinine	NOUN
dpc-4910	23	12	ratio	ratio	NOUN
dpc-4910	23	13	(	(	PUNCT
dpc-4910	23	14	uacr	uacr	INTJ
dpc-4910	23	15	)	)	PUNCT
dpc-4910	23	16	.	.	PUNCT
dpc-4910	24	1	results	result	NOUN
dpc-4910	24	2	:	:	PUNCT
dpc-4910	24	3	urinary	urinary	ADJ
dpc-4910	24	4	pdx	pdx	PROPN
dpc-4910	24	5	and	and	CCONJ
dpc-4910	24	6	nephrin	nephrin	PROPN
dpc-4910	24	7	levels	level	NOUN
dpc-4910	24	8	were	be	AUX
dpc-4910	24	9	significantly	significantly	ADV
dpc-4910	24	10	higher	high	ADJ
dpc-4910	24	11	in	in	ADP
dpc-4910	24	12	the	the	DET
dpc-4910	24	13	psoriasis	psoriasis	NOUN
dpc-4910	24	14	group	group	NOUN
dpc-4910	24	15	than	than	ADP
dpc-4910	24	16	in	in	ADP
dpc-4910	24	17	the	the	DET
dpc-4910	24	18	control	control	NOUN
dpc-4910	24	19	group	group	NOUN
dpc-4910	24	20	.	.	PUNCT
dpc-4910	25	1	urinary	urinary	ADJ
dpc-4910	25	2	pdx	pdx	PROPN
dpc-4910	25	3	and	and	CCONJ
dpc-4910	25	4	nephrin	nephrin	PROPN
dpc-4910	25	5	levels	level	NOUN
dpc-4910	25	6	in	in	ADP
dpc-4910	25	7	the	the	DET
dpc-4910	25	8	mild	mild	ADJ
dpc-4910	25	9	and	and	CCONJ
dpc-4910	25	10	moderate	moderate	ADJ
dpc-4910	25	11	psoriasis	psoriasis	NOUN
dpc-4910	25	12	groups	group	NOUN
dpc-4910	25	13	were	be	AUX
dpc-4910	25	14	similar	similar	ADJ
dpc-4910	25	15	but	but	CCONJ
dpc-4910	25	16	higher	high	ADJ
dpc-4910	25	17	than	than	ADP
dpc-4910	25	18	those	those	PRON
dpc-4910	25	19	in	in	ADP
dpc-4910	25	20	the	the	DET
dpc-4910	25	21	control	control	NOUN
dpc-4910	25	22	group	group	NOUN
dpc-4910	25	23	and	and	CCONJ
dpc-4910	25	24	significantly	significantly	ADV
dpc-4910	25	25	higher	high	ADJ
dpc-4910	25	26	in	in	ADP
dpc-4910	25	27	the	the	DET
dpc-4910	25	28	severe	severe	ADJ
dpc-4910	25	29	psoriasis	psoriasis	NOUN
dpc-4910	25	30	group	group	NOUN
dpc-4910	25	31	than	than	ADP
dpc-4910	25	32	in	in	ADP
dpc-4910	25	33	the	the	DET
dpc-4910	25	34	mild	mild	ADJ
dpc-4910	25	35	and	and	CCONJ
dpc-4910	25	36	moderate	moderate	ADJ
dpc-4910	25	37	psoriasis	psoriasis	NOUN
dpc-4910	25	38	groups	group	NOUN
dpc-4910	25	39	.	.	PUNCT
dpc-4910	26	1	the	the	DET
dpc-4910	26	2	microalbuminuria	microalbuminuria	PROPN
dpc-4910	26	3	rates	rate	NOUN
dpc-4910	26	4	were	be	AUX
dpc-4910	26	5	similar	similar	ADJ
dpc-4910	26	6	between	between	ADP
dpc-4910	26	7	the	the	DET
dpc-4910	26	8	psoriasis	psoriasis	NOUN
dpc-4910	26	9	and	and	CCONJ
dpc-4910	26	10	control	control	NOUN
dpc-4910	26	11	groups	group	NOUN
dpc-4910	26	12	.	.	PUNCT
dpc-4910	27	1	a	a	DET
dpc-4910	27	2	significant	significant	ADJ
dpc-4910	27	3	positive	positive	ADJ
dpc-4910	27	4	correlation	correlation	NOUN
dpc-4910	27	5	was	be	AUX
dpc-4910	27	6	observed	observe	VERB
dpc-4910	27	7	between	between	ADP
dpc-4910	27	8	urine	urine	NOUN
dpc-4910	27	9	pdx	pdx	PROPN
dpc-4910	27	10	,	,	PUNCT
dpc-4910	27	11	nephrin	nephrin	NOUN
dpc-4910	27	12	,	,	PUNCT
dpc-4910	27	13	uacr	uacr	INTJ
dpc-4910	27	14	,	,	PUNCT
dpc-4910	27	15	and	and	CCONJ
dpc-4910	27	16	sbp	sbp	NOUN
dpc-4910	27	17	.	.	PUNCT
dpc-4910	28	1	after	after	ADP
dpc-4910	28	2	adjusting	adjust	VERB
dpc-4910	28	3	for	for	ADP
dpc-4910	28	4	age	age	NOUN
dpc-4910	28	5	,	,	PUNCT
dpc-4910	28	6	bmi	bmi	NOUN
dpc-4910	28	7	,	,	PUNCT
dpc-4910	28	8	and	and	CCONJ
dpc-4910	28	9	sex	sex	NOUN
dpc-4910	28	10	,	,	PUNCT
dpc-4910	28	11	urine	urine	NOUN
dpc-4910	28	12	pdx	pdx	PROPN
dpc-4910	28	13	and	and	CCONJ
dpc-4910	28	14	nephrin	nephrin	PROPN
dpc-4910	28	15	levels	level	NOUN
dpc-4910	28	16	were	be	AUX
dpc-4910	28	17	found	find	VERB
dpc-4910	28	18	to	to	PART
dpc-4910	28	19	be	be	AUX
dpc-4910	28	20	independent	independent	ADJ
dpc-4910	28	21	risk	risk	NOUN
dpc-4910	28	22	factors	factor	NOUN
dpc-4910	28	23	for	for	ADP
dpc-4910	28	24	microalbuminuria	microalbuminuria	PROPN
dpc-4910	28	25	.	.	PUNCT
dpc-4910	29	1	conclusion	conclusion	NOUN
dpc-4910	29	2	:	:	PUNCT
dpc-4910	29	3	this	this	DET
dpc-4910	29	4	study	study	NOUN
dpc-4910	29	5	showed	show	VERB
dpc-4910	29	6	that	that	SCONJ
dpc-4910	29	7	podocyte	podocyte	NOUN
dpc-4910	29	8	damage	damage	NOUN
dpc-4910	29	9	in	in	ADP
dpc-4910	29	10	patients	patient	NOUN
dpc-4910	29	11	with	with	ADP
dpc-4910	29	12	psoriasis	psoriasis	NOUN
dpc-4910	29	13	begins	begin	VERB
dpc-4910	29	14	in	in	ADP
dpc-4910	29	15	the	the	DET
dpc-4910	29	16	early	early	ADJ
dpc-4910	29	17	stages	stage	NOUN
dpc-4910	29	18	of	of	ADP
dpc-4910	29	19	the	the	DET
dpc-4910	29	20	disease	disease	NOUN
dpc-4910	29	21	and	and	CCONJ
dpc-4910	29	22	significantly	significantly	ADV
dpc-4910	29	23	increases	increase	VERB
dpc-4910	29	24	in	in	ADP
dpc-4910	29	25	the	the	DET
dpc-4910	29	26	severe	severe	ADJ
dpc-4910	29	27	stage	stage	NOUN
dpc-4910	29	28	of	of	ADP
dpc-4910	29	29	the	the	DET
dpc-4910	29	30	disease	disease	NOUN
dpc-4910	29	31	.	.	PUNCT
dpc-4910	30	1	abstract	abstract	ADJ
dpc-4910	30	2	2	2	NUM
dpc-4910	30	3	original	original	ADJ
dpc-4910	30	4	article	article	NOUN
dpc-4910	30	5	|	|	ADV
dpc-4910	30	6	dermatol	dermatol	ADJ
dpc-4910	30	7	pract	pract	NOUN
dpc-4910	30	8	concept	concept	NOUN
dpc-4910	30	9	.	.	PUNCT
dpc-4910	31	1	2025;15(2):4910	2025;15(2):4910	NUM
dpc-4910	31	2	introduction	introduction	NOUN
dpc-4910	31	3	psoriasis	psoriasis	NOUN
dpc-4910	31	4	vulgaris	vulgaris	NOUN
dpc-4910	31	5	,	,	PUNCT
dpc-4910	31	6	also	also	ADV
dpc-4910	31	7	known	know	VERB
dpc-4910	31	8	as	as	ADP
dpc-4910	31	9	plaque	plaque	NOUN
dpc-4910	31	10	psoriasis	psoriasis	NOUN
dpc-4910	31	11	,	,	PUNCT
dpc-4910	31	12	is	be	AUX
dpc-4910	31	13	a	a	DET
dpc-4910	31	14	chronic	chronic	ADJ
dpc-4910	31	15	autoimmune	autoimmune	ADJ
dpc-4910	31	16	inflammatory	inflammatory	ADJ
dpc-4910	31	17	dermatosis	dermatosis	NOUN
dpc-4910	31	18	with	with	ADP
dpc-4910	31	19	a	a	DET
dpc-4910	31	20	worldwide	worldwide	ADJ
dpc-4910	31	21	prevalence	prevalence	NOUN
dpc-4910	31	22	of	of	ADP
dpc-4910	31	23	2	2	NUM
dpc-4910	31	24	%	%	NOUN
dpc-4910	31	25	[	[	X
dpc-4910	31	26	1	1	NUM
dpc-4910	31	27	]	]	PUNCT
dpc-4910	31	28	.	.	PUNCT
dpc-4910	32	1	cardiometabolic	cardiometabolic	NOUN
dpc-4910	32	2	comorbidities	comorbiditie	NOUN
dpc-4910	32	3	,	,	PUNCT
dpc-4910	32	4	such	such	ADJ
dpc-4910	32	5	as	as	ADP
dpc-4910	32	6	chronic	chronic	ADJ
dpc-4910	32	7	kidney	kidney	NOUN
dpc-4910	32	8	disease	disease	NOUN
dpc-4910	32	9	(	(	PUNCT
dpc-4910	32	10	ckd	ckd	NOUN
dpc-4910	32	11	)	)	PUNCT
dpc-4910	32	12	and	and	CCONJ
dpc-4910	32	13	end	end	NOUN
dpc-4910	32	14	-	-	PUNCT
dpc-4910	32	15	stage	stage	NOUN
dpc-4910	32	16	renal	renal	ADJ
dpc-4910	32	17	disease	disease	NOUN
dpc-4910	32	18	(	(	PUNCT
dpc-4910	32	19	esrd	esrd	PROPN
dpc-4910	32	20	)	)	PUNCT
dpc-4910	32	21	,	,	PUNCT
dpc-4910	32	22	are	be	AUX
dpc-4910	32	23	frequently	frequently	ADV
dpc-4910	32	24	observed	observe	VERB
dpc-4910	32	25	throughout	throughout	ADP
dpc-4910	32	26	the	the	DET
dpc-4910	32	27	course	course	NOUN
dpc-4910	32	28	of	of	ADP
dpc-4910	32	29	the	the	DET
dpc-4910	32	30	disease	disease	NOUN
dpc-4910	32	31	[	[	X
dpc-4910	32	32	2	2	NUM
dpc-4910	32	33	]	]	PUNCT
dpc-4910	32	34	.	.	PUNCT
dpc-4910	33	1	in	in	ADP
dpc-4910	33	2	particular	particular	ADJ
dpc-4910	33	3	,	,	PUNCT
dpc-4910	33	4	severe	severe	ADJ
dpc-4910	33	5	psoriasis	psoriasis	NOUN
dpc-4910	33	6	has	have	AUX
dpc-4910	33	7	been	be	AUX
dpc-4910	33	8	reported	report	VERB
dpc-4910	33	9	as	as	ADP
dpc-4910	33	10	an	an	DET
dpc-4910	33	11	independent	independent	ADJ
dpc-4910	33	12	risk	risk	NOUN
dpc-4910	33	13	factor	factor	NOUN
dpc-4910	33	14	for	for	ADP
dpc-4910	33	15	ckd	ckd	PROPN
dpc-4910	33	16	and	and	CCONJ
dpc-4910	33	17	esrd	esrd	PROPN
dpc-4910	33	18	.	.	PUNCT
dpc-4910	34	1	the	the	DET
dpc-4910	34	2	increased	increase	VERB
dpc-4910	34	3	incidence	incidence	NOUN
dpc-4910	34	4	of	of	ADP
dpc-4910	34	5	glomerulonephritis	glomerulonephritis	NOUN
dpc-4910	34	6	in	in	ADP
dpc-4910	34	7	psoriasis	psoriasis	NOUN
dpc-4910	34	8	has	have	AUX
dpc-4910	34	9	been	be	AUX
dpc-4910	34	10	reported	report	VERB
dpc-4910	34	11	to	to	PART
dpc-4910	34	12	be	be	AUX
dpc-4910	34	13	one	one	NUM
dpc-4910	34	14	of	of	ADP
dpc-4910	34	15	the	the	DET
dpc-4910	34	16	main	main	ADJ
dpc-4910	34	17	causes	cause	NOUN
dpc-4910	34	18	of	of	ADP
dpc-4910	34	19	ckd	ckd	NOUN
dpc-4910	35	1	[	[	X
dpc-4910	35	2	3	3	NUM
dpc-4910	35	3	]	]	PUNCT
dpc-4910	35	4	.	.	PUNCT
dpc-4910	36	1	although	although	SCONJ
dpc-4910	36	2	the	the	DET
dpc-4910	36	3	incidence	incidence	NOUN
dpc-4910	36	4	of	of	ADP
dpc-4910	36	5	kidney	kidney	NOUN
dpc-4910	36	6	disease	disease	NOUN
dpc-4910	36	7	increases	increase	VERB
dpc-4910	36	8	in	in	ADP
dpc-4910	36	9	proportion	proportion	NOUN
dpc-4910	36	10	to	to	ADP
dpc-4910	36	11	the	the	DET
dpc-4910	36	12	severity	severity	NOUN
dpc-4910	36	13	of	of	ADP
dpc-4910	36	14	the	the	DET
dpc-4910	36	15	disease	disease	NOUN
dpc-4910	36	16	,	,	PUNCT
dpc-4910	36	17	an	an	DET
dpc-4910	36	18	increased	increase	VERB
dpc-4910	36	19	risk	risk	NOUN
dpc-4910	36	20	can	can	AUX
dpc-4910	36	21	also	also	ADV
dpc-4910	36	22	be	be	AUX
dpc-4910	36	23	detected	detect	VERB
dpc-4910	36	24	in	in	ADP
dpc-4910	36	25	moderate	moderate	ADJ
dpc-4910	36	26	-	-	PUNCT
dpc-4910	36	27	type	type	NOUN
dpc-4910	36	28	psoriasis	psoriasis	NOUN
dpc-4910	36	29	[	[	X
dpc-4910	36	30	4	4	NUM
dpc-4910	36	31	-	-	SYM
dpc-4910	36	32	6	6	NUM
dpc-4910	36	33	]	]	PUNCT
dpc-4910	36	34	.	.	PUNCT
dpc-4910	37	1	activation	activation	NOUN
dpc-4910	37	2	of	of	ADP
dpc-4910	37	3	the	the	DET
dpc-4910	37	4	toll	toll	NOUN
dpc-4910	37	5	-	-	PUNCT
dpc-4910	37	6	like	like	ADJ
dpc-4910	37	7	receptor	receptor	NOUN
dpc-4910	37	8	/	/	SYM
dpc-4910	37	9	nuclear	nuclear	ADJ
dpc-4910	37	10	factor	factor	NOUN
dpc-4910	37	11	kappa	kappa	PROPN
dpc-4910	37	12	-	-	PROPN
dpc-4910	37	13	b	b	NOUN
dpc-4910	37	14	pathway	pathway	NOUN
dpc-4910	37	15	in	in	ADP
dpc-4910	37	16	the	the	DET
dpc-4910	37	17	glomeruli	glomeruli	NOUN
dpc-4910	37	18	due	due	ADP
dpc-4910	37	19	to	to	ADP
dpc-4910	37	20	the	the	DET
dpc-4910	37	21	chronic	chronic	ADJ
dpc-4910	37	22	inflammatory	inflammatory	ADJ
dpc-4910	37	23	nature	nature	NOUN
dpc-4910	37	24	of	of	ADP
dpc-4910	37	25	the	the	DET
dpc-4910	37	26	disease	disease	NOUN
dpc-4910	37	27	,	,	PUNCT
dpc-4910	37	28	redox	redox	ADJ
dpc-4910	37	29	balance	balance	NOUN
dpc-4910	37	30	disturbed	disturb	VERB
dpc-4910	37	31	in	in	ADP
dpc-4910	37	32	favor	favor	NOUN
dpc-4910	37	33	of	of	ADP
dpc-4910	37	34	oxidative	oxidative	ADJ
dpc-4910	37	35	stress	stress	NOUN
dpc-4910	37	36	,	,	PUNCT
dpc-4910	37	37	nephrotoxic	nephrotoxic	ADJ
dpc-4910	37	38	side	side	NOUN
dpc-4910	37	39	effects	effect	NOUN
dpc-4910	37	40	of	of	ADP
dpc-4910	37	41	some	some	DET
dpc-4910	37	42	drugs	drug	NOUN
dpc-4910	37	43	used	use	VERB
dpc-4910	37	44	in	in	ADP
dpc-4910	37	45	treatment	treatment	NOUN
dpc-4910	37	46	,	,	PUNCT
dpc-4910	37	47	and	and	CCONJ
dpc-4910	37	48	the	the	DET
dpc-4910	37	49	presence	presence	NOUN
dpc-4910	37	50	of	of	ADP
dpc-4910	37	51	osteoarthritis	osteoarthritis	NOUN
dpc-4910	37	52	are	be	AUX
dpc-4910	37	53	some	some	PRON
dpc-4910	37	54	of	of	ADP
dpc-4910	37	55	the	the	DET
dpc-4910	37	56	mechanisms	mechanism	NOUN
dpc-4910	37	57	that	that	PRON
dpc-4910	37	58	trigger	trigger	VERB
dpc-4910	37	59	chronic	chronic	ADJ
dpc-4910	37	60	renal	renal	ADJ
dpc-4910	37	61	damage	damage	NOUN
dpc-4910	38	1	[	[	X
dpc-4910	38	2	6,7	6,7	NUM
dpc-4910	38	3	]	]	PUNCT
dpc-4910	38	4	.	.	PUNCT
dpc-4910	39	1	the	the	DET
dpc-4910	39	2	association	association	NOUN
dpc-4910	39	3	between	between	ADP
dpc-4910	39	4	psoriasis	psoriasis	NOUN
dpc-4910	39	5	and	and	CCONJ
dpc-4910	39	6	ckd	ckd	PROPN
dpc-4910	39	7	and	and	CCONJ
dpc-4910	39	8	death	death	NOUN
dpc-4910	39	9	from	from	ADP
dpc-4910	39	10	esrd	esrd	PROPN
dpc-4910	39	11	has	have	AUX
dpc-4910	39	12	been	be	AUX
dpc-4910	39	13	reported	report	VERB
dpc-4910	39	14	to	to	PART
dpc-4910	39	15	persist	persist	VERB
dpc-4910	39	16	even	even	ADV
dpc-4910	39	17	after	after	ADP
dpc-4910	39	18	adjusting	adjust	VERB
dpc-4910	39	19	for	for	ADP
dpc-4910	39	20	potential	potential	ADJ
dpc-4910	39	21	confounders	confounder	NOUN
dpc-4910	39	22	such	such	ADJ
dpc-4910	39	23	as	as	ADP
dpc-4910	39	24	age	age	NOUN
dpc-4910	39	25	,	,	PUNCT
dpc-4910	39	26	sex	sex	NOUN
dpc-4910	39	27	,	,	PUNCT
dpc-4910	39	28	osteoarthritis	osteoarthritis	NOUN
dpc-4910	39	29	,	,	PUNCT
dpc-4910	39	30	and	and	CCONJ
dpc-4910	39	31	use	use	NOUN
dpc-4910	39	32	of	of	ADP
dpc-4910	39	33	methotrexate	methotrexate	NOUN
dpc-4910	39	34	,	,	PUNCT
dpc-4910	39	35	cyclosporine	cyclosporine	NOUN
dpc-4910	39	36	,	,	PUNCT
dpc-4910	39	37	or	or	CCONJ
dpc-4910	39	38	nonsteroidal	nonsteroidal	NOUN
dpc-4910	39	39	anti	anti	ADJ
dpc-4910	39	40	inflammatory	inflammatory	ADJ
dpc-4910	39	41	drugs	drug	NOUN
dpc-4910	40	1	[	[	X
dpc-4910	40	2	2,4	2,4	NUM
dpc-4910	40	3	]	]	PUNCT
dpc-4910	40	4	.	.	PUNCT
dpc-4910	41	1	podocytes	podocyte	NOUN
dpc-4910	41	2	,	,	PUNCT
dpc-4910	41	3	which	which	PRON
dpc-4910	41	4	form	form	VERB
dpc-4910	41	5	the	the	DET
dpc-4910	41	6	outer	outer	ADJ
dpc-4910	41	7	surface	surface	NOUN
dpc-4910	41	8	of	of	ADP
dpc-4910	41	9	the	the	DET
dpc-4910	41	10	glomerular	glomerular	ADJ
dpc-4910	41	11	basement	basement	NOUN
dpc-4910	41	12	membrane	membrane	NOUN
dpc-4910	41	13	,	,	PUNCT
dpc-4910	41	14	are	be	AUX
dpc-4910	41	15	important	important	ADJ
dpc-4910	41	16	filtration	filtration	NOUN
dpc-4910	41	17	barriers	barrier	NOUN
dpc-4910	41	18	in	in	ADP
dpc-4910	41	19	the	the	DET
dpc-4910	41	20	glomeruli	glomeruli	NOUN
dpc-4910	41	21	.	.	PUNCT
dpc-4910	42	1	structural	structural	ADJ
dpc-4910	42	2	or	or	CCONJ
dpc-4910	42	3	functional	functional	ADJ
dpc-4910	42	4	podocyte	podocyte	NOUN
dpc-4910	42	5	pathologies	pathology	NOUN
dpc-4910	42	6	are	be	AUX
dpc-4910	42	7	the	the	DET
dpc-4910	42	8	main	main	ADJ
dpc-4910	42	9	causes	cause	NOUN
dpc-4910	42	10	of	of	ADP
dpc-4910	42	11	albumin	albumin	ADJ
dpc-4910	42	12	leakage	leakage	NOUN
dpc-4910	42	13	into	into	ADP
dpc-4910	42	14	bowman	bowman	PROPN
dpc-4910	42	15	’s	’s	PART
dpc-4910	42	16	space	space	NOUN
dpc-4910	42	17	[	[	X
dpc-4910	42	18	8	8	NUM
dpc-4910	42	19	-	-	SYM
dpc-4910	42	20	11	11	NUM
dpc-4910	42	21	]	]	PUNCT
dpc-4910	42	22	.	.	PUNCT
dpc-4910	43	1	podocalyxin	podocalyxin	NOUN
dpc-4910	43	2	(	(	PUNCT
dpc-4910	43	3	pdx	pdx	PROPN
dpc-4910	43	4	)	)	PUNCT
dpc-4910	43	5	and	and	CCONJ
dpc-4910	43	6	nephrin	nephrin	NOUN
dpc-4910	43	7	are	be	AUX
dpc-4910	43	8	podocyte	podocyte	NOUN
dpc-4910	43	9	proteins	protein	NOUN
dpc-4910	43	10	that	that	PRON
dpc-4910	43	11	ensure	ensure	VERB
dpc-4910	43	12	the	the	DET
dpc-4910	43	13	integrity	integrity	NOUN
dpc-4910	43	14	of	of	ADP
dpc-4910	43	15	the	the	DET
dpc-4910	43	16	renal	renal	ADJ
dpc-4910	43	17	filtration	filtration	NOUN
dpc-4910	43	18	barrier	barrier	NOUN
dpc-4910	43	19	both	both	CCONJ
dpc-4910	43	20	physically	physically	ADV
dpc-4910	43	21	and	and	CCONJ
dpc-4910	43	22	chemically	chemically	ADV
dpc-4910	43	23	.	.	PUNCT
dpc-4910	44	1	while	while	SCONJ
dpc-4910	44	2	nephrin	nephrin	NOUN
dpc-4910	44	3	creates	create	VERB
dpc-4910	44	4	a	a	DET
dpc-4910	44	5	physical	physical	ADJ
dpc-4910	44	6	barrier	barrier	NOUN
dpc-4910	44	7	with	with	ADP
dpc-4910	44	8	its	its	PRON
dpc-4910	44	9	transmembrane	transmembrane	ADJ
dpc-4910	44	10	protein	protein	NOUN
dpc-4910	44	11	feature	feature	VERB
dpc-4910	44	12	specific	specific	ADJ
dpc-4910	44	13	to	to	ADP
dpc-4910	44	14	the	the	DET
dpc-4910	44	15	slit	slit	ADJ
dpc-4910	44	16	diaphragm	diaphragm	NOUN
dpc-4910	44	17	,	,	PUNCT
dpc-4910	44	18	pdx	pdx	PROPN
dpc-4910	44	19	creates	create	VERB
dpc-4910	44	20	a	a	DET
dpc-4910	44	21	chemical	chemical	ADJ
dpc-4910	44	22	barrier	barrier	NOUN
dpc-4910	44	23	with	with	ADP
dpc-4910	44	24	its	its	PRON
dpc-4910	44	25	glycocalyx	glycocalyx	NOUN
dpc-4910	44	26	feature	feature	NOUN
dpc-4910	44	27	[	[	X
dpc-4910	44	28	9,10	9,10	NUM
dpc-4910	44	29	]	]	X
dpc-4910	44	30	.	.	PUNCT
dpc-4910	45	1	denaturation	denaturation	NOUN
dpc-4910	45	2	of	of	ADP
dpc-4910	45	3	these	these	DET
dpc-4910	45	4	proteins	protein	NOUN
dpc-4910	45	5	causes	cause	VERB
dpc-4910	45	6	a	a	DET
dpc-4910	45	7	defect	defect	NOUN
dpc-4910	45	8	in	in	ADP
dpc-4910	45	9	the	the	DET
dpc-4910	45	10	glomerular	glomerular	ADJ
dpc-4910	45	11	endothelial	endothelial	ADJ
dpc-4910	45	12	barrier	barrier	NOUN
dpc-4910	45	13	,	,	PUNCT
dpc-4910	45	14	leading	lead	VERB
dpc-4910	45	15	to	to	ADP
dpc-4910	45	16	podocyte	podocyte	NOUN
dpc-4910	45	17	dysfunction	dysfunction	NOUN
dpc-4910	45	18	,	,	PUNCT
dpc-4910	45	19	glomerulosclerosis	glomerulosclerosis	NOUN
dpc-4910	45	20	,	,	PUNCT
dpc-4910	45	21	and	and	CCONJ
dpc-4910	45	22	subsequent	subsequent	ADJ
dpc-4910	45	23	renal	renal	ADJ
dpc-4910	45	24	failure	failure	NOUN
dpc-4910	45	25	[	[	X
dpc-4910	45	26	10,11	10,11	NOUN
dpc-4910	45	27	]	]	PUNCT
dpc-4910	45	28	.	.	PUNCT
dpc-4910	46	1	in	in	ADP
dpc-4910	46	2	the	the	DET
dpc-4910	46	3	early	early	ADJ
dpc-4910	46	4	diagnosis	diagnosis	NOUN
dpc-4910	46	5	of	of	ADP
dpc-4910	46	6	kidney	kidney	NOUN
dpc-4910	46	7	damage	damage	NOUN
dpc-4910	46	8	due	due	ADP
dpc-4910	46	9	to	to	ADP
dpc-4910	46	10	psoriasis	psoriasis	NOUN
dpc-4910	46	11	,	,	PUNCT
dpc-4910	46	12	it	it	PRON
dpc-4910	46	13	is	be	AUX
dpc-4910	46	14	recommended	recommend	VERB
dpc-4910	46	15	to	to	PART
dpc-4910	46	16	check	check	VERB
dpc-4910	46	17	serum	serum	NOUN
dpc-4910	46	18	creatinine	creatinine	NOUN
dpc-4910	46	19	and	and	CCONJ
dpc-4910	46	20	blood	blood	NOUN
dpc-4910	46	21	urea	urea	NOUN
dpc-4910	46	22	nitrogen	nitrogen	NOUN
dpc-4910	46	23	levelsando	levelsando	NOUN
dpc-4910	46	24	perform	perform	VERB
dpc-4910	46	25	routine	routine	ADJ
dpc-4910	46	26	urine	urine	NOUN
dpc-4910	46	27	analysis	analysis	NOUN
dpc-4910	46	28	for	for	ADP
dpc-4910	46	29	microalbuminuria	microalbuminuria	NOUN
dpc-4910	46	30	.	.	PUNCT
dpc-4910	47	1	although	although	SCONJ
dpc-4910	47	2	predictive	predictive	ADJ
dpc-4910	47	3	tests	test	NOUN
dpc-4910	47	4	have	have	VERB
dpc-4910	47	5	a	a	DET
dpc-4910	47	6	high	high	ADJ
dpc-4910	47	7	rate	rate	NOUN
dpc-4910	47	8	of	of	ADP
dpc-4910	47	9	detecting	detect	VERB
dpc-4910	47	10	renal	renal	ADJ
dpc-4910	47	11	damage	damage	NOUN
dpc-4910	47	12	in	in	ADP
dpc-4910	47	13	severe	severe	ADJ
dpc-4910	47	14	psoriasis	psoriasis	NOUN
dpc-4910	47	15	cases	case	NOUN
dpc-4910	47	16	with	with	ADP
dpc-4910	47	17	a	a	DET
dpc-4910	47	18	body	body	NOUN
dpc-4910	47	19	surface	surface	NOUN
dpc-4910	47	20	area	area	NOUN
dpc-4910	47	21	of	of	ADP
dpc-4910	47	22	≥3	≥3	NOUN
dpc-4910	47	23	%	%	NOUN
dpc-4910	47	24	,	,	PUNCT
dpc-4910	47	25	albumin	albumin	ADJ
dpc-4910	47	26	leakage	leakage	NOUN
dpc-4910	47	27	,	,	PUNCT
dpc-4910	47	28	serum	serum	NOUN
dpc-4910	47	29	creatinine	creatinine	NOUN
dpc-4910	47	30	,	,	PUNCT
dpc-4910	47	31	and	and	CCONJ
dpc-4910	47	32	serum	serum	NOUN
dpc-4910	47	33	nitrogen	nitrogen	NOUN
dpc-4910	47	34	levels	level	NOUN
dpc-4910	47	35	may	may	AUX
dpc-4910	47	36	be	be	AUX
dpc-4910	47	37	normal	normal	ADJ
dpc-4910	47	38	in	in	ADP
dpc-4910	47	39	mild	mild	ADJ
dpc-4910	47	40	and	and	CCONJ
dpc-4910	47	41	moderate	moderate	ADJ
dpc-4910	47	42	psoriasis	psoriasis	NOUN
dpc-4910	47	43	despite	despite	SCONJ
dpc-4910	47	44	the	the	DET
dpc-4910	47	45	presence	presence	NOUN
dpc-4910	47	46	of	of	ADP
dpc-4910	47	47	early	early	ADJ
dpc-4910	47	48	stage	stage	NOUN
dpc-4910	47	49	glomerular	glomerular	ADJ
dpc-4910	47	50	damage	damage	NOUN
dpc-4910	47	51	[	[	X
dpc-4910	47	52	6,12	6,12	NUM
dpc-4910	47	53	]	]	PUNCT
dpc-4910	47	54	.	.	PUNCT
dpc-4910	48	1	since	since	SCONJ
dpc-4910	48	2	albumin	albumin	ADJ
dpc-4910	48	3	passage	passage	NOUN
dpc-4910	48	4	into	into	ADP
dpc-4910	48	5	the	the	DET
dpc-4910	48	6	urine	urine	NOUN
dpc-4910	48	7	occurs	occur	VERB
dpc-4910	48	8	following	follow	VERB
dpc-4910	48	9	podocyte	podocyte	NOUN
dpc-4910	48	10	damage	damage	NOUN
dpc-4910	48	11	,	,	PUNCT
dpc-4910	48	12	podocytespecific	podocytespecific	NOUN
dpc-4910	48	13	proteins	protein	NOUN
dpc-4910	48	14	pdx	pdx	PROPN
dpc-4910	48	15	and	and	CCONJ
dpc-4910	48	16	nephrin	nephrin	PROPN
dpc-4910	48	17	can	can	AUX
dpc-4910	48	18	be	be	AUX
dpc-4910	48	19	detected	detect	VERB
dpc-4910	48	20	in	in	ADP
dpc-4910	48	21	mild	mild	ADJ
dpc-4910	48	22	or	or	CCONJ
dpc-4910	48	23	moderate	moderate	ADJ
dpc-4910	48	24	psoriasis	psoriasis	NOUN
dpc-4910	48	25	cases	case	NOUN
dpc-4910	48	26	,	,	PUNCT
dpc-4910	48	27	where	where	SCONJ
dpc-4910	48	28	no	no	DET
dpc-4910	48	29	protein	protein	NOUN
dpc-4910	48	30	is	be	AUX
dpc-4910	48	31	detected	detect	VERB
dpc-4910	48	32	in	in	ADP
dpc-4910	48	33	urine	urine	NOUN
dpc-4910	48	34	spot	spot	NOUN
dpc-4910	48	35	samples	sample	NOUN
dpc-4910	48	36	.	.	PUNCT
dpc-4910	49	1	objectives	objective	NOUN
dpc-4910	49	2	in	in	ADP
dpc-4910	49	3	systemic	systemic	ADJ
dpc-4910	49	4	diseases	disease	NOUN
dpc-4910	49	5	accompanied	accompany	VERB
dpc-4910	49	6	by	by	ADP
dpc-4910	49	7	glomerular	glomerular	ADJ
dpc-4910	49	8	damage	damage	NOUN
dpc-4910	49	9	,	,	PUNCT
dpc-4910	49	10	such	such	ADJ
dpc-4910	49	11	as	as	ADP
dpc-4910	49	12	psoriasis	psoriasis	NOUN
dpc-4910	49	13	,	,	PUNCT
dpc-4910	49	14	chronic	chronic	ADJ
dpc-4910	49	15	inflammation	inflammation	NOUN
dpc-4910	49	16	,	,	PUNCT
dpc-4910	49	17	and	and	CCONJ
dpc-4910	49	18	oxidative	oxidative	ADJ
dpc-4910	49	19	stress	stress	NOUN
dpc-4910	49	20	,	,	PUNCT
dpc-4910	49	21	inflammatory	inflammatory	ADJ
dpc-4910	49	22	damage	damage	NOUN
dpc-4910	49	23	,	,	PUNCT
dpc-4910	49	24	adhesion	adhesion	NOUN
dpc-4910	49	25	,	,	PUNCT
dpc-4910	49	26	and	and	CCONJ
dpc-4910	49	27	scarring	scar	VERB
dpc-4910	49	28	in	in	ADP
dpc-4910	49	29	the	the	DET
dpc-4910	49	30	glomeruli	glomeruli	NOUN
dpc-4910	49	31	can	can	AUX
dpc-4910	49	32	cause	cause	VERB
dpc-4910	49	33	disruption	disruption	NOUN
dpc-4910	49	34	of	of	ADP
dpc-4910	49	35	the	the	DET
dpc-4910	49	36	podocyte	podocyte	NOUN
dpc-4910	49	37	barrier	barrier	NOUN
dpc-4910	49	38	and	and	CCONJ
dpc-4910	49	39	leakage	leakage	NOUN
dpc-4910	49	40	of	of	ADP
dpc-4910	49	41	podocyte	podocyte	NOUN
dpc-4910	49	42	degradation	degradation	NOUN
dpc-4910	49	43	products	product	NOUN
dpc-4910	49	44	into	into	ADP
dpc-4910	49	45	the	the	DET
dpc-4910	49	46	urine	urine	NOUN
dpc-4910	49	47	before	before	ADP
dpc-4910	49	48	protein	protein	NOUN
dpc-4910	49	49	leakage	leakage	NOUN
dpc-4910	49	50	[	[	X
dpc-4910	49	51	7	7	NUM
dpc-4910	49	52	]	]	PUNCT
dpc-4910	49	53	.	.	PUNCT
dpc-4910	50	1	however	however	ADV
dpc-4910	50	2	,	,	PUNCT
dpc-4910	50	3	except	except	SCONJ
dpc-4910	50	4	for	for	ADP
dpc-4910	50	5	a	a	DET
dpc-4910	50	6	few	few	ADJ
dpc-4910	50	7	experimental	experimental	ADJ
dpc-4910	50	8	studies	study	NOUN
dpc-4910	50	9	,	,	PUNCT
dpc-4910	50	10	data	datum	NOUN
dpc-4910	50	11	on	on	ADP
dpc-4910	50	12	the	the	DET
dpc-4910	50	13	role	role	NOUN
dpc-4910	50	14	of	of	ADP
dpc-4910	50	15	urine	urine	NOUN
dpc-4910	50	16	podocyte	podocyte	NOUN
dpc-4910	50	17	-	-	PUNCT
dpc-4910	50	18	specific	specific	ADJ
dpc-4910	50	19	protein	protein	NOUN
dpc-4910	50	20	analysis	analysis	NOUN
dpc-4910	50	21	in	in	ADP
dpc-4910	50	22	the	the	DET
dpc-4910	50	23	early	early	ADJ
dpc-4910	50	24	diagnosis	diagnosis	NOUN
dpc-4910	50	25	of	of	ADP
dpc-4910	50	26	renal	renal	ADJ
dpc-4910	50	27	involvement	involvement	NOUN
dpc-4910	50	28	in	in	ADP
dpc-4910	50	29	psoriasis	psoriasis	NOUN
dpc-4910	50	30	are	be	AUX
dpc-4910	50	31	limited	limit	VERB
dpc-4910	50	32	.	.	PUNCT
dpc-4910	51	1	in	in	ADP
dpc-4910	51	2	this	this	DET
dpc-4910	51	3	study	study	NOUN
dpc-4910	51	4	,	,	PUNCT
dpc-4910	51	5	we	we	PRON
dpc-4910	51	6	analyzed	analyze	VERB
dpc-4910	51	7	the	the	DET
dpc-4910	51	8	levels	level	NOUN
dpc-4910	51	9	of	of	ADP
dpc-4910	51	10	the	the	DET
dpc-4910	51	11	podocyte	podocyte	NOUN
dpc-4910	51	12	surface	surface	NOUN
dpc-4910	51	13	glycoprotein	glycoprotein	NOUN
dpc-4910	51	14	podocalyxin	podocalyxin	NOUN
dpc-4910	51	15	and	and	CCONJ
dpc-4910	51	16	podocyte	podocyte	NOUN
dpc-4910	51	17	slit	slit	ADJ
dpc-4910	51	18	protein	protein	NOUN
dpc-4910	51	19	nephrin	nephrin	NOUN
dpc-4910	51	20	in	in	ADP
dpc-4910	51	21	spot	spot	NOUN
dpc-4910	51	22	urine	urine	NOUN
dpc-4910	51	23	samples	sample	NOUN
dpc-4910	51	24	of	of	ADP
dpc-4910	51	25	patients	patient	NOUN
dpc-4910	51	26	diagnosed	diagnose	VERB
dpc-4910	51	27	with	with	ADP
dpc-4910	51	28	mild	mild	ADJ
dpc-4910	51	29	,	,	PUNCT
dpc-4910	51	30	moderate	moderate	ADJ
dpc-4910	51	31	,	,	PUNCT
dpc-4910	51	32	or	or	CCONJ
dpc-4910	51	33	severe	severe	ADJ
dpc-4910	51	34	psoriasis	psoriasis	NOUN
dpc-4910	51	35	vulgaris	vulgaris	NOUN
dpc-4910	51	36	to	to	PART
dpc-4910	51	37	reveal	reveal	VERB
dpc-4910	51	38	the	the	DET
dpc-4910	51	39	relationship	relationship	NOUN
dpc-4910	51	40	between	between	ADP
dpc-4910	51	41	disease	disease	NOUN
dpc-4910	51	42	severity	severity	NOUN
dpc-4910	51	43	and	and	CCONJ
dpc-4910	51	44	podocyte	podocyte	NOUN
dpc-4910	51	45	damage	damage	NOUN
dpc-4910	51	46	.	.	PUNCT
dpc-4910	52	1	methods	method	NOUN
dpc-4910	52	2	this	this	DET
dpc-4910	52	3	cross	cross	ADJ
dpc-4910	52	4	-	-	ADJ
dpc-4910	52	5	sectional	sectional	ADJ
dpc-4910	52	6	study	study	NOUN
dpc-4910	52	7	was	be	AUX
dpc-4910	52	8	approved	approve	VERB
dpc-4910	52	9	by	by	ADP
dpc-4910	52	10	the	the	DET
dpc-4910	52	11	ethics	ethic	NOUN
dpc-4910	52	12	committee	committee	PROPN
dpc-4910	52	13	of	of	ADP
dpc-4910	52	14	the	the	DET
dpc-4910	52	15	firat	firat	PROPN
dpc-4910	52	16	university	university	PROPN
dpc-4910	52	17	non	non	ADJ
dpc-4910	52	18	-	-	ADJ
dpc-4910	52	19	interventional	interventional	ADJ
dpc-4910	52	20	research	research	NOUN
dpc-4910	52	21	(	(	PUNCT
dpc-4910	52	22	ethical	ethical	ADJ
dpc-4910	52	23	approval	approval	NOUN
dpc-4910	52	24	number	number	NOUN
dpc-4910	52	25	:	:	PUNCT
dpc-4910	52	26	2024/01	2024/01	NUM
dpc-4910	52	27	-	-	SYM
dpc-4910	52	28	35	35	NUM
dpc-4910	52	29	,	,	PUNCT
dpc-4910	52	30	date	date	NOUN
dpc-4910	52	31	:	:	PUNCT
dpc-4910	52	32	09.01.2024	09.01.2024	NUM
dpc-4910	52	33	)	)	PUNCT
dpc-4910	52	34	.	.	PUNCT
dpc-4910	53	1	a	a	DET
dpc-4910	53	2	total	total	NOUN
dpc-4910	53	3	of	of	ADP
dpc-4910	53	4	78	78	NUM
dpc-4910	53	5	participants	participant	NOUN
dpc-4910	53	6	,	,	PUNCT
dpc-4910	53	7	58	58	NUM
dpc-4910	53	8	with	with	ADP
dpc-4910	53	9	psoriasis	psoriasis	NOUN
dpc-4910	53	10	vulgaris	vulgaris	NOUN
dpc-4910	53	11	at	at	ADP
dpc-4910	53	12	different	different	ADJ
dpc-4910	53	13	stages	stage	NOUN
dpc-4910	53	14	of	of	ADP
dpc-4910	53	15	severity	severity	NOUN
dpc-4910	53	16	(	(	PUNCT
dpc-4910	53	17	mild	mild	ADJ
dpc-4910	53	18	,	,	PUNCT
dpc-4910	53	19	moderate	moderate	ADJ
dpc-4910	53	20	,	,	PUNCT
dpc-4910	53	21	or	or	CCONJ
dpc-4910	53	22	severe	severe	ADJ
dpc-4910	53	23	psoriasis	psoriasis	NOUN
dpc-4910	53	24	vulgaris	vulgaris	NOUN
dpc-4910	53	25	)	)	PUNCT
dpc-4910	53	26	and	and	CCONJ
dpc-4910	53	27	20	20	NUM
dpc-4910	53	28	controls	control	NOUN
dpc-4910	53	29	were	be	AUX
dpc-4910	53	30	included	include	VERB
dpc-4910	53	31	in	in	ADP
dpc-4910	53	32	the	the	DET
dpc-4910	53	33	study	study	NOUN
dpc-4910	53	34	.	.	PUNCT
dpc-4910	54	1	twenty	twenty	NUM
dpc-4910	54	2	patients	patient	NOUN
dpc-4910	54	3	who	who	PRON
dpc-4910	54	4	did	do	AUX
dpc-4910	54	5	not	not	PART
dpc-4910	54	6	have	have	VERB
dpc-4910	54	7	chronic	chronic	ADJ
dpc-4910	54	8	,	,	PUNCT
dpc-4910	54	9	inflammatory	inflammatory	ADJ
dpc-4910	54	10	,	,	PUNCT
dpc-4910	54	11	or	or	CCONJ
dpc-4910	54	12	systemic	systemic	ADJ
dpc-4910	54	13	dermatosis	dermatosis	NOUN
dpc-4910	54	14	and	and	CCONJ
dpc-4910	54	15	who	who	PRON
dpc-4910	54	16	were	be	AUX
dpc-4910	54	17	matched	match	VERB
dpc-4910	54	18	with	with	ADP
dpc-4910	54	19	the	the	DET
dpc-4910	54	20	psoriasis	psoriasis	NOUN
dpc-4910	54	21	group	group	NOUN
dpc-4910	54	22	in	in	ADP
dpc-4910	54	23	terms	term	NOUN
dpc-4910	54	24	of	of	ADP
dpc-4910	54	25	age	age	NOUN
dpc-4910	54	26	and	and	CCONJ
dpc-4910	54	27	bmi	bmi	NOUN
dpc-4910	54	28	were	be	AUX
dpc-4910	54	29	included	include	VERB
dpc-4910	54	30	in	in	ADP
dpc-4910	54	31	the	the	DET
dpc-4910	54	32	control	control	NOUN
dpc-4910	54	33	group	group	NOUN
dpc-4910	54	34	.	.	PUNCT
dpc-4910	55	1	participants	participant	NOUN
dpc-4910	55	2	were	be	AUX
dpc-4910	55	3	selected	select	VERB
dpc-4910	55	4	from	from	ADP
dpc-4910	55	5	patients	patient	NOUN
dpc-4910	55	6	admitted	admit	VERB
dpc-4910	55	7	to	to	ADP
dpc-4910	55	8	the	the	DET
dpc-4910	55	9	gozde	gozde	PROPN
dpc-4910	55	10	academy	academy	PROPN
dpc-4910	55	11	hospital	hospital	PROPN
dpc-4910	55	12	dermatology	dermatology	NOUN
dpc-4910	55	13	clinic	clinic	NOUN
dpc-4910	55	14	.	.	PUNCT
dpc-4910	56	1	some	some	DET
dpc-4910	56	2	patients	patient	NOUN
dpc-4910	56	3	were	be	AUX
dpc-4910	56	4	previously	previously	ADV
dpc-4910	56	5	diagnosed	diagnose	VERB
dpc-4910	56	6	with	with	ADP
dpc-4910	56	7	psoriasis	psoriasis	NOUN
dpc-4910	56	8	,	,	PUNCT
dpc-4910	56	9	whereas	whereas	SCONJ
dpc-4910	56	10	others	other	NOUN
dpc-4910	56	11	were	be	AUX
dpc-4910	56	12	newly	newly	ADV
dpc-4910	56	13	diagnosed	diagnose	VERB
dpc-4910	56	14	with	with	ADP
dpc-4910	56	15	the	the	DET
dpc-4910	56	16	disease	disease	NOUN
dpc-4910	56	17	.	.	PUNCT
dpc-4910	57	1	considering	consider	VERB
dpc-4910	57	2	the	the	DET
dpc-4910	57	3	prevalence	prevalence	NOUN
dpc-4910	57	4	of	of	ADP
dpc-4910	57	5	the	the	DET
dpc-4910	57	6	disease	disease	NOUN
dpc-4910	57	7	,	,	PUNCT
dpc-4910	57	8	the	the	DET
dpc-4910	57	9	number	number	NOUN
dpc-4910	57	10	of	of	ADP
dpc-4910	57	11	psoriasis	psoriasis	NOUN
dpc-4910	57	12	patients	patient	NOUN
dpc-4910	57	13	who	who	PRON
dpc-4910	57	14	attending	attend	VERB
dpc-4910	57	15	our	our	PRON
dpc-4910	57	16	outpatient	outpatient	NOUN
dpc-4910	57	17	clinic	clinic	NOUN
dpc-4910	57	18	was	be	AUX
dpc-4910	57	19	not	not	PART
dpc-4910	57	20	very	very	ADV
dpc-4910	57	21	high	high	ADJ
dpc-4910	57	22	,	,	PUNCT
dpc-4910	57	23	so	so	ADV
dpc-4910	57	24	we	we	PRON
dpc-4910	57	25	invited	invite	VERB
dpc-4910	57	26	patients	patient	NOUN
dpc-4910	57	27	diagnosed	diagnose	VERB
dpc-4910	57	28	with	with	ADP
dpc-4910	57	29	psoriasis	psoriasis	NOUN
dpc-4910	57	30	from	from	ADP
dpc-4910	57	31	other	other	ADJ
dpc-4910	57	32	centers	center	NOUN
dpc-4910	57	33	to	to	PART
dpc-4910	57	34	participate	participate	VERB
dpc-4910	57	35	in	in	ADP
dpc-4910	57	36	the	the	DET
dpc-4910	57	37	study	study	NOUN
dpc-4910	57	38	.	.	PUNCT
dpc-4910	58	1	psoriasis	psoriasis	NOUN
dpc-4910	58	2	was	be	AUX
dpc-4910	58	3	diagnosed	diagnose	VERB
dpc-4910	58	4	based	base	VERB
dpc-4910	58	5	on	on	ADP
dpc-4910	58	6	the	the	DET
dpc-4910	58	7	typical	typical	ADJ
dpc-4910	58	8	morphological	morphological	ADJ
dpc-4910	58	9	appearance	appearance	NOUN
dpc-4910	58	10	of	of	ADP
dpc-4910	58	11	the	the	DET
dpc-4910	58	12	lesions	lesion	NOUN
dpc-4910	58	13	.	.	PUNCT
dpc-4910	59	1	the	the	DET
dpc-4910	59	2	diagnosis	diagnosis	NOUN
dpc-4910	59	3	was	be	AUX
dpc-4910	59	4	confirmed	confirm	VERB
dpc-4910	59	5	based	base	VERB
dpc-4910	59	6	on	on	ADP
dpc-4910	59	7	the	the	DET
dpc-4910	59	8	presence	presence	NOUN
dpc-4910	59	9	of	of	ADP
dpc-4910	59	10	a	a	DET
dpc-4910	59	11	symmetrical	symmetrical	ADJ
dpc-4910	59	12	,	,	PUNCT
dpc-4910	59	13	sharply	sharply	ADV
dpc-4910	59	14	demarcated	demarcate	VERB
dpc-4910	59	15	erythematous	erythematous	ADJ
dpc-4910	59	16	plaque	plaque	NOUN
dpc-4910	59	17	covered	cover	VERB
dpc-4910	59	18	with	with	ADP
dpc-4910	59	19	silver	silver	NOUN
dpc-4910	59	20	scales	scale	NOUN
dpc-4910	59	21	.	.	PUNCT
dpc-4910	60	1	although	although	SCONJ
dpc-4910	60	2	psoriasis	psoriasis	NOUN
dpc-4910	60	3	is	be	AUX
dpc-4910	60	4	histopathologically	histopathologically	ADV
dpc-4910	60	5	characterized	characterize	VERB
dpc-4910	60	6	by	by	ADP
dpc-4910	60	7	epidermal	epidermal	ADJ
dpc-4910	60	8	acanthosis	acanthosis	NOUN
dpc-4910	60	9	,	,	PUNCT
dpc-4910	60	10	hyperkeratosis	hyperkeratosis	NOUN
dpc-4910	60	11	,	,	PUNCT
dpc-4910	60	12	and	and	CCONJ
dpc-4910	60	13	parakeratosis	parakeratosis	NOUN
dpc-4910	60	14	,	,	PUNCT
dpc-4910	60	15	a	a	DET
dpc-4910	60	16	biopsy	biopsy	NOUN
dpc-4910	60	17	is	be	AUX
dpc-4910	60	18	not	not	PART
dpc-4910	60	19	required	require	VERB
dpc-4910	60	20	for	for	ADP
dpc-4910	60	21	diagnosis	diagnosis	NOUN
dpc-4910	60	22	in	in	ADP
dpc-4910	60	23	any	any	DET
dpc-4910	60	24	patient	patient	NOUN
dpc-4910	60	25	[	[	X
dpc-4910	60	26	13	13	NUM
dpc-4910	60	27	]	]	PUNCT
dpc-4910	60	28	.	.	PUNCT
dpc-4910	61	1	the	the	DET
dpc-4910	61	2	distribution	distribution	NOUN
dpc-4910	61	3	of	of	ADP
dpc-4910	61	4	plaques	plaque	NOUN
dpc-4910	61	5	differed	differ	VERB
dpc-4910	61	6	among	among	ADP
dpc-4910	61	7	the	the	DET
dpc-4910	61	8	patients	patient	NOUN
dpc-4910	61	9	.	.	PUNCT
dpc-4910	62	1	in	in	ADP
dpc-4910	62	2	addition	addition	NOUN
dpc-4910	62	3	to	to	ADP
dpc-4910	62	4	isolated	isolated	ADJ
dpc-4910	62	5	plaques	plaque	NOUN
dpc-4910	62	6	,	,	PUNCT
dpc-4910	62	7	the	the	DET
dpc-4910	62	8	plaques	plaque	NOUN
dpc-4910	62	9	merged	merge	VERB
dpc-4910	62	10	and	and	CCONJ
dpc-4910	62	11	occupied	occupy	VERB
dpc-4910	62	12	large	large	ADJ
dpc-4910	62	13	skin	skin	NOUN
dpc-4910	62	14	areas	area	NOUN
dpc-4910	62	15	.	.	PUNCT
dpc-4910	63	1	plaques	plaque	NOUN
dpc-4910	63	2	were	be	AUX
dpc-4910	63	3	more	more	ADV
dpc-4910	63	4	frequently	frequently	ADV
dpc-4910	63	5	located	locate	VERB
dpc-4910	63	6	on	on	ADP
dpc-4910	63	7	the	the	DET
dpc-4910	63	8	trunk	trunk	NOUN
dpc-4910	63	9	,	,	PUNCT
dpc-4910	63	10	scalp	scalp	NOUN
dpc-4910	63	11	,	,	PUNCT
dpc-4910	63	12	lower	low	ADJ
dpc-4910	63	13	and	and	CCONJ
dpc-4910	63	14	upper	upper	ADJ
dpc-4910	63	15	extremities	extremity	NOUN
dpc-4910	63	16	,	,	PUNCT
dpc-4910	63	17	and	and	CCONJ
dpc-4910	63	18	the	the	DET
dpc-4910	63	19	buttocks	buttock	NOUN
dpc-4910	63	20	.	.	PUNCT
dpc-4910	64	1	disease	disease	NOUN
dpc-4910	64	2	severity	severity	NOUN
dpc-4910	64	3	was	be	AUX
dpc-4910	64	4	determined	determine	VERB
dpc-4910	64	5	using	use	VERB
dpc-4910	64	6	data	datum	NOUN
dpc-4910	64	7	from	from	ADP
dpc-4910	64	8	the	the	DET
dpc-4910	64	9	canadian	canadian	ADJ
dpc-4910	64	10	psoriasis	psoriasis	NOUN
dpc-4910	64	11	guideline	guideline	NOUN
dpc-4910	64	12	committee	committee	NOUN
dpc-4910	65	1	[	[	X
dpc-4910	65	2	14	14	NUM
dpc-4910	65	3	]	]	PUNCT
dpc-4910	65	4	.	.	PUNCT
dpc-4910	66	1	patients	patient	NOUN
dpc-4910	66	2	with	with	ADP
dpc-4910	66	3	<3	<3	NOUN
dpc-4910	66	4	%	%	NOUN
dpc-4910	66	5	body	body	NOUN
dpc-4910	66	6	surface	surface	NOUN
dpc-4910	66	7	area	area	NOUN
dpc-4910	66	8	(	(	PUNCT
dpc-4910	66	9	bsa	bsa	PROPN
dpc-4910	66	10	)	)	PUNCT
dpc-4910	66	11	involvement	involvement	NOUN
dpc-4910	66	12	,	,	PUNCT
dpc-4910	66	13	whose	whose	DET
dpc-4910	66	14	quality	quality	NOUN
dpc-4910	66	15	of	of	ADP
dpc-4910	66	16	life	life	NOUN
dpc-4910	66	17	was	be	AUX
dpc-4910	66	18	minimallyaffected	minimallyaffecte	VERB
dpc-4910	66	19	,	,	PUNCT
dpc-4910	66	20	d	d	PROPN
dpc-4910	66	21	and	and	CCONJ
dpc-4910	66	22	whose	whose	DET
dpc-4910	66	23	lesions	lesion	NOUN
dpc-4910	66	24	were	be	AUX
dpc-4910	66	25	controlled	control	VERB
dpc-4910	66	26	with	with	ADP
dpc-4910	66	27	topical	topical	ADJ
dpc-4910	66	28	treatment	treatment	NOUN
dpc-4910	66	29	were	be	AUX
dpc-4910	66	30	included	include	VERB
dpc-4910	66	31	in	in	ADP
dpc-4910	66	32	the	the	DET
dpc-4910	66	33	mild	mild	ADJ
dpc-4910	66	34	disease	disease	NOUN
dpc-4910	66	35	group	group	NOUN
dpc-4910	66	36	.	.	PUNCT
dpc-4910	67	1	patients	patient	NOUN
dpc-4910	67	2	with	with	ADP
dpc-4910	67	3	3–10	3–10	PROPN
dpc-4910	67	4	%	%	NOUN
dpc-4910	67	5	bsa	bsa	PROPN
dpc-4910	67	6	original	original	ADJ
dpc-4910	67	7	article	article	NOUN
dpc-4910	67	8	|	|	ADV
dpc-4910	67	9	dermatol	dermatol	ADJ
dpc-4910	67	10	pract	pract	NOUN
dpc-4910	67	11	concept	concept	NOUN
dpc-4910	67	12	.	.	PUNCT
dpc-4910	68	1	2025;15(2):4910	2025;15(2):4910	NUM
dpc-4910	68	2	3	3	NUM
dpc-4910	68	3	involvement	involvement	NOUN
dpc-4910	68	4	that	that	PRON
dpc-4910	68	5	was	be	AUX
dpc-4910	68	6	difficult	difficult	ADJ
dpc-4910	68	7	to	to	PART
dpc-4910	68	8	control	control	VERB
dpc-4910	68	9	with	with	ADP
dpc-4910	68	10	routine	routine	ADJ
dpc-4910	68	11	topical	topical	ADJ
dpc-4910	68	12	use	use	NOUN
dpc-4910	68	13	and	and	CCONJ
dpc-4910	68	14	whose	whose	DET
dpc-4910	68	15	quality	quality	NOUN
dpc-4910	68	16	of	of	ADP
dpc-4910	68	17	life	life	NOUN
dpc-4910	68	18	was	be	AUX
dpc-4910	68	19	significantly	significantly	ADV
dpc-4910	68	20	affected	affect	VERB
dpc-4910	68	21	were	be	AUX
dpc-4910	68	22	considered	consider	VERB
dpc-4910	68	23	to	to	PART
dpc-4910	68	24	have	have	VERB
dpc-4910	68	25	moderate	moderate	ADJ
dpc-4910	68	26	disease	disease	NOUN
dpc-4910	68	27	.	.	PUNCT
dpc-4910	69	1	patients	patient	NOUN
dpc-4910	69	2	who	who	PRON
dpc-4910	69	3	did	do	AUX
dpc-4910	69	4	not	not	PART
dpc-4910	69	5	benefit	benefit	VERB
dpc-4910	69	6	from	from	ADP
dpc-4910	69	7	topical	topical	ADJ
dpc-4910	69	8	treatments	treatment	NOUN
dpc-4910	69	9	,	,	PUNCT
dpc-4910	69	10	had	have	VERB
dpc-4910	69	11	>	>	SYM
dpc-4910	69	12	10	10	NUM
dpc-4910	69	13	%	%	NOUN
dpc-4910	69	14	bsa	bsa	NOUN
dpc-4910	69	15	covered	cover	VERB
dpc-4910	69	16	with	with	ADP
dpc-4910	69	17	plaques	plaque	NOUN
dpc-4910	69	18	,	,	PUNCT
dpc-4910	69	19	and	and	CCONJ
dpc-4910	69	20	showed	show	VERB
dpc-4910	69	21	severe	severe	ADJ
dpc-4910	69	22	deterioration	deterioration	NOUN
dpc-4910	69	23	in	in	ADP
dpc-4910	69	24	quality	quality	NOUN
dpc-4910	69	25	of	of	ADP
dpc-4910	69	26	life	life	NOUN
dpc-4910	69	27	were	be	AUX
dpc-4910	69	28	considered	consider	VERB
dpc-4910	69	29	to	to	PART
dpc-4910	69	30	have	have	VERB
dpc-4910	69	31	severe	severe	ADJ
dpc-4910	69	32	disease	disease	NOUN
dpc-4910	69	33	.	.	PUNCT
dpc-4910	70	1	patients	patient	NOUN
dpc-4910	70	2	with	with	ADP
dpc-4910	70	3	a	a	DET
dpc-4910	70	4	history	history	NOUN
dpc-4910	70	5	of	of	ADP
dpc-4910	70	6	urinary	urinary	ADJ
dpc-4910	70	7	tract	tract	NOUN
dpc-4910	70	8	infection	infection	NOUN
dpc-4910	70	9	,	,	PUNCT
dpc-4910	70	10	metabolic	metabolic	NOUN
dpc-4910	70	11	syndrome	syndrome	NOUN
dpc-4910	70	12	,	,	PUNCT
dpc-4910	70	13	nephritic	nephritic	ADJ
dpc-4910	70	14	or	or	CCONJ
dpc-4910	70	15	nephrotic	nephrotic	ADJ
dpc-4910	70	16	syndrome	syndrome	NOUN
dpc-4910	70	17	,	,	PUNCT
dpc-4910	70	18	or	or	CCONJ
dpc-4910	70	19	diabetes	diabetes	NOUN
dpc-4910	70	20	were	be	AUX
dpc-4910	70	21	excluded	exclude	VERB
dpc-4910	70	22	from	from	ADP
dpc-4910	70	23	the	the	DET
dpc-4910	70	24	study	study	NOUN
dpc-4910	70	25	.	.	PUNCT
dpc-4910	71	1	patients	patient	NOUN
dpc-4910	71	2	who	who	PRON
dpc-4910	71	3	had	have	AUX
dpc-4910	71	4	used	use	VERB
dpc-4910	71	5	nephrotoxic	nephrotoxic	ADJ
dpc-4910	71	6	drugs	drug	NOUN
dpc-4910	71	7	in	in	ADP
dpc-4910	71	8	the	the	DET
dpc-4910	71	9	preceding	precede	VERB
dpc-4910	71	10	six	six	NUM
dpc-4910	71	11	months	month	NOUN
dpc-4910	71	12	,	,	PUNCT
dpc-4910	71	13	had	have	VERB
dpc-4910	71	14	diabetic	diabetic	ADJ
dpc-4910	71	15	nephropathy	nephropathy	NOUN
dpc-4910	71	16	,	,	PUNCT
dpc-4910	71	17	were	be	AUX
dpc-4910	71	18	diagnosed	diagnose	VERB
dpc-4910	71	19	with	with	ADP
dpc-4910	71	20	chronic	chronic	ADJ
dpc-4910	71	21	kidney	kidney	NOUN
dpc-4910	71	22	disease	disease	NOUN
dpc-4910	71	23	,	,	PUNCT
dpc-4910	71	24	underwent	underwent	ADJ
dpc-4910	71	25	hemodialysis	hemodialysis	NOUN
dpc-4910	71	26	,	,	PUNCT
dpc-4910	71	27	or	or	CCONJ
dpc-4910	71	28	had	have	VERB
dpc-4910	71	29	a	a	DET
dpc-4910	71	30	history	history	NOUN
dpc-4910	71	31	of	of	ADP
dpc-4910	71	32	single	single	ADJ
dpc-4910	71	33	or	or	CCONJ
dpc-4910	71	34	combined	combine	VERB
dpc-4910	71	35	use	use	NOUN
dpc-4910	71	36	of	of	ADP
dpc-4910	71	37	azathioprine	azathioprine	NOUN
dpc-4910	71	38	,	,	PUNCT
dpc-4910	71	39	cyclosporine	cyclosporine	NOUN
dpc-4910	71	40	,	,	PUNCT
dpc-4910	71	41	or	or	CCONJ
dpc-4910	71	42	methotrexate	methotrexate	NOUN
dpc-4910	71	43	were	be	AUX
dpc-4910	71	44	not	not	PART
dpc-4910	71	45	included	include	VERB
dpc-4910	71	46	in	in	ADP
dpc-4910	71	47	the	the	DET
dpc-4910	71	48	study	study	NOUN
dpc-4910	71	49	.	.	PUNCT
dpc-4910	72	1	urine	urine	NOUN
dpc-4910	72	2	samples	sample	NOUN
dpc-4910	72	3	were	be	AUX
dpc-4910	72	4	not	not	PART
dpc-4910	72	5	collected	collect	VERB
dpc-4910	72	6	from	from	ADP
dpc-4910	72	7	patients	patient	NOUN
dpc-4910	72	8	with	with	ADP
dpc-4910	72	9	psoriasis	psoriasis	NOUN
dpc-4910	72	10	flares	flare	NOUN
dpc-4910	72	11	upon	upon	SCONJ
dpc-4910	72	12	admission	admission	NOUN
dpc-4910	72	13	.	.	PUNCT
dpc-4910	73	1	the	the	DET
dpc-4910	73	2	exclusion	exclusion	NOUN
dpc-4910	73	3	criteria	criterion	NOUN
dpc-4910	73	4	were	be	AUX
dpc-4910	73	5	also	also	ADV
dpc-4910	73	6	applied	apply	VERB
dpc-4910	73	7	to	to	ADP
dpc-4910	73	8	the	the	DET
dpc-4910	73	9	control	control	NOUN
dpc-4910	73	10	group	group	NOUN
dpc-4910	73	11	.	.	PUNCT
dpc-4910	74	1	measurements	measurement	NOUN
dpc-4910	74	2	of	of	ADP
dpc-4910	74	3	urine	urine	NOUN
dpc-4910	74	4	podocalyxin	podocalyxin	NOUN
dpc-4910	74	5	,	,	PUNCT
dpc-4910	74	6	nephrin	nephrin	NOUN
dpc-4910	74	7	,	,	PUNCT
dpc-4910	74	8	and	and	CCONJ
dpc-4910	74	9	albumin	albumin	ADJ
dpc-4910	74	10	-	-	PUNCT
dpc-4910	74	11	creatinine	creatinine	NOUN
dpc-4910	74	12	ratio	ratio	NOUN
dpc-4910	74	13	morning	morning	NOUN
dpc-4910	74	14	urine	urine	NOUN
dpc-4910	74	15	samples	sample	NOUN
dpc-4910	74	16	were	be	AUX
dpc-4910	74	17	used	use	VERB
dpc-4910	74	18	to	to	PART
dpc-4910	74	19	evaluate	evaluate	VERB
dpc-4910	74	20	the	the	DET
dpc-4910	74	21	urine	urine	NOUN
dpc-4910	74	22	pdx	pdx	PROPN
dpc-4910	74	23	and	and	CCONJ
dpc-4910	74	24	nephrin	nephrin	PROPN
dpc-4910	74	25	levels	level	NOUN
dpc-4910	74	26	.	.	PUNCT
dpc-4910	75	1	strenuous	strenuous	ADJ
dpc-4910	75	2	exercise	exercise	NOUN
dpc-4910	75	3	was	be	AUX
dpc-4910	75	4	prohibited	prohibit	VERB
dpc-4910	75	5	two	two	NUM
dpc-4910	75	6	days	day	NOUN
dpc-4910	75	7	before	before	ADP
dpc-4910	75	8	sample	sample	NOUN
dpc-4910	75	9	collection	collection	NOUN
dpc-4910	75	10	because	because	SCONJ
dpc-4910	75	11	of	of	ADP
dpc-4910	75	12	the	the	DET
dpc-4910	75	13	possibility	possibility	NOUN
dpc-4910	75	14	of	of	ADP
dpc-4910	75	15	increasing	increase	VERB
dpc-4910	75	16	the	the	DET
dpc-4910	75	17	risk	risk	NOUN
dpc-4910	75	18	of	of	ADP
dpc-4910	75	19	protein	protein	NOUN
dpc-4910	75	20	leakage	leakage	NOUN
dpc-4910	75	21	from	from	ADP
dpc-4910	75	22	urine	urine	NOUN
dpc-4910	75	23	.	.	PUNCT
dpc-4910	76	1	fresh	fresh	ADJ
dpc-4910	76	2	urine	urine	NOUN
dpc-4910	76	3	samples	sample	NOUN
dpc-4910	76	4	were	be	AUX
dpc-4910	76	5	collected	collect	VERB
dpc-4910	76	6	in	in	ADP
dpc-4910	76	7	sterile	sterile	ADJ
dpc-4910	76	8	containers	container	NOUN
dpc-4910	76	9	,	,	PUNCT
dpc-4910	76	10	centrifuged	centrifuge	VERB
dpc-4910	76	11	at	at	ADP
dpc-4910	76	12	3000	3000	NUM
dpc-4910	76	13	rpm	rpm	NOUN
dpc-4910	76	14	for	for	ADP
dpc-4910	76	15	3	3	NUM
dpc-4910	76	16	min	min	NOUN
dpc-4910	76	17	,	,	PUNCT
dpc-4910	76	18	and	and	CCONJ
dpc-4910	76	19	then	then	ADV
dpc-4910	76	20	stored	store	VERB
dpc-4910	76	21	frozen	frozen	ADJ
dpc-4910	76	22	until	until	ADP
dpc-4910	76	23	the	the	DET
dpc-4910	76	24	day	day	NOUN
dpc-4910	76	25	of	of	ADP
dpc-4910	76	26	analysis	analysis	NOUN
dpc-4910	76	27	.	.	PUNCT
dpc-4910	77	1	urinary	urinary	ADJ
dpc-4910	77	2	podocalyxin	podocalyxin	NOUN
dpc-4910	77	3	and	and	CCONJ
dpc-4910	77	4	nephrin	nephrin	NOUN
dpc-4910	77	5	levels	level	NOUN
dpc-4910	77	6	were	be	AUX
dpc-4910	77	7	measured	measure	VERB
dpc-4910	77	8	using	use	VERB
dpc-4910	77	9	elisa	elisa	NOUN
dpc-4910	77	10	with	with	ADP
dpc-4910	77	11	commercially	commercially	ADV
dpc-4910	77	12	available	available	ADJ
dpc-4910	77	13	kits	kit	NOUN
dpc-4910	77	14	.	.	PUNCT
dpc-4910	78	1	kits	kit	NOUN
dpc-4910	78	2	for	for	ADP
dpc-4910	78	3	nephrin	nephrin	NOUN
dpc-4910	78	4	and	and	CCONJ
dpc-4910	78	5	podocalyxin	podocalyxin	NOUN
dpc-4910	78	6	measurements	measurement	NOUN
dpc-4910	78	7	were	be	AUX
dpc-4910	78	8	purchased	purchase	VERB
dpc-4910	78	9	from	from	ADP
dpc-4910	78	10	sunred	sunre	VERB
dpc-4910	78	11	biotechnology	biotechnology	NOUN
dpc-4910	78	12	company	company	NOUN
dpc-4910	78	13	(	(	PUNCT
dpc-4910	78	14	shanghai	shanghai	PROPN
dpc-4910	78	15	,	,	PUNCT
dpc-4910	78	16	china	china	PROPN
dpc-4910	78	17	)	)	PUNCT
dpc-4910	78	18	.	.	PUNCT
dpc-4910	79	1	analyses	analysis	NOUN
dpc-4910	79	2	were	be	AUX
dpc-4910	79	3	performed	perform	VERB
dpc-4910	79	4	in	in	ADP
dpc-4910	79	5	accordance	accordance	NOUN
dpc-4910	79	6	with	with	ADP
dpc-4910	79	7	the	the	DET
dpc-4910	79	8	manufacturer	manufacturer	NOUN
dpc-4910	79	9	’s	’s	PART
dpc-4910	79	10	instructions	instruction	NOUN
dpc-4910	79	11	,	,	PUNCT
dpc-4910	79	12	as	as	SCONJ
dpc-4910	79	13	specified	specify	VERB
dpc-4910	79	14	in	in	ADP
dpc-4910	79	15	the	the	DET
dpc-4910	79	16	kit	kit	NOUN
dpc-4910	79	17	catalogue	catalogue	NOUN
dpc-4910	79	18	.	.	PUNCT
dpc-4910	80	1	an	an	DET
dpc-4910	80	2	automatic	automatic	ADJ
dpc-4910	80	3	washer	washer	NOUN
dpc-4910	80	4	(	(	PUNCT
dpc-4910	80	5	biochrom	biochrom	NOUN
dpc-4910	80	6	anthos	anthos	NOUN
dpc-4910	80	7	fluido	fluido	PROPN
dpc-4910	80	8	2	2	NUM
dpc-4910	80	9	;	;	PUNCT
dpc-4910	80	10	biochrom	biochrom	PROPN
dpc-4910	80	11	ltd	ltd	PROPN
dpc-4910	80	12	.	.	PROPN
dpc-4910	80	13	,	,	PUNCT
dpc-4910	80	14	cambridge	cambridge	PROPN
dpc-4910	80	15	,	,	PUNCT
dpc-4910	80	16	uk	uk	PROPN
dpc-4910	80	17	)	)	PUNCT
dpc-4910	80	18	was	be	AUX
dpc-4910	80	19	used	use	VERB
dpc-4910	80	20	for	for	ADP
dpc-4910	80	21	plate	plate	NOUN
dpc-4910	80	22	washing	washing	NOUN
dpc-4910	80	23	.	.	PUNCT
dpc-4910	81	1	absorbance	absorbance	NOUN
dpc-4910	81	2	was	be	AUX
dpc-4910	81	3	measured	measure	VERB
dpc-4910	81	4	at	at	ADP
dpc-4910	81	5	450	450	NUM
dpc-4910	81	6	nm	nm	NOUN
dpc-4910	81	7	using	use	VERB
dpc-4910	81	8	a	a	DET
dpc-4910	81	9	clariostar	clariostar	NOUN
dpc-4910	81	10	plus	plus	CCONJ
dpc-4910	81	11	microplate	microplate	NOUN
dpc-4910	81	12	reader	reader	NOUN
dpc-4910	81	13	(	(	PUNCT
dpc-4910	81	14	bmg	bmg	PROPN
dpc-4910	81	15	labtech	labtech	PROPN
dpc-4910	81	16	,	,	PUNCT
dpc-4910	81	17	germany	germany	PROPN
dpc-4910	81	18	)	)	PUNCT
dpc-4910	81	19	.	.	PUNCT
dpc-4910	82	1	the	the	DET
dpc-4910	82	2	test	test	NOUN
dpc-4910	82	3	results	result	NOUN
dpc-4910	82	4	were	be	AUX
dpc-4910	82	5	expressed	express	VERB
dpc-4910	82	6	as	as	ADP
dpc-4910	82	7	ng	ng	PROPN
dpc-4910	82	8	/	/	SYM
dpc-4910	82	9	ml	ml	PROPN
dpc-4910	82	10	.	.	PUNCT
dpc-4910	83	1	the	the	DET
dpc-4910	83	2	measurement	measurement	NOUN
dpc-4910	83	3	range	range	NOUN
dpc-4910	83	4	of	of	ADP
dpc-4910	83	5	the	the	DET
dpc-4910	83	6	pdx	pdx	PROPN
dpc-4910	83	7	was	be	AUX
dpc-4910	83	8	0.2	0.2	NUM
dpc-4910	83	9	-	-	SYM
dpc-4910	83	10	60	60	NUM
dpc-4910	83	11	ng	ng	PROPN
dpc-4910	83	12	/	/	SYM
dpc-4910	83	13	ml	ml	PROPN
dpc-4910	83	14	and	and	CCONJ
dpc-4910	83	15	the	the	DET
dpc-4910	83	16	minimum	minimum	ADJ
dpc-4910	83	17	measurable	measurable	ADJ
dpc-4910	83	18	level	level	NOUN
dpc-4910	83	19	was	be	AUX
dpc-4910	83	20	0.153	0.153	NUM
dpc-4910	83	21	ng	ng	PROPN
dpc-4910	83	22	/	/	SYM
dpc-4910	83	23	ml	ml	PROPN
dpc-4910	83	24	.	.	PUNCT
dpc-4910	84	1	the	the	DET
dpc-4910	84	2	standard	standard	ADJ
dpc-4910	84	3	curve	curve	NOUN
dpc-4910	84	4	range	range	NOUN
dpc-4910	84	5	for	for	ADP
dpc-4910	84	6	nephrin	nephrin	NOUN
dpc-4910	84	7	was	be	AUX
dpc-4910	84	8	0.2	0.2	NUM
dpc-4910	84	9	-	-	SYM
dpc-4910	84	10	40	40	NUM
dpc-4910	84	11	ng/	ng/	ADJ
dpc-4910	84	12	ml	ml	NOUN
dpc-4910	84	13	.	.	PUNCT
dpc-4910	85	1	the	the	DET
dpc-4910	85	2	minimum	minimum	ADJ
dpc-4910	85	3	measurable	measurable	ADJ
dpc-4910	85	4	nephrin	nephrin	NOUN
dpc-4910	85	5	level	level	NOUN
dpc-4910	85	6	was	be	AUX
dpc-4910	85	7	0.166	0.166	NUM
dpc-4910	85	8	ng/	ng/	ADJ
dpc-4910	85	9	ml	ml	NOUN
dpc-4910	85	10	.	.	PUNCT
dpc-4910	86	1	while	while	SCONJ
dpc-4910	86	2	the	the	DET
dpc-4910	86	3	intra	intra	ADJ
dpc-4910	86	4	-	-	ADJ
dpc-4910	86	5	assay	assay	ADJ
dpc-4910	86	6	cv	cv	NOUN
dpc-4910	86	7	value	value	NOUN
dpc-4910	86	8	for	for	ADP
dpc-4910	86	9	both	both	DET
dpc-4910	86	10	kits	kit	NOUN
dpc-4910	86	11	was	be	AUX
dpc-4910	86	12	<	<	X
dpc-4910	86	13	10	10	NUM
dpc-4910	86	14	%	%	NOUN
dpc-4910	86	15	,	,	PUNCT
dpc-4910	86	16	the	the	DET
dpc-4910	86	17	inter	inter	ADJ
dpc-4910	86	18	-	-	ADJ
dpc-4910	86	19	assay	assay	ADJ
dpc-4910	86	20	cv	cv	PROPN
dpc-4910	86	21	value	value	NOUN
dpc-4910	86	22	was	be	AUX
dpc-4910	86	23	<	<	X
dpc-4910	86	24	12	12	NUM
dpc-4910	86	25	%	%	NOUN
dpc-4910	86	26	.	.	PUNCT
dpc-4910	87	1	albuminuria	albuminuria	PROPN
dpc-4910	87	2	was	be	AUX
dpc-4910	87	3	evaluated	evaluate	VERB
dpc-4910	87	4	by	by	ADP
dpc-4910	87	5	calculating	calculate	VERB
dpc-4910	87	6	the	the	DET
dpc-4910	87	7	albumin	albumin	NOUN
dpc-4910	87	8	-	-	PUNCT
dpc-4910	87	9	to	to	ADP
dpc-4910	87	10	-	-	PUNCT
dpc-4910	87	11	creatinine	creatinine	NOUN
dpc-4910	87	12	ratio	ratio	NOUN
dpc-4910	87	13	(	(	PUNCT
dpc-4910	87	14	uacr	uacr	INTJ
dpc-4910	87	15	)	)	PUNCT
dpc-4910	87	16	in	in	ADP
dpc-4910	87	17	morning	morning	NOUN
dpc-4910	87	18	urine	urine	NOUN
dpc-4910	87	19	samples	sample	NOUN
dpc-4910	87	20	.	.	PUNCT
dpc-4910	88	1	normal	normal	ADJ
dpc-4910	88	2	albuminuria	albuminuria	NOUN
dpc-4910	88	3	was	be	AUX
dpc-4910	88	4	defined	define	VERB
dpc-4910	88	5	as	as	ADP
dpc-4910	88	6	albumin	albumin	ADJ
dpc-4910	88	7	/	/	SYM
dpc-4910	88	8	g	g	NOUN
dpc-4910	88	9	creatinine	creatinine	NOUN
dpc-4910	88	10	≤	≤	NUM
dpc-4910	88	11	30	30	NUM
dpc-4910	88	12	mg	mg	NOUN
dpc-4910	88	13	.	.	PUNCT
dpc-4910	89	1	microalbuminuria	microalbuminuria	PROPN
dpc-4910	89	2	was	be	AUX
dpc-4910	89	3	defined	define	VERB
dpc-4910	89	4	as	as	ADP
dpc-4910	89	5	uacr	uacr	PRON
dpc-4910	89	6	>	>	NOUN
dpc-4910	89	7	30–300	30–300	NUM
dpc-4910	89	8	mg	mg	PROPN
dpc-4910	89	9	albumin	albumin	PROPN
dpc-4910	89	10	/	/	SYM
dpc-4910	89	11	g	g	PROPN
dpc-4910	89	12	cr	cr	PROPN
dpc-4910	89	13	.	.	PUNCT
dpc-4910	90	1	as	as	SCONJ
dpc-4910	90	2	psoriasis	psoriasis	NOUN
dpc-4910	90	3	is	be	AUX
dpc-4910	90	4	associated	associate	VERB
dpc-4910	90	5	with	with	ADP
dpc-4910	90	6	many	many	ADJ
dpc-4910	90	7	comorbidities	comorbiditie	NOUN
dpc-4910	90	8	such	such	ADJ
dpc-4910	90	9	as	as	ADP
dpc-4910	90	10	obesity	obesity	NOUN
dpc-4910	90	11	,	,	PUNCT
dpc-4910	90	12	diabetes	diabetes	NOUN
dpc-4910	90	13	,	,	PUNCT
dpc-4910	90	14	hypertension	hypertension	NOUN
dpc-4910	90	15	,	,	PUNCT
dpc-4910	90	16	and	and	CCONJ
dpc-4910	90	17	cardiovascular	cardiovascular	ADJ
dpc-4910	90	18	disease	disease	NOUN
dpc-4910	90	19	,	,	PUNCT
dpc-4910	90	20	the	the	DET
dpc-4910	90	21	following	follow	VERB
dpc-4910	90	22	biochemical	biochemical	ADJ
dpc-4910	90	23	and	and	CCONJ
dpc-4910	90	24	demographic	demographic	ADJ
dpc-4910	90	25	parameters	parameter	NOUN
dpc-4910	90	26	were	be	AUX
dpc-4910	90	27	analyzed	analyze	VERB
dpc-4910	90	28	[	[	X
dpc-4910	90	29	15	15	NUM
dpc-4910	90	30	]	]	X
dpc-4910	90	31	:	:	PUNCT
dpc-4910	90	32	systolic	systolic	ADJ
dpc-4910	90	33	and	and	CCONJ
dpc-4910	90	34	diastolic	diastolic	ADJ
dpc-4910	90	35	blood	blood	NOUN
dpc-4910	90	36	pressures	pressure	NOUN
dpc-4910	90	37	of	of	ADP
dpc-4910	90	38	each	each	DET
dpc-4910	90	39	participant	participant	NOUN
dpc-4910	90	40	were	be	AUX
dpc-4910	90	41	recorded	record	VERB
dpc-4910	90	42	,	,	PUNCT
dpc-4910	90	43	the	the	DET
dpc-4910	90	44	height	height	NOUN
dpc-4910	90	45	and	and	CCONJ
dpc-4910	90	46	weight	weight	NOUN
dpc-4910	90	47	of	of	ADP
dpc-4910	90	48	the	the	DET
dpc-4910	90	49	participants	participant	NOUN
dpc-4910	90	50	in	in	ADP
dpc-4910	90	51	the	the	DET
dpc-4910	90	52	psoriasis	psoriasis	NOUN
dpc-4910	90	53	and	and	CCONJ
dpc-4910	90	54	control	control	NOUN
dpc-4910	90	55	groups	group	NOUN
dpc-4910	90	56	were	be	AUX
dpc-4910	90	57	measured	measure	VERB
dpc-4910	90	58	,	,	PUNCT
dpc-4910	90	59	and	and	CCONJ
dpc-4910	90	60	their	their	PRON
dpc-4910	90	61	bmi	bmi	NOUN
dpc-4910	90	62	values	value	NOUN
dpc-4910	90	63	were	be	AUX
dpc-4910	90	64	calculated	calculate	VERB
dpc-4910	90	65	[	[	PUNCT
dpc-4910	90	66	weight	weight	NOUN
dpc-4910	90	67	(	(	PUNCT
dpc-4910	90	68	kg)/square	kg)/square	NOUN
dpc-4910	90	69	of	of	ADP
dpc-4910	90	70	height	height	NOUN
dpc-4910	90	71	(	(	PUNCT
dpc-4910	90	72	kg	kg	NOUN
dpc-4910	90	73	/	/	SYM
dpc-4910	90	74	m2	m2	PROPN
dpc-4910	90	75	]	]	PUNCT
dpc-4910	90	76	)	)	PUNCT
dpc-4910	90	77	.	.	PUNCT
dpc-4910	91	1	following	follow	VERB
dpc-4910	91	2	an	an	PRON
dpc-4910	91	3	8–10h	8–10h	NUM
dpc-4910	91	4	overnight	overnight	ADV
dpc-4910	91	5	fast	fast	ADV
dpc-4910	91	6	,	,	PUNCT
dpc-4910	91	7	blood	blood	NOUN
dpc-4910	91	8	samples	sample	NOUN
dpc-4910	91	9	were	be	AUX
dpc-4910	91	10	collected	collect	VERB
dpc-4910	91	11	from	from	ADP
dpc-4910	91	12	both	both	DET
dpc-4910	91	13	groups	group	NOUN
dpc-4910	91	14	and	and	CCONJ
dpc-4910	91	15	stored	store	VERB
dpc-4910	91	16	until	until	ADP
dpc-4910	91	17	analysis	analysis	NOUN
dpc-4910	91	18	.	.	PUNCT
dpc-4910	92	1	fasting	fast	VERB
dpc-4910	92	2	blood	blood	NOUN
dpc-4910	92	3	glucose	glucose	NOUN
dpc-4910	92	4	,	,	PUNCT
dpc-4910	92	5	triglyceride	triglyceride	ADP
dpc-4910	92	6	(	(	PUNCT
dpc-4910	92	7	tg	tg	PROPN
dpc-4910	92	8	)	)	PUNCT
dpc-4910	92	9	,	,	PUNCT
dpc-4910	92	10	high	high	ADJ
dpc-4910	92	11	-	-	PUNCT
dpc-4910	92	12	density	density	NOUN
dpc-4910	92	13	lipoprotein	lipoprotein	ADJ
dpc-4910	92	14	cholesterol	cholesterol	NOUN
dpc-4910	92	15	(	(	PUNCT
dpc-4910	92	16	hdl	hdl	NOUN
dpc-4910	92	17	-	-	PUNCT
dpc-4910	92	18	c	c	NOUN
dpc-4910	92	19	)	)	PUNCT
dpc-4910	92	20	,	,	PUNCT
dpc-4910	92	21	and	and	CCONJ
dpc-4910	92	22	creatinine	creatinine	NOUN
dpc-4910	92	23	levels	level	NOUN
dpc-4910	92	24	were	be	AUX
dpc-4910	92	25	measured	measure	VERB
dpc-4910	92	26	using	use	VERB
dpc-4910	92	27	an	an	DET
dpc-4910	92	28	autoanalyzer	autoanalyzer	NOUN
dpc-4910	92	29	.	.	PUNCT
dpc-4910	93	1	fasting	fast	VERB
dpc-4910	93	2	blood	blood	NOUN
dpc-4910	93	3	glucose	glucose	NOUN
dpc-4910	93	4	and	and	CCONJ
dpc-4910	93	5	creatinine	creatinine	NOUN
dpc-4910	93	6	levels	level	NOUN
dpc-4910	93	7	were	be	AUX
dpc-4910	93	8	measured	measure	VERB
dpc-4910	93	9	using	use	VERB
dpc-4910	93	10	the	the	DET
dpc-4910	93	11	hexokinase	hexokinase	NOUN
dpc-4910	93	12	and	and	CCONJ
dpc-4910	93	13	jaffe	jaffe	PROPN
dpc-4910	93	14	methods	method	NOUN
dpc-4910	93	15	,	,	PUNCT
dpc-4910	93	16	respectively	respectively	ADV
dpc-4910	93	17	.	.	PUNCT
dpc-4910	94	1	insulin	insulin	NOUN
dpc-4910	94	2	resistance	resistance	NOUN
dpc-4910	94	3	was	be	AUX
dpc-4910	94	4	calculated	calculate	VERB
dpc-4910	94	5	using	use	VERB
dpc-4910	94	6	the	the	DET
dpc-4910	94	7	homeostasis	homeostasis	NOUN
dpc-4910	94	8	model	model	NOUN
dpc-4910	94	9	assessment	assessment	NOUN
dpc-4910	94	10	of	of	ADP
dpc-4910	94	11	insulin	insulin	NOUN
dpc-4910	94	12	resistance	resistance	NOUN
dpc-4910	94	13	(	(	PUNCT
dpc-4910	94	14	homa	homa	NOUN
dpc-4910	94	15	-	-	PUNCT
dpc-4910	94	16	ir	ir	PROPN
dpc-4910	94	17	):	):	PUNCT
dpc-4910	94	18	insulin	insulin	NOUN
dpc-4910	94	19	(	(	PUNCT
dpc-4910	94	20	μu	μu	NOUN
dpc-4910	94	21	/	/	SYM
dpc-4910	94	22	ml	ml	NOUN
dpc-4910	94	23	)	)	PUNCT
dpc-4910	94	24	×	×	NOUN
dpc-4910	94	25	glucose	glucose	NOUN
dpc-4910	94	26	(	(	PUNCT
dpc-4910	94	27	mg	mg	PROPN
dpc-4910	94	28	/	/	SYM
dpc-4910	94	29	dl)/405	dl)/405	PROPN
dpc-4910	95	1	[	[	X
dpc-4910	95	2	16	16	NUM
dpc-4910	95	3	]	]	PUNCT
dpc-4910	95	4	.	.	PUNCT
dpc-4910	96	1	statistical	statistical	ADJ
dpc-4910	96	2	analysis	analysis	NOUN
dpc-4910	96	3	statistical	statistical	ADJ
dpc-4910	96	4	analyses	analysis	NOUN
dpc-4910	96	5	were	be	AUX
dpc-4910	96	6	performed	perform	VERB
dpc-4910	96	7	using	use	VERB
dpc-4910	96	8	spssv-27	spssv-27	PROPN
dpc-4910	96	9	(	(	PUNCT
dpc-4910	96	10	ibm	ibm	PROPN
dpc-4910	96	11	corp	corp	PROPN
dpc-4910	96	12	.	.	PROPN
dpc-4910	96	13	,	,	PUNCT
dpc-4910	96	14	armonk	armonk	PROPN
dpc-4910	96	15	,	,	PUNCT
dpc-4910	96	16	ny	ny	PROPN
dpc-4910	96	17	,	,	PUNCT
dpc-4910	96	18	usa	usa	PROPN
dpc-4910	96	19	)	)	PUNCT
dpc-4910	96	20	.	.	PUNCT
dpc-4910	97	1	graphs	graph	NOUN
dpc-4910	97	2	were	be	AUX
dpc-4910	97	3	created	create	VERB
dpc-4910	97	4	using	use	VERB
dpc-4910	97	5	graphpad	graphpad	NOUN
dpc-4910	97	6	prism	prism	NOUN
dpc-4910	97	7	8.3.0	8.3.0	NUM
dpc-4910	97	8	(	(	PUNCT
dpc-4910	97	9	graphpad	graphpad	NOUN
dpc-4910	97	10	software	software	NOUN
dpc-4910	97	11	,	,	PUNCT
dpc-4910	97	12	san	san	PROPN
dpc-4910	97	13	diego	diego	PROPN
dpc-4910	97	14	,	,	PUNCT
dpc-4910	97	15	california	california	PROPN
dpc-4910	97	16	,	,	PUNCT
dpc-4910	97	17	usa	usa	PROPN
dpc-4910	97	18	)	)	PUNCT
dpc-4910	97	19	.	.	PUNCT
dpc-4910	98	1	the	the	DET
dpc-4910	98	2	suitability	suitability	NOUN
dpc-4910	98	3	of	of	ADP
dpc-4910	98	4	the	the	DET
dpc-4910	98	5	variables	variable	NOUN
dpc-4910	98	6	for	for	ADP
dpc-4910	98	7	normal	normal	ADJ
dpc-4910	98	8	distribution	distribution	NOUN
dpc-4910	98	9	was	be	AUX
dpc-4910	98	10	examined	examine	VERB
dpc-4910	98	11	using	use	VERB
dpc-4910	98	12	the	the	DET
dpc-4910	98	13	shapiro	shapiro	PROPN
dpc-4910	98	14	-	-	PUNCT
dpc-4910	98	15	wilk	wilk	NOUN
dpc-4910	98	16	test	test	NOUN
dpc-4910	98	17	.	.	PUNCT
dpc-4910	99	1	data	datum	NOUN
dpc-4910	99	2	are	be	AUX
dpc-4910	99	3	presented	present	VERB
dpc-4910	99	4	as	as	ADP
dpc-4910	99	5	mean	mean	NOUN
dpc-4910	99	6	±	±	NUM
dpc-4910	99	7	standard	standard	ADJ
dpc-4910	99	8	deviation	deviation	NOUN
dpc-4910	99	9	or	or	CCONJ
dpc-4910	99	10	median	median	NOUN
dpc-4910	99	11	(	(	PUNCT
dpc-4910	99	12	1st	1st	ADJ
dpc-4910	99	13	quartile–3rd	quartile–3rd	ADJ
dpc-4910	99	14	quartile	quartile	NOUN
dpc-4910	99	15	)	)	PUNCT
dpc-4910	99	16	for	for	ADP
dpc-4910	99	17	continuous	continuous	ADJ
dpc-4910	99	18	variables	variable	NOUN
dpc-4910	99	19	according	accord	VERB
dpc-4910	99	20	to	to	ADP
dpc-4910	99	21	the	the	DET
dpc-4910	99	22	normality	normality	NOUN
dpc-4910	99	23	of	of	ADP
dpc-4910	99	24	distribution	distribution	NOUN
dpc-4910	99	25	and	and	CCONJ
dpc-4910	99	26	as	as	ADP
dpc-4910	99	27	frequencies	frequency	NOUN
dpc-4910	99	28	(	(	PUNCT
dpc-4910	99	29	percentages	percentage	NOUN
dpc-4910	99	30	)	)	PUNCT
dpc-4910	99	31	for	for	ADP
dpc-4910	99	32	categorical	categorical	ADJ
dpc-4910	99	33	variables	variable	NOUN
dpc-4910	99	34	.	.	PUNCT
dpc-4910	100	1	variables	variable	NOUN
dpc-4910	100	2	with	with	ADP
dpc-4910	100	3	a	a	DET
dpc-4910	100	4	normal	normal	ADJ
dpc-4910	100	5	distribution	distribution	NOUN
dpc-4910	100	6	were	be	AUX
dpc-4910	100	7	analyzed	analyze	VERB
dpc-4910	100	8	using	use	VERB
dpc-4910	100	9	the	the	DET
dpc-4910	100	10	independent	independent	ADJ
dpc-4910	100	11	samples	sample	NOUN
dpc-4910	100	12	t	t	NOUN
dpc-4910	100	13	-	-	PUNCT
dpc-4910	100	14	test	test	NOUN
dpc-4910	100	15	,	,	PUNCT
dpc-4910	100	16	and	and	CCONJ
dpc-4910	100	17	those	those	PRON
dpc-4910	100	18	with	with	ADP
dpc-4910	100	19	a	a	DET
dpc-4910	100	20	non	non	ADJ
dpc-4910	100	21	-	-	ADJ
dpc-4910	100	22	normal	normal	ADJ
dpc-4910	100	23	distribution	distribution	NOUN
dpc-4910	100	24	were	be	AUX
dpc-4910	100	25	analyzed	analyze	VERB
dpc-4910	100	26	using	use	VERB
dpc-4910	100	27	the	the	DET
dpc-4910	100	28	mann	mann	PROPN
dpc-4910	100	29	-	-	PUNCT
dpc-4910	100	30	whitney	whitney	PROPN
dpc-4910	100	31	u	u	PROPN
dpc-4910	100	32	test	test	NOUN
dpc-4910	100	33	.	.	PUNCT
dpc-4910	101	1	categorical	categorical	ADJ
dpc-4910	101	2	variables	variable	NOUN
dpc-4910	101	3	were	be	AUX
dpc-4910	101	4	analyzed	analyze	VERB
dpc-4910	101	5	using	use	VERB
dpc-4910	101	6	the	the	DET
dpc-4910	101	7	chi	chi	ADJ
dpc-4910	101	8	-	-	PUNCT
dpc-4910	101	9	square	square	NOUN
dpc-4910	101	10	or	or	CCONJ
dpc-4910	101	11	fisher	fisher	NOUN
dpc-4910	101	12	’s	’s	PART
dpc-4910	101	13	exact	exact	ADJ
dpc-4910	101	14	tests	test	NOUN
dpc-4910	101	15	.	.	PUNCT
dpc-4910	102	1	a	a	DET
dpc-4910	102	2	one	one	NUM
dpc-4910	102	3	-	-	PUNCT
dpc-4910	102	4	way	way	NOUN
dpc-4910	102	5	anova	anova	PROPN
dpc-4910	102	6	test	test	PROPN
dpc-4910	102	7	was	be	AUX
dpc-4910	102	8	used	use	VERB
dpc-4910	102	9	to	to	PART
dpc-4910	102	10	compare	compare	VERB
dpc-4910	102	11	more	more	ADJ
dpc-4910	102	12	than	than	ADP
dpc-4910	102	13	two	two	NUM
dpc-4910	102	14	groups	group	NOUN
dpc-4910	102	15	with	with	ADP
dpc-4910	102	16	normal	normal	ADJ
dpc-4910	102	17	distribution	distribution	NOUN
dpc-4910	102	18	,	,	PUNCT
dpc-4910	102	19	and	and	CCONJ
dpc-4910	102	20	parameters	parameter	NOUN
dpc-4910	102	21	that	that	PRON
dpc-4910	102	22	did	do	AUX
dpc-4910	102	23	not	not	PART
dpc-4910	102	24	show	show	VERB
dpc-4910	102	25	normal	normal	ADJ
dpc-4910	102	26	distribution	distribution	NOUN
dpc-4910	102	27	within	within	ADP
dpc-4910	102	28	groups	group	NOUN
dpc-4910	102	29	were	be	AUX
dpc-4910	102	30	compared	compare	VERB
dpc-4910	102	31	using	use	VERB
dpc-4910	102	32	the	the	DET
dpc-4910	102	33	kruskal	kruskal	PROPN
dpc-4910	102	34	-	-	PUNCT
dpc-4910	102	35	wallis	wallis	PROPN
dpc-4910	102	36	test	test	NOUN
dpc-4910	102	37	.	.	PUNCT
dpc-4910	103	1	the	the	DET
dpc-4910	103	2	bonferroni	bonferroni	NOUN
dpc-4910	103	3	test	test	NOUN
dpc-4910	103	4	was	be	AUX
dpc-4910	103	5	used	use	VERB
dpc-4910	103	6	for	for	ADP
dpc-4910	103	7	post	post	X
dpc-4910	103	8	hoc	hoc	X
dpc-4910	103	9	pairwise	pairwise	NOUN
dpc-4910	103	10	comparisons	comparison	NOUN
dpc-4910	103	11	.	.	PUNCT
dpc-4910	104	1	spearman	spearman	NOUN
dpc-4910	104	2	’s	’s	PART
dpc-4910	104	3	correlation	correlation	NOUN
dpc-4910	104	4	test	test	NOUN
dpc-4910	104	5	was	be	AUX
dpc-4910	104	6	used	use	VERB
dpc-4910	104	7	to	to	PART
dpc-4910	104	8	determine	determine	VERB
dpc-4910	104	9	the	the	DET
dpc-4910	104	10	relationship	relationship	NOUN
dpc-4910	104	11	between	between	ADP
dpc-4910	104	12	variables	variable	NOUN
dpc-4910	104	13	.	.	PUNCT
dpc-4910	105	1	multivariate	multivariate	NOUN
dpc-4910	105	2	regression	regression	NOUN
dpc-4910	105	3	analysis	analysis	NOUN
dpc-4910	105	4	was	be	AUX
dpc-4910	105	5	performed	perform	VERB
dpc-4910	105	6	to	to	PART
dpc-4910	105	7	identify	identify	VERB
dpc-4910	105	8	independent	independent	ADJ
dpc-4910	105	9	risk	risk	NOUN
dpc-4910	105	10	factors	factor	NOUN
dpc-4910	105	11	for	for	ADP
dpc-4910	105	12	albuminuria	albuminuria	NOUN
dpc-4910	105	13	in	in	ADP
dpc-4910	105	14	patients	patient	NOUN
dpc-4910	105	15	with	with	ADP
dpc-4910	105	16	psoriasis	psoriasis	NOUN
dpc-4910	105	17	vulgaris	vulgaris	NOUN
dpc-4910	105	18	after	after	ADP
dpc-4910	105	19	adjusting	adjust	VERB
dpc-4910	105	20	for	for	ADP
dpc-4910	105	21	age	age	NOUN
dpc-4910	105	22	,	,	PUNCT
dpc-4910	105	23	body	body	NOUN
dpc-4910	105	24	mass	mass	NOUN
dpc-4910	105	25	index	index	NOUN
dpc-4910	105	26	(	(	PUNCT
dpc-4910	105	27	bmi	bmi	PROPN
dpc-4910	105	28	)	)	PUNCT
dpc-4910	105	29	,	,	PUNCT
dpc-4910	105	30	and	and	CCONJ
dpc-4910	105	31	sex	sex	NOUN
dpc-4910	105	32	.	.	PUNCT
dpc-4910	106	1	the	the	DET
dpc-4910	106	2	“	"	PUNCT
dpc-4910	106	3	metan	metan	NOUN
dpc-4910	106	4	”	"	PUNCT
dpc-4910	106	5	r	r	NOUN
dpc-4910	106	6	package	package	NOUN
dpc-4910	106	7	was	be	AUX
dpc-4910	106	8	used	use	VERB
dpc-4910	106	9	to	to	PART
dpc-4910	106	10	generate	generate	VERB
dpc-4910	106	11	a	a	DET
dpc-4910	106	12	correlation	correlation	NOUN
dpc-4910	106	13	heatmap	heatmap	NOUN
dpc-4910	106	14	using	use	VERB
dpc-4910	106	15	spearman	spearman	NOUN
dpc-4910	106	16	’s	’s	PART
dpc-4910	106	17	method	method	NOUN
dpc-4910	106	18	[	[	X
dpc-4910	106	19	17	17	NUM
dpc-4910	106	20	]	]	PUNCT
dpc-4910	106	21	.	.	PUNCT
dpc-4910	107	1	statistical	statistical	ADJ
dpc-4910	107	2	significance	significance	NOUN
dpc-4910	107	3	was	be	AUX
dpc-4910	107	4	set	set	VERB
dpc-4910	107	5	at	at	ADP
dpc-4910	107	6	p<.05	p<.05	NOUN
dpc-4910	107	7	.	.	PUNCT
dpc-4910	108	1	results	result	NOUN
dpc-4910	108	2	when	when	SCONJ
dpc-4910	108	3	classified	classify	VERB
dpc-4910	108	4	according	accord	VERB
dpc-4910	108	5	to	to	ADP
dpc-4910	108	6	disease	disease	NOUN
dpc-4910	108	7	severity	severity	NOUN
dpc-4910	108	8	,	,	PUNCT
dpc-4910	108	9	22	22	NUM
dpc-4910	108	10	of	of	ADP
dpc-4910	108	11	the	the	DET
dpc-4910	108	12	58	58	NUM
dpc-4910	108	13	patients	patient	NOUN
dpc-4910	108	14	had	have	VERB
dpc-4910	108	15	mild	mild	ADJ
dpc-4910	108	16	psoriasis	psoriasis	NOUN
dpc-4910	108	17	,	,	PUNCT
dpc-4910	108	18	16	16	NUM
dpc-4910	108	19	had	have	VERB
dpc-4910	108	20	moderate	moderate	ADJ
dpc-4910	108	21	psoriasis	psoriasis	NOUN
dpc-4910	108	22	,	,	PUNCT
dpc-4910	108	23	and	and	CCONJ
dpc-4910	108	24	20	20	NUM
dpc-4910	108	25	had	have	VERB
dpc-4910	108	26	severe	severe	ADJ
dpc-4910	108	27	psoriasis	psoriasis	NOUN
dpc-4910	108	28	.	.	PUNCT
dpc-4910	109	1	of	of	ADP
dpc-4910	109	2	the	the	DET
dpc-4910	109	3	58	58	NUM
dpc-4910	109	4	patients	patient	NOUN
dpc-4910	109	5	,	,	PUNCT
dpc-4910	109	6	32	32	NUM
dpc-4910	109	7	were	be	AUX
dpc-4910	109	8	male	male	ADJ
dpc-4910	109	9	and	and	CCONJ
dpc-4910	109	10	26	26	NUM
dpc-4910	109	11	were	be	AUX
dpc-4910	109	12	female	female	ADJ
dpc-4910	109	13	(	(	PUNCT
dpc-4910	109	14	m	m	NOUN
dpc-4910	109	15	/	/	SYM
dpc-4910	109	16	f	f	PROPN
dpc-4910	109	17	ratio	ratio	NOUN
dpc-4910	109	18	,	,	PUNCT
dpc-4910	109	19	32/26	32/26	NUM
dpc-4910	109	20	)	)	PUNCT
dpc-4910	109	21	.	.	PUNCT
dpc-4910	110	1	the	the	DET
dpc-4910	110	2	mean	mean	ADJ
dpc-4910	110	3	age	age	NOUN
dpc-4910	110	4	and	and	CCONJ
dpc-4910	110	5	bmi	bmi	NOUN
dpc-4910	110	6	of	of	ADP
dpc-4910	110	7	the	the	DET
dpc-4910	110	8	psoriasis	psoriasis	NOUN
dpc-4910	110	9	and	and	CCONJ
dpc-4910	110	10	control	control	NOUN
dpc-4910	110	11	groups	group	NOUN
dpc-4910	110	12	were	be	AUX
dpc-4910	110	13	similar	similar	ADJ
dpc-4910	110	14	.	.	PUNCT
dpc-4910	111	1	in	in	ADP
dpc-4910	111	2	addition	addition	NOUN
dpc-4910	111	3	to	to	ADP
dpc-4910	111	4	sbp	sbp	PROPN
dpc-4910	111	5	and	and	CCONJ
dpc-4910	111	6	dbp	dbp	PROPN
dpc-4910	111	7	,	,	PUNCT
dpc-4910	111	8	serum	serum	NOUN
dpc-4910	111	9	creatinine	creatinine	NOUN
dpc-4910	111	10	and	and	CCONJ
dpc-4910	111	11	fbg	fbg	PROPN
dpc-4910	111	12	levels	level	NOUN
dpc-4910	111	13	were	be	AUX
dpc-4910	111	14	similar	similar	ADJ
dpc-4910	111	15	between	between	ADP
dpc-4910	111	16	the	the	DET
dpc-4910	111	17	psoriasis	psoriasis	NOUN
dpc-4910	111	18	and	and	CCONJ
dpc-4910	111	19	control	control	NOUN
dpc-4910	111	20	groups	group	NOUN
dpc-4910	111	21	(	(	PUNCT
dpc-4910	111	22	table	table	NOUN
dpc-4910	111	23	1	1	NUM
dpc-4910	111	24	)	)	PUNCT
dpc-4910	111	25	.	.	PUNCT
dpc-4910	112	1	hdl	hdl	PROPN
dpc-4910	112	2	-	-	PUNCT
dpc-4910	112	3	c	c	PROPN
dpc-4910	112	4	levels	level	NOUN
dpc-4910	112	5	were	be	AUX
dpc-4910	112	6	significantly	significantly	ADV
dpc-4910	112	7	lower	low	ADJ
dpc-4910	112	8	and	and	CCONJ
dpc-4910	112	9	tg	tg	PROPN
dpc-4910	112	10	levels	level	NOUN
dpc-4910	112	11	were	be	AUX
dpc-4910	112	12	higher	high	ADJ
dpc-4910	112	13	in	in	ADP
dpc-4910	112	14	the	the	DET
dpc-4910	112	15	psoriasis	psoriasis	NOUN
dpc-4910	112	16	group	group	NOUN
dpc-4910	112	17	than	than	ADP
dpc-4910	112	18	in	in	ADP
dpc-4910	112	19	the	the	DET
dpc-4910	112	20	control	control	NOUN
dpc-4910	112	21	group	group	NOUN
dpc-4910	112	22	.	.	PUNCT
dpc-4910	113	1	the	the	DET
dpc-4910	113	2	mean	mean	ADJ
dpc-4910	113	3	homa	homa	PROPN
dpc-4910	113	4	-	-	PUNCT
dpc-4910	113	5	ir	ir	PROPN
dpc-4910	113	6	values	value	NOUN
dpc-4910	113	7	in	in	ADP
dpc-4910	113	8	the	the	DET
dpc-4910	113	9	psoriasis	psoriasis	NOUN
dpc-4910	113	10	group	group	NOUN
dpc-4910	113	11	were	be	AUX
dpc-4910	113	12	significantly	significantly	ADV
dpc-4910	113	13	higher	high	ADJ
dpc-4910	113	14	than	than	ADP
dpc-4910	113	15	those	those	PRON
dpc-4910	113	16	in	in	ADP
dpc-4910	113	17	the	the	DET
dpc-4910	113	18	control	control	NOUN
dpc-4910	113	19	group	group	NOUN
dpc-4910	113	20	.	.	PUNCT
dpc-4910	114	1	mean	mean	VERB
dpc-4910	114	2	urinary	urinary	ADJ
dpc-4910	114	3	4	4	NUM
dpc-4910	114	4	original	original	ADJ
dpc-4910	114	5	article	article	NOUN
dpc-4910	114	6	|	|	ADV
dpc-4910	114	7	dermatol	dermatol	ADJ
dpc-4910	114	8	pract	pract	NOUN
dpc-4910	114	9	concept	concept	NOUN
dpc-4910	114	10	.	.	PUNCT
dpc-4910	115	1	2025;15(2):4910	2025;15(2):4910	NUM
dpc-4910	115	2	table	table	NOUN
dpc-4910	115	3	1	1	NUM
dpc-4910	115	4	.	.	PUNCT
dpc-4910	115	5	demographic	demographic	ADJ
dpc-4910	115	6	and	and	CCONJ
dpc-4910	115	7	laboratory	laboratory	NOUN
dpc-4910	115	8	characteristics	characteristic	NOUN
dpc-4910	115	9	of	of	ADP
dpc-4910	115	10	psoriasis	psoriasis	NOUN
dpc-4910	115	11	vulgaris	vulgaris	NOUN
dpc-4910	115	12	and	and	CCONJ
dpc-4910	115	13	control	control	NOUN
dpc-4910	115	14	groups	group	NOUN
dpc-4910	115	15	.	.	PUNCT
dpc-4910	116	1	parameter	parameter	NOUN
dpc-4910	116	2	psoriasis	psoriasis	NOUN
dpc-4910	116	3	(	(	PUNCT
dpc-4910	116	4	n=58	n=58	ADJ
dpc-4910	116	5	)	)	PUNCT
dpc-4910	116	6	control	control	NOUN
dpc-4910	116	7	(	(	PUNCT
dpc-4910	116	8	n=20	n=20	PROPN
dpc-4910	116	9	)	)	PUNCT
dpc-4910	116	10	p	p	ADJ
dpc-4910	116	11	-	-	PUNCT
dpc-4910	116	12	value	value	NOUN
dpc-4910	116	13	age	age	NOUN
dpc-4910	116	14	(	(	PUNCT
dpc-4910	116	15	years	year	NOUN
dpc-4910	116	16	)	)	PUNCT
dpc-4910	116	17	35.03±	35.03±	NUM
dpc-4910	116	18	4.96	4.96	NUM
dpc-4910	116	19	34.05±	34.05±	NUM
dpc-4910	116	20	4.95	4.95	NUM
dpc-4910	116	21	0.447	0.447	NUM
dpc-4910	116	22	sex	sex	NOUN
dpc-4910	116	23	(	(	PUNCT
dpc-4910	116	24	male	male	NOUN
dpc-4910	116	25	/	/	SYM
dpc-4910	116	26	female	female	NOUN
dpc-4910	116	27	)	)	PUNCT
dpc-4910	116	28	32/26	32/26	NUM
dpc-4910	116	29	(	(	PUNCT
dpc-4910	116	30	55.2	55.2	NUM
dpc-4910	116	31	%	%	NOUN
dpc-4910	116	32	)	)	PUNCT
dpc-4910	116	33	10/10	10/10	NUM
dpc-4910	116	34	(	(	PUNCT
dpc-4910	116	35	50	50	NUM
dpc-4910	116	36	%	%	NOUN
dpc-4910	116	37	)	)	PUNCT
dpc-4910	116	38	0.889	0.889	NUM
dpc-4910	116	39	body	body	NOUN
dpc-4910	116	40	mass	mass	NOUN
dpc-4910	116	41	index	index	NOUN
dpc-4910	116	42	(	(	PUNCT
dpc-4910	116	43	kg	kg	NOUN
dpc-4910	116	44	/	/	SYM
dpc-4910	116	45	m2	m2	PROPN
dpc-4910	116	46	)	)	PUNCT
dpc-4910	116	47	24.7	24.7	NUM
dpc-4910	116	48	±	±	NUM
dpc-4910	116	49	1.5	1.5	NUM
dpc-4910	116	50	23.86±	23.86±	NUM
dpc-4910	116	51	2.21	2.21	NUM
dpc-4910	116	52	0.060	0.060	NUM
dpc-4910	116	53	pdx	pdx	PROPN
dpc-4910	116	54	(	(	PUNCT
dpc-4910	116	55	ng	ng	PROPN
dpc-4910	116	56	/	/	SYM
dpc-4910	116	57	ml	ml	PROPN
dpc-4910	116	58	)	)	PUNCT
dpc-4910	116	59	42.38	42.38	NUM
dpc-4910	116	60	±	±	NUM
dpc-4910	116	61	10.10	10.10	NUM
dpc-4910	116	62	17.76	17.76	NUM
dpc-4910	116	63	±5.87	±5.87	PROPN
dpc-4910	116	64	<	<	X
dpc-4910	116	65	0.001	0.001	NUM
dpc-4910	116	66	nephrin	nephrin	NOUN
dpc-4910	116	67	(	(	PUNCT
dpc-4910	116	68	ng	ng	PROPN
dpc-4910	116	69	/	/	SYM
dpc-4910	116	70	ml	ml	PROPN
dpc-4910	116	71	)	)	PUNCT
dpc-4910	116	72	32.57	32.57	NUM
dpc-4910	116	73	±	±	NUM
dpc-4910	116	74	8.4	8.4	NUM
dpc-4910	116	75	13.54	13.54	NUM
dpc-4910	116	76	±	±	NUM
dpc-4910	116	77	2.83	2.83	NUM
dpc-4910	116	78	<	<	NOUN
dpc-4910	116	79	0.001	0.001	NUM
dpc-4910	116	80	fbg	fbg	NOUN
dpc-4910	116	81	(	(	PUNCT
dpc-4910	116	82	mg	mg	PROPN
dpc-4910	116	83	/	/	SYM
dpc-4910	116	84	dl	dl	NOUN
dpc-4910	116	85	)	)	PUNCT
dpc-4910	116	86	90.5	90.5	NUM
dpc-4910	116	87	(	(	PUNCT
dpc-4910	116	88	85	85	NUM
dpc-4910	116	89	-	-	SYM
dpc-4910	116	90	97	97	NUM
dpc-4910	116	91	)	)	PUNCT
dpc-4910	116	92	91.5	91.5	NUM
dpc-4910	116	93	(	(	PUNCT
dpc-4910	116	94	88	88	NUM
dpc-4910	116	95	-	-	SYM
dpc-4910	116	96	98	98	NUM
dpc-4910	116	97	)	)	PUNCT
dpc-4910	116	98	0.753	0.753	NUM
dpc-4910	116	99	urea	urea	NOUN
dpc-4910	116	100	(	(	PUNCT
dpc-4910	116	101	mg	mg	PROPN
dpc-4910	116	102	/	/	SYM
dpc-4910	116	103	dl	dl	PROPN
dpc-4910	116	104	)	)	PUNCT
dpc-4910	116	105	30.16±	30.16±	NUM
dpc-4910	116	106	6.59	6.59	NUM
dpc-4910	116	107	28.95±	28.95±	NUM
dpc-4910	116	108	6.64	6.64	NUM
dpc-4910	116	109	0.482	0.482	NUM
dpc-4910	116	110	creatinine	creatinine	NOUN
dpc-4910	116	111	(	(	PUNCT
dpc-4910	116	112	mg	mg	PROPN
dpc-4910	116	113	/	/	SYM
dpc-4910	116	114	dl	dl	PROPN
dpc-4910	116	115	)	)	PUNCT
dpc-4910	116	116	0.75	0.75	NUM
dpc-4910	116	117	(	(	PUNCT
dpc-4910	116	118	0.72	0.72	NUM
dpc-4910	116	119	0.89	0.89	NUM
dpc-4910	116	120	)	)	PUNCT
dpc-4910	116	121	0.72	0.72	NUM
dpc-4910	116	122	(	(	PUNCT
dpc-4910	116	123	0.63	0.63	NUM
dpc-4910	116	124	0.83	0.83	NUM
dpc-4910	116	125	)	)	PUNCT
dpc-4910	116	126	0.065	0.065	NUM
dpc-4910	116	127	sbp	sbp	NOUN
dpc-4910	116	128	(	(	PUNCT
dpc-4910	116	129	mm	mm	PROPN
dpc-4910	116	130	/	/	SYM
dpc-4910	116	131	hg	hg	NOUN
dpc-4910	116	132	)	)	PUNCT
dpc-4910	116	133	115.0	115.0	NUM
dpc-4910	116	134	(	(	PUNCT
dpc-4910	116	135	110	110	NUM
dpc-4910	116	136	-	-	SYM
dpc-4910	116	137	120	120	NUM
dpc-4910	116	138	)	)	PUNCT
dpc-4910	116	139	110	110	NUM
dpc-4910	116	140	(	(	PUNCT
dpc-4910	116	141	110	110	NUM
dpc-4910	116	142	-	-	SYM
dpc-4910	116	143	115	115	NUM
dpc-4910	116	144	)	)	PUNCT
dpc-4910	116	145	0.180	0.180	NUM
dpc-4910	116	146	dbp	dbp	PROPN
dpc-4910	116	147	(	(	PUNCT
dpc-4910	116	148	mm	mm	PROPN
dpc-4910	116	149	/	/	SYM
dpc-4910	116	150	hg	hg	NOUN
dpc-4910	116	151	)	)	PUNCT
dpc-4910	116	152	75	75	NUM
dpc-4910	116	153	(	(	PUNCT
dpc-4910	116	154	70	70	NUM
dpc-4910	116	155	-	-	SYM
dpc-4910	116	156	80	80	NUM
dpc-4910	116	157	)	)	PUNCT
dpc-4910	116	158	72.5	72.5	NUM
dpc-4910	116	159	(	(	PUNCT
dpc-4910	116	160	70	70	NUM
dpc-4910	116	161	-	-	SYM
dpc-4910	116	162	80	80	NUM
dpc-4910	116	163	)	)	PUNCT
dpc-4910	116	164	0.098	0.098	NUM
dpc-4910	116	165	hdl	hdl	PROPN
dpc-4910	116	166	-	-	PUNCT
dpc-4910	116	167	c	c	PROPN
dpc-4910	116	168	(	(	PUNCT
dpc-4910	116	169	mg	mg	PROPN
dpc-4910	116	170	/	/	SYM
dpc-4910	116	171	dl	dl	PROPN
dpc-4910	116	172	)	)	PUNCT
dpc-4910	116	173	34.45±	34.45±	NUM
dpc-4910	116	174	11.09	11.09	NUM
dpc-4910	116	175	46.7±	46.7±	NOUN
dpc-4910	116	176	15.85	15.85	NUM
dpc-4910	116	177	0.004	0.004	NUM
dpc-4910	116	178	tg	tg	PROPN
dpc-4910	116	179	(	(	PUNCT
dpc-4910	116	180	mg	mg	PROPN
dpc-4910	116	181	/	/	SYM
dpc-4910	116	182	dl	dl	PROPN
dpc-4910	116	183	)	)	PUNCT
dpc-4910	116	184	127	127	NUM
dpc-4910	116	185	(	(	PUNCT
dpc-4910	116	186	89170	89170	NUM
dpc-4910	116	187	)	)	PUNCT
dpc-4910	116	188	92.5	92.5	NUM
dpc-4910	116	189	(	(	PUNCT
dpc-4910	116	190	75.5119.5	75.5119.5	NUM
dpc-4910	116	191	)	)	PUNCT
dpc-4910	116	192	0.006	0.006	NUM
dpc-4910	116	193	homa	homa	NOUN
dpc-4910	116	194	-	-	PUNCT
dpc-4910	116	195	ir	ir	NOUN
dpc-4910	116	196	2.05±	2.05±	NUM
dpc-4910	116	197	0.35	0.35	NUM
dpc-4910	116	198	1.29±	1.29±	NUM
dpc-4910	116	199	0.15	0.15	NUM
dpc-4910	116	200	<	<	NOUN
dpc-4910	116	201	0.001	0.001	NUM
dpc-4910	116	202	uacr	uacr	NOUN
dpc-4910	116	203	14	14	NUM
dpc-4910	116	204	(	(	PUNCT
dpc-4910	116	205	8	8	NUM
dpc-4910	116	206	21	21	NUM
dpc-4910	116	207	)	)	PUNCT
dpc-4910	116	208	7	7	NUM
dpc-4910	116	209	(	(	PUNCT
dpc-4910	116	210	4	4	NUM
dpc-4910	116	211	-	-	SYM
dpc-4910	116	212	8)	8)	NUM
dpc-4910	116	213	<	<	NOUN
dpc-4910	116	214	0.001	0.001	NUM
dpc-4910	116	215	micro	micro	NOUN
dpc-4910	116	216	-	-	NOUN
dpc-4910	116	217	albuminuria	albuminuria	PROPN
dpc-4910	116	218	(	(	PUNCT
dpc-4910	116	219	uacr	uacr	INTJ
dpc-4910	116	220	>	>	X
dpc-4910	116	221	30	30	NUM
dpc-4910	116	222	-	-	SYM
dpc-4910	116	223	300	300	NUM
dpc-4910	116	224	mg	mg	PROPN
dpc-4910	116	225	/	/	SYM
dpc-4910	116	226	gcr	gcr	NOUN
dpc-4910	116	227	)	)	PUNCT
dpc-4910	116	228	10	10	NUM
dpc-4910	116	229	(	(	PUNCT
dpc-4910	116	230	17.2	17.2	NUM
dpc-4910	116	231	%	%	NOUN
dpc-4910	116	232	)	)	PUNCT
dpc-4910	116	233	1	1	NUM
dpc-4910	116	234	(	(	PUNCT
dpc-4910	116	235	5	5	NUM
dpc-4910	116	236	%	%	NOUN
dpc-4910	116	237	)	)	PUNCT
dpc-4910	116	238	0.272	0.272	NUM
dpc-4910	116	239	data	datum	NOUN
dpc-4910	116	240	are	be	AUX
dpc-4910	116	241	given	give	VERB
dpc-4910	116	242	as	as	ADP
dpc-4910	116	243	mean	mean	PROPN
dpc-4910	116	244	±	±	NUM
dpc-4910	116	245	standard	standard	ADJ
dpc-4910	116	246	deviation	deviation	NOUN
dpc-4910	116	247	or	or	CCONJ
dpc-4910	116	248	median	median	NOUN
dpc-4910	116	249	(	(	PUNCT
dpc-4910	116	250	1st	1st	ADJ
dpc-4910	116	251	quartile–3rd	quartile–3rd	ADJ
dpc-4910	116	252	quartile	quartile	NOUN
dpc-4910	116	253	)	)	PUNCT
dpc-4910	116	254	for	for	ADP
dpc-4910	116	255	continuous	continuous	ADJ
dpc-4910	116	256	variables	variable	NOUN
dpc-4910	116	257	according	accord	VERB
dpc-4910	116	258	to	to	ADP
dpc-4910	116	259	normality	normality	NOUN
dpc-4910	116	260	of	of	ADP
dpc-4910	116	261	distribution	distribution	NOUN
dpc-4910	116	262	and	and	CCONJ
dpc-4910	116	263	as	as	ADP
dpc-4910	116	264	frequency	frequency	NOUN
dpc-4910	116	265	(	(	PUNCT
dpc-4910	116	266	percentage	percentage	NOUN
dpc-4910	116	267	)	)	PUNCT
dpc-4910	116	268	for	for	ADP
dpc-4910	116	269	categorical	categorical	ADJ
dpc-4910	116	270	variable	variable	NOUN
dpc-4910	116	271	.	.	PUNCT
dpc-4910	117	1	abbreviations	abbreviation	NOUN
dpc-4910	117	2	:	:	PUNCT
dpc-4910	117	3	dbp	dbp	PROPN
dpc-4910	117	4	=	=	SYM
dpc-4910	117	5	diastolic	diastolic	NOUN
dpc-4910	117	6	blood	blood	NOUN
dpc-4910	117	7	pressure	pressure	NOUN
dpc-4910	117	8	;	;	PUNCT
dpc-4910	118	1	fbg	fbg	NOUN
dpc-4910	118	2	=	=	PUNCT
dpc-4910	118	3	fasting	fast	VERB
dpc-4910	118	4	blood	blood	NOUN
dpc-4910	118	5	glucose	glucose	NOUN
dpc-4910	118	6	;	;	PUNCT
dpc-4910	118	7	hdl	hdl	PROPN
dpc-4910	118	8	-	-	PUNCT
dpc-4910	118	9	c	c	NOUN
dpc-4910	118	10	=	=	SYM
dpc-4910	118	11	high	high	ADJ
dpc-4910	118	12	-	-	PUNCT
dpc-4910	118	13	density	density	NOUN
dpc-4910	118	14	lipoprotein	lipoprotein	ADJ
dpc-4910	118	15	cholesterol	cholesterol	NOUN
dpc-4910	118	16	;	;	PUNCT
dpc-4910	118	17	homa	homa	NOUN
dpc-4910	118	18	-	-	PUNCT
dpc-4910	118	19	ir	ir	NOUN
dpc-4910	118	20	=	=	NOUN
dpc-4910	118	21	homeostasis	homeostasis	NOUN
dpc-4910	118	22	model	model	NOUN
dpc-4910	118	23	assessment	assessment	NOUN
dpc-4910	118	24	insulin	insulin	NOUN
dpc-4910	118	25	resistance	resistance	NOUN
dpc-4910	118	26	;	;	PUNCT
dpc-4910	118	27	sbp	sbp	NOUN
dpc-4910	118	28	=	=	SYM
dpc-4910	118	29	systolic	systolic	ADJ
dpc-4910	118	30	blood	blood	NOUN
dpc-4910	118	31	pressure	pressure	NOUN
dpc-4910	118	32	;	;	PUNCT
dpc-4910	118	33	pdx	pdx	PROPN
dpc-4910	118	34	=	=	PROPN
dpc-4910	118	35	podocalyxin	podocalyxin	PROPN
dpc-4910	118	36	;	;	PUNCT
dpc-4910	118	37	tg	tg	PROPN
dpc-4910	118	38	=	=	PUNCT
dpc-4910	118	39	triglyceride	triglyceride	ADJ
dpc-4910	118	40	;	;	PUNCT
dpc-4910	118	41	uacr	uacr	NOUN
dpc-4910	118	42	=	=	SYM
dpc-4910	118	43	albumin	albumin	ADJ
dpc-4910	118	44	-	-	PUNCT
dpc-4910	118	45	creatinine	creatinine	NOUN
dpc-4910	118	46	ratio	ratio	NOUN
dpc-4910	118	47	.	.	PUNCT
dpc-4910	119	1	pdx	pdx	PROPN
dpc-4910	119	2	(	(	PUNCT
dpc-4910	119	3	42.38±10.10	42.38±10.10	NOUN
dpc-4910	119	4	ng	ng	PROPN
dpc-4910	119	5	/	/	SYM
dpc-4910	119	6	ml	ml	PROPN
dpc-4910	119	7	vs.	vs.	ADP
dpc-4910	119	8	17.76±5.87	17.76±5.87	PROPN
dpc-4910	119	9	ng	ng	PROPN
dpc-4910	119	10	/	/	SYM
dpc-4910	119	11	ml	ml	PROPN
dpc-4910	119	12	,	,	PUNCT
dpc-4910	119	13	p<0.001	p<0.001	ADJ
dpc-4910	119	14	)	)	PUNCT
dpc-4910	119	15	levels	level	NOUN
dpc-4910	119	16	of	of	ADP
dpc-4910	119	17	psoriasis	psoriasis	NOUN
dpc-4910	119	18	group	group	NOUN
dpc-4910	119	19	were	be	AUX
dpc-4910	119	20	significantly	significantly	ADV
dpc-4910	119	21	higher	high	ADJ
dpc-4910	119	22	than	than	ADP
dpc-4910	119	23	the	the	DET
dpc-4910	119	24	control	control	NOUN
dpc-4910	119	25	group	group	NOUN
dpc-4910	119	26	(	(	PUNCT
dpc-4910	119	27	table	table	NOUN
dpc-4910	119	28	1	1	NUM
dpc-4910	119	29	and	and	CCONJ
dpc-4910	119	30	figure	figure	VERB
dpc-4910	119	31	1	1	NUM
dpc-4910	119	32	)	)	PUNCT
dpc-4910	119	33	.	.	PUNCT
dpc-4910	120	1	the	the	DET
dpc-4910	120	2	mean	mean	ADJ
dpc-4910	120	3	urinary	urinary	ADJ
dpc-4910	120	4	pdx	pdx	PROPN
dpc-4910	120	5	levels	level	NOUN
dpc-4910	120	6	in	in	ADP
dpc-4910	120	7	the	the	DET
dpc-4910	120	8	mild	mild	ADJ
dpc-4910	120	9	(	(	PUNCT
dpc-4910	120	10	37.20	37.20	NUM
dpc-4910	120	11	±	±	NUM
dpc-4910	120	12	8.87	8.87	NUM
dpc-4910	120	13	ng	ng	PROPN
dpc-4910	120	14	/	/	SYM
dpc-4910	120	15	ml	ml	PROPN
dpc-4910	120	16	)	)	PUNCT
dpc-4910	120	17	and	and	CCONJ
dpc-4910	120	18	moderate	moderate	ADJ
dpc-4910	120	19	(	(	PUNCT
dpc-4910	120	20	38.51	38.51	NUM
dpc-4910	120	21	±	±	NUM
dpc-4910	120	22	7.87	7.87	NUM
dpc-4910	120	23	ng	ng	PROPN
dpc-4910	120	24	/	/	SYM
dpc-4910	120	25	ml	ml	NOUN
dpc-4910	120	26	)	)	PUNCT
dpc-4910	120	27	psoriasis	psoriasis	NOUN
dpc-4910	120	28	groups	group	NOUN
dpc-4910	120	29	were	be	AUX
dpc-4910	120	30	similar	similar	ADJ
dpc-4910	120	31	but	but	CCONJ
dpc-4910	120	32	higher	high	ADJ
dpc-4910	120	33	than	than	ADP
dpc-4910	120	34	those	those	PRON
dpc-4910	120	35	in	in	ADP
dpc-4910	120	36	the	the	DET
dpc-4910	120	37	control	control	NOUN
dpc-4910	120	38	group	group	NOUN
dpc-4910	120	39	(	(	PUNCT
dpc-4910	120	40	17.76±5.87	17.76±5.87	PROPN
dpc-4910	120	41	ng	ng	PROPN
dpc-4910	120	42	/	/	SYM
dpc-4910	120	43	ml	ml	PROPN
dpc-4910	120	44	)	)	PUNCT
dpc-4910	120	45	.	.	PUNCT
dpc-4910	121	1	mean	mean	VERB
dpc-4910	121	2	urinary	urinary	ADJ
dpc-4910	121	3	nephrin	nephrin	NOUN
dpc-4910	121	4	(	(	PUNCT
dpc-4910	121	5	32.57±8.4	32.57±8.4	NUM
dpc-4910	121	6	ng	ng	PROPN
dpc-4910	121	7	/	/	SYM
dpc-4910	121	8	ml	ml	X
dpc-4910	121	9	vs.	vs.	ADP
dpc-4910	121	10	13.54	13.54	NUM
dpc-4910	121	11	±	±	NUM
dpc-4910	121	12	2.83	2.83	NUM
dpc-4910	121	13	ng	ng	PROPN
dpc-4910	121	14	/	/	SYM
dpc-4910	121	15	ml	ml	PROPN
dpc-4910	121	16	,	,	PUNCT
dpc-4910	121	17	p<0.001	p<0.001	ADJ
dpc-4910	121	18	)	)	PUNCT
dpc-4910	121	19	levels	level	NOUN
dpc-4910	121	20	of	of	ADP
dpc-4910	121	21	psoriasis	psoriasis	NOUN
dpc-4910	121	22	group	group	NOUN
dpc-4910	121	23	were	be	AUX
dpc-4910	121	24	significantly	significantly	ADV
dpc-4910	121	25	higher	high	ADJ
dpc-4910	121	26	than	than	ADP
dpc-4910	121	27	the	the	DET
dpc-4910	121	28	control	control	NOUN
dpc-4910	121	29	group	group	NOUN
dpc-4910	121	30	(	(	PUNCT
dpc-4910	121	31	table	table	NOUN
dpc-4910	121	32	1	1	NUM
dpc-4910	121	33	and	and	CCONJ
dpc-4910	121	34	figure	figure	VERB
dpc-4910	121	35	1	1	NUM
dpc-4910	121	36	)	)	PUNCT
dpc-4910	121	37	.	.	PUNCT
dpc-4910	122	1	the	the	DET
dpc-4910	122	2	mean	mean	ADJ
dpc-4910	122	3	urinary	urinary	ADJ
dpc-4910	122	4	nephrin	nephrin	NOUN
dpc-4910	122	5	levels	level	NOUN
dpc-4910	122	6	in	in	ADP
dpc-4910	122	7	the	the	DET
dpc-4910	122	8	mild	mild	ADJ
dpc-4910	122	9	(	(	PUNCT
dpc-4910	122	10	28.21	28.21	NUM
dpc-4910	122	11	±7.04	±7.04	PROPN
dpc-4910	122	12	ng	ng	PROPN
dpc-4910	122	13	/	/	SYM
dpc-4910	122	14	ml	ml	PROPN
dpc-4910	122	15	)	)	PUNCT
dpc-4910	122	16	and	and	CCONJ
dpc-4910	122	17	moderate	moderate	ADJ
dpc-4910	122	18	(	(	PUNCT
dpc-4910	122	19	29.59±	29.59±	NUM
dpc-4910	122	20	5.03	5.03	NUM
dpc-4910	122	21	ng	ng	PROPN
dpc-4910	122	22	/	/	SYM
dpc-4910	122	23	ml	ml	NOUN
dpc-4910	122	24	)	)	PUNCT
dpc-4910	122	25	psoriasis	psoriasis	NOUN
dpc-4910	122	26	groups	group	NOUN
dpc-4910	122	27	were	be	AUX
dpc-4910	122	28	similar	similar	ADJ
dpc-4910	122	29	but	but	CCONJ
dpc-4910	122	30	higher	high	ADJ
dpc-4910	122	31	than	than	ADP
dpc-4910	122	32	those	those	PRON
dpc-4910	122	33	in	in	ADP
dpc-4910	122	34	the	the	DET
dpc-4910	122	35	control	control	NOUN
dpc-4910	122	36	group	group	NOUN
dpc-4910	122	37	(	(	PUNCT
dpc-4910	122	38	13.54	13.54	NUM
dpc-4910	122	39	±	±	NUM
dpc-4910	122	40	2.83	2.83	NUM
dpc-4910	122	41	ng	ng	PROPN
dpc-4910	122	42	/	/	SYM
dpc-4910	122	43	ml	ml	NOUN
dpc-4910	122	44	)	)	PUNCT
dpc-4910	122	45	.	.	PUNCT
dpc-4910	123	1	urinary	urinary	ADJ
dpc-4910	123	2	pdx	pdx	PROPN
dpc-4910	123	3	(	(	PUNCT
dpc-4910	123	4	51.17±6.73	51.17±6.73	PROPN
dpc-4910	123	5	ng	ng	PROPN
dpc-4910	123	6	/	/	SYM
dpc-4910	123	7	ml	ml	PROPN
dpc-4910	123	8	)	)	PUNCT
dpc-4910	123	9	and	and	CCONJ
dpc-4910	123	10	nephrin	nephrin	NOUN
dpc-4910	123	11	(	(	PUNCT
dpc-4910	123	12	39.74	39.74	NUM
dpc-4910	123	13	±7.33	±7.33	PROPN
dpc-4910	123	14	ng	ng	PROPN
dpc-4910	123	15	/	/	SYM
dpc-4910	123	16	ml	ml	NOUN
dpc-4910	123	17	)	)	PUNCT
dpc-4910	123	18	levels	level	NOUN
dpc-4910	123	19	of	of	ADP
dpc-4910	123	20	the	the	DET
dpc-4910	123	21	severe	severe	ADJ
dpc-4910	123	22	psoriasis	psoriasis	NOUN
dpc-4910	123	23	group	group	NOUN
dpc-4910	123	24	were	be	AUX
dpc-4910	123	25	significantly	significantly	ADV
dpc-4910	123	26	higher	high	ADJ
dpc-4910	123	27	than	than	ADP
dpc-4910	123	28	the	the	DET
dpc-4910	123	29	mild	mild	ADJ
dpc-4910	123	30	and	and	CCONJ
dpc-4910	123	31	moderate	moderate	ADJ
dpc-4910	123	32	psoriasis	psoriasis	NOUN
dpc-4910	123	33	groups	group	NOUN
dpc-4910	123	34	(	(	PUNCT
dpc-4910	123	35	table	table	NOUN
dpc-4910	123	36	2	2	NUM
dpc-4910	123	37	and	and	CCONJ
dpc-4910	123	38	figure	figure	NOUN
dpc-4910	123	39	2	2	NUM
dpc-4910	123	40	)	)	PUNCT
dpc-4910	123	41	.	.	PUNCT
dpc-4910	124	1	microalbuminuria	microalbuminuria	PROPN
dpc-4910	124	2	was	be	AUX
dpc-4910	124	3	detected	detect	VERB
dpc-4910	124	4	in	in	ADP
dpc-4910	124	5	10	10	NUM
dpc-4910	124	6	of	of	ADP
dpc-4910	124	7	the	the	DET
dpc-4910	124	8	58	58	NUM
dpc-4910	124	9	patients	patient	NOUN
dpc-4910	124	10	in	in	ADP
dpc-4910	124	11	the	the	DET
dpc-4910	124	12	psoriasis	psoriasis	NOUN
dpc-4910	124	13	group	group	NOUN
dpc-4910	124	14	and	and	CCONJ
dpc-4910	124	15	in	in	ADP
dpc-4910	124	16	one	one	NUM
dpc-4910	124	17	of	of	ADP
dpc-4910	124	18	the	the	DET
dpc-4910	124	19	20	20	NUM
dpc-4910	124	20	patients	patient	NOUN
dpc-4910	124	21	in	in	ADP
dpc-4910	124	22	the	the	DET
dpc-4910	124	23	control	control	NOUN
dpc-4910	124	24	group	group	NOUN
dpc-4910	124	25	.	.	PUNCT
dpc-4910	125	1	the	the	DET
dpc-4910	125	2	microalbuminuria	microalbuminuria	PROPN
dpc-4910	125	3	rates	rate	NOUN
dpc-4910	125	4	were	be	AUX
dpc-4910	125	5	similar	similar	ADJ
dpc-4910	125	6	in	in	ADP
dpc-4910	125	7	the	the	DET
dpc-4910	125	8	psoriasis	psoriasis	NOUN
dpc-4910	125	9	and	and	CCONJ
dpc-4910	125	10	control	control	NOUN
dpc-4910	125	11	groups	group	NOUN
dpc-4910	125	12	(	(	PUNCT
dpc-4910	125	13	17.2	17.2	NUM
dpc-4910	125	14	%	%	NOUN
dpc-4910	125	15	vs.	vs.	ADP
dpc-4910	125	16	5	5	NUM
dpc-4910	125	17	%	%	NOUN
dpc-4910	125	18	,	,	PUNCT
dpc-4910	125	19	p=0.272	p=0.272	NOUN
dpc-4910	125	20	)	)	PUNCT
dpc-4910	125	21	.	.	PUNCT
dpc-4910	126	1	the	the	DET
dpc-4910	126	2	risk	risk	NOUN
dpc-4910	126	3	of	of	ADP
dpc-4910	126	4	microalbuminuria	microalbuminuria	PROPN
dpc-4910	126	5	did	do	AUX
dpc-4910	126	6	not	not	PART
dpc-4910	126	7	vary	vary	VERB
dpc-4910	126	8	with	with	ADP
dpc-4910	126	9	psoriasis	psoriasis	NOUN
dpc-4910	126	10	severity	severity	NOUN
dpc-4910	126	11	.	.	PUNCT
dpc-4910	127	1	a	a	DET
dpc-4910	127	2	significant	significant	ADJ
dpc-4910	127	3	positive	positive	ADJ
dpc-4910	127	4	correlation	correlation	NOUN
dpc-4910	127	5	was	be	AUX
dpc-4910	127	6	detected	detect	VERB
dpc-4910	127	7	between	between	ADP
dpc-4910	127	8	the	the	DET
dpc-4910	127	9	urine	urine	NOUN
dpc-4910	127	10	pdx	pdx	PROPN
dpc-4910	127	11	and	and	CCONJ
dpc-4910	127	12	nephrin	nephrin	PROPN
dpc-4910	127	13	levels	level	NOUN
dpc-4910	127	14	(	(	PUNCT
dpc-4910	127	15	r=0.612	r=0.612	NOUN
dpc-4910	127	16	,	,	PUNCT
dpc-4910	127	17	p<0.001	p<0.001	PROPN
dpc-4910	127	18	)	)	PUNCT
dpc-4910	127	19	.	.	PUNCT
dpc-4910	128	1	urine	urine	NOUN
dpc-4910	128	2	pdx	pdx	PROPN
dpc-4910	128	3	showed	show	VERB
dpc-4910	128	4	a	a	DET
dpc-4910	128	5	significant	significant	ADJ
dpc-4910	128	6	positive	positive	ADJ
dpc-4910	128	7	correlation	correlation	NOUN
dpc-4910	128	8	with	with	ADP
dpc-4910	128	9	sbp	sbp	PROPN
dpc-4910	128	10	(	(	PUNCT
dpc-4910	128	11	r=0.515	r=0.515	NOUN
dpc-4910	128	12	,	,	PUNCT
dpc-4910	128	13	p<0.001	p<0.001	PROPN
dpc-4910	128	14	)	)	PUNCT
dpc-4910	128	15	and	and	CCONJ
dpc-4910	128	16	uacr	uacr	INTJ
dpc-4910	128	17	(	(	PUNCT
dpc-4910	128	18	r=0.644	r=0.644	X
dpc-4910	128	19	,	,	PUNCT
dpc-4910	128	20	p<0.001	p<0.001	PROPN
dpc-4910	128	21	)	)	PUNCT
dpc-4910	128	22	.	.	PUNCT
dpc-4910	129	1	urine	urine	PROPN
dpc-4910	129	2	nephrin	nephrin	PROPN
dpc-4910	129	3	levels	level	NOUN
dpc-4910	129	4	were	be	AUX
dpc-4910	129	5	also	also	ADV
dpc-4910	129	6	significantly	significantly	ADV
dpc-4910	129	7	positively	positively	ADV
dpc-4910	129	8	correlated	correlate	VERB
dpc-4910	129	9	with	with	ADP
dpc-4910	129	10	sbp	sbp	PROPN
dpc-4910	129	11	(	(	PUNCT
dpc-4910	129	12	r=0.337	r=0.337	NOUN
dpc-4910	129	13	,	,	PUNCT
dpc-4910	129	14	p=0.01	p=0.01	PROPN
dpc-4910	129	15	)	)	PUNCT
dpc-4910	129	16	and	and	CCONJ
dpc-4910	129	17	uacr	uacr	INTJ
dpc-4910	129	18	(	(	PUNCT
dpc-4910	129	19	r=0.312	r=0.312	ADJ
dpc-4910	129	20	,	,	PUNCT
dpc-4910	129	21	p=0.017	p=0.017	PRON
dpc-4910	129	22	)	)	PUNCT
dpc-4910	129	23	.	.	PUNCT
dpc-4910	130	1	no	no	DET
dpc-4910	130	2	significant	significant	ADJ
dpc-4910	130	3	correlation	correlation	NOUN
dpc-4910	130	4	was	be	AUX
dpc-4910	130	5	found	find	VERB
dpc-4910	130	6	between	between	ADP
dpc-4910	130	7	urine	urine	NOUN
dpc-4910	130	8	pdx	pdx	PROPN
dpc-4910	130	9	,	,	PUNCT
dpc-4910	130	10	nephrin	nephrin	NOUN
dpc-4910	130	11	,	,	PUNCT
dpc-4910	130	12	and	and	CCONJ
dpc-4910	130	13	serum	serum	NOUN
dpc-4910	130	14	creatinine	creatinine	NOUN
dpc-4910	130	15	levels	level	NOUN
dpc-4910	130	16	(	(	PUNCT
dpc-4910	130	17	figure	figure	NOUN
dpc-4910	130	18	3	3	NUM
dpc-4910	130	19	)	)	PUNCT
dpc-4910	130	20	.	.	PUNCT
dpc-4910	131	1	in	in	ADP
dpc-4910	131	2	the	the	DET
dpc-4910	131	3	logistic	logistic	ADJ
dpc-4910	131	4	regression	regression	NOUN
dpc-4910	131	5	analysis	analysis	NOUN
dpc-4910	131	6	performed	perform	VERB
dpc-4910	131	7	after	after	ADP
dpc-4910	131	8	adjusting	adjust	VERB
dpc-4910	131	9	for	for	ADP
dpc-4910	131	10	age	age	NOUN
dpc-4910	131	11	,	,	PUNCT
dpc-4910	131	12	bmi	bmi	NOUN
dpc-4910	131	13	,	,	PUNCT
dpc-4910	131	14	and	and	CCONJ
dpc-4910	131	15	sex	sex	NOUN
dpc-4910	131	16	,	,	PUNCT
dpc-4910	131	17	urine	urine	NOUN
dpc-4910	131	18	pdx	pdx	PROPN
dpc-4910	131	19	and	and	CCONJ
dpc-4910	131	20	nephrin	nephrin	PROPN
dpc-4910	131	21	levels	level	NOUN
dpc-4910	131	22	were	be	AUX
dpc-4910	131	23	found	find	VERB
dpc-4910	131	24	to	to	PART
dpc-4910	131	25	be	be	AUX
dpc-4910	131	26	independent	independent	ADJ
dpc-4910	131	27	risk	risk	NOUN
dpc-4910	131	28	factors	factor	NOUN
dpc-4910	131	29	for	for	ADP
dpc-4910	131	30	microalbuminuria	microalbuminuria	NOUN
dpc-4910	131	31	in	in	ADP
dpc-4910	131	32	psoriasis	psoriasis	NOUN
dpc-4910	131	33	.	.	PUNCT
dpc-4910	132	1	a	a	DET
dpc-4910	132	2	1	1	NUM
dpc-4910	132	3	-	-	PUNCT
dpc-4910	132	4	unit	unit	NOUN
dpc-4910	132	5	increase	increase	NOUN
dpc-4910	132	6	in	in	ADP
dpc-4910	132	7	pdx	pdx	PROPN
dpc-4910	132	8	(	(	PUNCT
dpc-4910	132	9	or	or	CCONJ
dpc-4910	132	10	,	,	PUNCT
dpc-4910	132	11	1.831	1.831	NUM
dpc-4910	132	12	;	;	PUNCT
dpc-4910	132	13	95	95	NUM
dpc-4910	132	14	%	%	NOUN
dpc-4910	132	15	ci	ci	NOUN
dpc-4910	132	16	:	:	PUNCT
dpc-4910	132	17	1.189–2.821	1.189–2.821	NUM
dpc-4910	132	18	;	;	PUNCT
dpc-4910	132	19	p=0.006	p=0.006	X
dpc-4910	132	20	)	)	PUNCT
dpc-4910	132	21	and	and	CCONJ
dpc-4910	132	22	nephrin	nephrin	NOUN
dpc-4910	132	23	(	(	PUNCT
dpc-4910	132	24	or	or	CCONJ
dpc-4910	132	25	:	:	PUNCT
dpc-4910	132	26	1.625	1.625	NUM
dpc-4910	132	27	,	,	PUNCT
dpc-4910	132	28	95	95	NUM
dpc-4910	132	29	%	%	NOUN
dpc-4910	132	30	ci	ci	NOUN
dpc-4910	132	31	:	:	PUNCT
dpc-4910	132	32	1.129–2.339	1.129–2.339	NUM
dpc-4910	132	33	;	;	PUNCT
dpc-4910	132	34	p=0.009	p=0.009	X
dpc-4910	132	35	)	)	PUNCT
dpc-4910	132	36	led	lead	VERB
dpc-4910	132	37	to	to	ADP
dpc-4910	132	38	a	a	DET
dpc-4910	132	39	1.83	1.83	NUM
dpc-4910	132	40	-	-	ADJ
dpc-4910	132	41	fold	fold	ADJ
dpc-4910	132	42	and	and	CCONJ
dpc-4910	132	43	1.62fold	1.62fold	NOUN
dpc-4910	132	44	increase	increase	NOUN
dpc-4910	132	45	in	in	ADP
dpc-4910	132	46	the	the	DET
dpc-4910	132	47	risk	risk	NOUN
dpc-4910	132	48	of	of	ADP
dpc-4910	132	49	microalbuminuria	microalbuminuria	NOUN
dpc-4910	132	50	,	,	PUNCT
dpc-4910	132	51	respectively	respectively	ADV
dpc-4910	132	52	.	.	PUNCT
dpc-4910	133	1	conclusions	conclusion	NOUN
dpc-4910	133	2	many	many	ADJ
dpc-4910	133	3	studies	study	NOUN
dpc-4910	133	4	have	have	AUX
dpc-4910	133	5	shown	show	VERB
dpc-4910	133	6	that	that	SCONJ
dpc-4910	133	7	the	the	DET
dpc-4910	133	8	risk	risk	NOUN
dpc-4910	133	9	of	of	ADP
dpc-4910	133	10	renal	renal	ADJ
dpc-4910	133	11	disease	disease	NOUN
dpc-4910	133	12	is	be	AUX
dpc-4910	133	13	higher	high	ADJ
dpc-4910	133	14	in	in	ADP
dpc-4910	133	15	patients	patient	NOUN
dpc-4910	133	16	with	with	ADP
dpc-4910	133	17	psoriasis	psoriasis	NOUN
dpc-4910	133	18	vulgaris	vulgaris	NOUN
dpc-4910	133	19	than	than	ADP
dpc-4910	133	20	in	in	ADP
dpc-4910	133	21	the	the	DET
dpc-4910	133	22	disease	disease	NOUN
dpc-4910	133	23	free	free	ADJ
dpc-4910	133	24	population	population	NOUN
dpc-4910	133	25	and	and	CCONJ
dpc-4910	133	26	that	that	SCONJ
dpc-4910	133	27	this	this	DET
dpc-4910	133	28	risk	risk	NOUN
dpc-4910	133	29	increases	increase	VERB
dpc-4910	133	30	withpsoriasis	withpsoriasis	NOUN
dpc-4910	133	31	severitys	severitys	NOUN
dpc-4910	134	1	[	[	X
dpc-4910	134	2	1	1	NUM
dpc-4910	134	3	-	-	SYM
dpc-4910	134	4	3	3	NUM
dpc-4910	134	5	]	]	PUNCT
dpc-4910	134	6	.	.	PUNCT
dpc-4910	135	1	the	the	DET
dpc-4910	135	2	chronic	chronic	ADJ
dpc-4910	135	3	inflammatory	inflammatory	ADJ
dpc-4910	135	4	nature	nature	NOUN
dpc-4910	135	5	of	of	ADP
dpc-4910	135	6	psoriasis	psoriasis	NOUN
dpc-4910	135	7	and	and	CCONJ
dpc-4910	135	8	its	its	PRON
dpc-4910	135	9	association	association	NOUN
dpc-4910	135	10	with	with	ADP
dpc-4910	135	11	obesity	obesity	NOUN
dpc-4910	135	12	,	,	PUNCT
dpc-4910	135	13	diabetes	diabetes	NOUN
dpc-4910	135	14	,	,	PUNCT
dpc-4910	135	15	and	and	CCONJ
dpc-4910	135	16	cardiovascular	cardiovascular	ADJ
dpc-4910	135	17	diseases	disease	NOUN
dpc-4910	135	18	are	be	AUX
dpc-4910	135	19	considered	consider	VERB
dpc-4910	135	20	the	the	DET
dpc-4910	135	21	main	main	ADJ
dpc-4910	135	22	causes	cause	NOUN
dpc-4910	135	23	of	of	ADP
dpc-4910	135	24	renal	renal	ADJ
dpc-4910	135	25	damage	damage	NOUN
dpc-4910	135	26	[	[	X
dpc-4910	135	27	15	15	NUM
dpc-4910	135	28	]	]	PUNCT
dpc-4910	135	29	.	.	PUNCT
dpc-4910	136	1	accompanying	accompany	VERB
dpc-4910	136	2	osteoarthritis	osteoarthritis	NOUN
dpc-4910	136	3	with	with	ADP
dpc-4910	136	4	psoriasis	psoriasis	NOUN
dpc-4910	136	5	and	and	CCONJ
dpc-4910	136	6	the	the	DET
dpc-4910	136	7	use	use	NOUN
dpc-4910	136	8	of	of	ADP
dpc-4910	136	9	methotrexate	methotrexate	NOUN
dpc-4910	136	10	,	,	PUNCT
dpc-4910	136	11	cyclosporine	cyclosporine	NOUN
dpc-4910	136	12	,	,	PUNCT
dpc-4910	136	13	or	or	CCONJ
dpc-4910	136	14	nonsteroidal	nonsteroidal	NOUN
dpc-4910	136	15	anti	anti	ADJ
dpc-4910	136	16	-	-	ADJ
dpc-4910	136	17	inflammatory	inflammatory	ADJ
dpc-4910	136	18	drugs	drug	NOUN
dpc-4910	136	19	for	for	ADP
dpc-4910	136	20	therapeutic	therapeutic	ADJ
dpc-4910	136	21	purposes	purpose	NOUN
dpc-4910	136	22	significantly	significantly	ADV
dpc-4910	136	23	increases	increase	VERB
dpc-4910	136	24	the	the	DET
dpc-4910	136	25	risk	risk	NOUN
dpc-4910	136	26	of	of	ADP
dpc-4910	136	27	renal	renal	ADJ
dpc-4910	136	28	damage	damage	NOUN
dpc-4910	137	1	[	[	X
dpc-4910	137	2	2,4	2,4	NUM
dpc-4910	137	3	]	]	PUNCT
dpc-4910	137	4	.	.	PUNCT
dpc-4910	138	1	in	in	ADP
dpc-4910	138	2	contrast	contrast	NOUN
dpc-4910	138	3	,	,	PUNCT
dpc-4910	138	4	psoriasis	psoriasis	NOUN
dpc-4910	138	5	is	be	AUX
dpc-4910	138	6	thought	think	VERB
dpc-4910	138	7	to	to	PART
dpc-4910	138	8	initiate	initiate	VERB
dpc-4910	138	9	kidney	kidney	NOUN
dpc-4910	138	10	damage	damage	NOUN
dpc-4910	138	11	by	by	ADP
dpc-4910	138	12	causing	cause	VERB
dpc-4910	138	13	nephritis	nephritis	NOUN
dpc-4910	138	14	in	in	ADP
dpc-4910	138	15	the	the	DET
dpc-4910	138	16	glomeruli	glomeruli	NOUN
dpc-4910	138	17	,	,	PUNCT
dpc-4910	138	18	regardless	regardless	ADV
dpc-4910	138	19	of	of	ADP
dpc-4910	138	20	the	the	DET
dpc-4910	138	21	accompanying	accompany	VERB
dpc-4910	138	22	comorbidities	comorbiditie	NOUN
dpc-4910	138	23	[	[	X
dpc-4910	138	24	3	3	NUM
dpc-4910	138	25	]	]	PUNCT
dpc-4910	138	26	.	.	PUNCT
dpc-4910	139	1	therefore	therefore	ADV
dpc-4910	139	2	,	,	PUNCT
dpc-4910	139	3	early	early	ADJ
dpc-4910	139	4	detection	detection	NOUN
dpc-4910	139	5	of	of	ADP
dpc-4910	139	6	subclinical	subclinical	ADJ
dpc-4910	139	7	renal	renal	ADJ
dpc-4910	139	8	dysfunction	dysfunction	NOUN
dpc-4910	139	9	in	in	ADP
dpc-4910	139	10	psoriasis	psoriasis	NOUN
dpc-4910	139	11	is	be	AUX
dpc-4910	139	12	important	important	ADJ
dpc-4910	139	13	to	to	PART
dpc-4910	139	14	prevent	prevent	VERB
dpc-4910	139	15	the	the	DET
dpc-4910	139	16	progression	progression	NOUN
dpc-4910	139	17	of	of	ADP
dpc-4910	139	18	renal	renal	ADJ
dpc-4910	139	19	damage	damage	NOUN
dpc-4910	139	20	.	.	PUNCT
dpc-4910	140	1	although	although	SCONJ
dpc-4910	140	2	predictive	predictive	ADJ
dpc-4910	140	3	tests	test	NOUN
dpc-4910	140	4	are	be	AUX
dpc-4910	140	5	more	more	ADV
dpc-4910	140	6	likely	likely	ADJ
dpc-4910	140	7	to	to	PART
dpc-4910	140	8	detect	detect	VERB
dpc-4910	140	9	kidney	kidney	NOUN
dpc-4910	140	10	damage	damage	NOUN
dpc-4910	140	11	in	in	ADP
dpc-4910	140	12	severe	severe	ADJ
dpc-4910	140	13	psoriasis	psoriasis	NOUN
dpc-4910	140	14	original	original	ADJ
dpc-4910	140	15	article	article	NOUN
dpc-4910	140	16	|	|	ADV
dpc-4910	140	17	dermatol	dermatol	ADJ
dpc-4910	140	18	pract	pract	NOUN
dpc-4910	140	19	concept	concept	NOUN
dpc-4910	140	20	.	.	PUNCT
dpc-4910	141	1	2025;15(2):4910	2025;15(2):4910	NUM
dpc-4910	141	2	5	5	NUM
dpc-4910	141	3	figure	figure	NOUN
dpc-4910	141	4	1	1	NUM
dpc-4910	141	5	.	.	PUNCT
dpc-4910	141	6	graphical	graphical	ADJ
dpc-4910	141	7	representation	representation	NOUN
dpc-4910	141	8	of	of	ADP
dpc-4910	141	9	podocalyxin	podocalyxin	NOUN
dpc-4910	141	10	(	(	PUNCT
dpc-4910	141	11	pdx	pdx	PROPN
dpc-4910	141	12	)	)	PUNCT
dpc-4910	141	13	and	and	CCONJ
dpc-4910	141	14	nephrin	nephrin	ADJ
dpc-4910	141	15	levels	level	NOUN
dpc-4910	141	16	of	of	ADP
dpc-4910	141	17	psoriasis	psoriasis	NOUN
dpc-4910	141	18	and	and	CCONJ
dpc-4910	141	19	control	control	NOUN
dpc-4910	141	20	groups	group	NOUN
dpc-4910	141	21	.	.	PUNCT
dpc-4910	142	1	note	note	VERB
dpc-4910	142	2	that	that	SCONJ
dpc-4910	142	3	both	both	DET
dpc-4910	142	4	markers	marker	NOUN
dpc-4910	142	5	were	be	AUX
dpc-4910	142	6	higher	high	ADJ
dpc-4910	142	7	in	in	ADP
dpc-4910	142	8	the	the	DET
dpc-4910	142	9	psoriasis	psoriasis	NOUN
dpc-4910	142	10	group	group	NOUN
dpc-4910	142	11	compared	compare	VERB
dpc-4910	142	12	to	to	ADP
dpc-4910	142	13	controls	control	NOUN
dpc-4910	142	14	.	.	PUNCT
dpc-4910	143	1	table	table	NOUN
dpc-4910	143	2	2	2	NUM
dpc-4910	143	3	.	.	PUNCT
dpc-4910	143	4	comparison	comparison	NOUN
dpc-4910	143	5	of	of	ADP
dpc-4910	143	6	demographic	demographic	ADJ
dpc-4910	143	7	and	and	CCONJ
dpc-4910	143	8	laboratory	laboratory	NOUN
dpc-4910	143	9	parameters	parameter	NOUN
dpc-4910	143	10	of	of	ADP
dpc-4910	143	11	the	the	DET
dpc-4910	143	12	groups	group	NOUN
dpc-4910	143	13	according	accord	VERB
dpc-4910	143	14	to	to	ADP
dpc-4910	143	15	psoriasis	psoriasis	NOUN
dpc-4910	143	16	severity	severity	NOUN
dpc-4910	143	17	.	.	PUNCT
dpc-4910	144	1	mild	mild	ADJ
dpc-4910	144	2	psoriasis	psoriasis	NOUN
dpc-4910	144	3	(	(	PUNCT
dpc-4910	144	4	n=22	n=22	NOUN
dpc-4910	144	5	)	)	PUNCT
dpc-4910	144	6	moderate	moderate	ADJ
dpc-4910	144	7	psoriasis	psoriasis	NOUN
dpc-4910	144	8	(	(	PUNCT
dpc-4910	144	9	n=16	n=16	NOUN
dpc-4910	144	10	)	)	PUNCT
dpc-4910	144	11	severe	severe	ADJ
dpc-4910	144	12	psoriasis	psoriasis	NOUN
dpc-4910	144	13	(	(	PUNCT
dpc-4910	144	14	n=20	n=20	NOUN
dpc-4910	144	15	)	)	PUNCT
dpc-4910	144	16	control(n=20	control(n=20	PROPN
dpc-4910	144	17	)	)	PUNCT
dpc-4910	144	18	age	age	NOUN
dpc-4910	144	19	(	(	PUNCT
dpc-4910	144	20	year	year	NOUN
dpc-4910	144	21	)	)	PUNCT
dpc-4910	144	22	34.59	34.59	NUM
dpc-4910	144	23	±	±	NUM
dpc-4910	144	24	3.9	3.9	NUM
dpc-4910	144	25	33.56±5.49	33.56±5.49	NUM
dpc-4910	144	26	36.70±5.32	36.70±5.32	NUM
dpc-4910	144	27	34.05	34.05	NUM
dpc-4910	144	28	±	±	NUM
dpc-4910	144	29	4.95	4.95	NUM
dpc-4910	144	30	bmi	bmi	NOUN
dpc-4910	144	31	(	(	PUNCT
dpc-4910	144	32	kg	kg	NOUN
dpc-4910	144	33	/	/	SYM
dpc-4910	144	34	m2	m2	PROPN
dpc-4910	144	35	)	)	PUNCT
dpc-4910	144	36	24.53±1.51	24.53±1.51	PROPN
dpc-4910	144	37	24.49±1.64	24.49±1.64	NUM
dpc-4910	144	38	25.06±1.38	25.06±1.38	NUM
dpc-4910	144	39	23.86±2.21	23.86±2.21	PROPN
dpc-4910	144	40	bsa	bsa	NOUN
dpc-4910	144	41	(	(	PUNCT
dpc-4910	144	42	%	%	INTJ
dpc-4910	144	43	)	)	PUNCT
dpc-4910	145	1	<3	<3	X
dpc-4910	145	2	%	%	NOUN
dpc-4910	145	3	3	3	NUM
dpc-4910	145	4	%	%	NOUN
dpc-4910	145	5	to	to	PART
dpc-4910	145	6	10	10	NUM
dpc-4910	145	7	%	%	NOUN
dpc-4910	145	8	>	>	SYM
dpc-4910	145	9	10	10	NUM
dpc-4910	145	10	%	%	NOUN
dpc-4910	145	11	male	male	NOUN
dpc-4910	145	12	/	/	SYM
dpc-4910	145	13	female	female	NOUN
dpc-4910	145	14	12/10	12/10	NUM
dpc-4910	145	15	(	(	PUNCT
dpc-4910	145	16	54.5	54.5	NUM
dpc-4910	145	17	%	%	NOUN
dpc-4910	145	18	)	)	PUNCT
dpc-4910	145	19	10/6	10/6	NUM
dpc-4910	145	20	(	(	PUNCT
dpc-4910	145	21	62.5	62.5	NUM
dpc-4910	145	22	%	%	NOUN
dpc-4910	145	23	)	)	PUNCT
dpc-4910	145	24	10/10	10/10	NUM
dpc-4910	145	25	(	(	PUNCT
dpc-4910	145	26	50	50	NUM
dpc-4910	145	27	%	%	NOUN
dpc-4910	145	28	)	)	PUNCT
dpc-4910	145	29	10/10	10/10	NUM
dpc-4910	145	30	(	(	PUNCT
dpc-4910	145	31	50	50	NUM
dpc-4910	145	32	%	%	NOUN
dpc-4910	145	33	)	)	PUNCT
dpc-4910	145	34	pdx	pdx	PROPN
dpc-4910	145	35	(	(	PUNCT
dpc-4910	145	36	ng	ng	PROPN
dpc-4910	145	37	/	/	SYM
dpc-4910	145	38	ml	ml	PROPN
dpc-4910	145	39	)	)	PUNCT
dpc-4910	145	40	37.20	37.20	NUM
dpc-4910	145	41	±	±	NUM
dpc-4910	145	42	8.87	8.87	NUM
dpc-4910	145	43	*	*	PUNCT
dpc-4910	145	44	*	*	PUNCT
dpc-4910	145	45	*	*	NOUN
dpc-4910	145	46	,	,	PUNCT
dpc-4910	145	47	#	#	SYM
dpc-4910	145	48	#	#	SYM
dpc-4910	145	49	#	#	NOUN
dpc-4910	145	50	38.51	38.51	NUM
dpc-4910	145	51	±7.87	±7.87	PROPN
dpc-4910	145	52	*	*	PROPN
dpc-4910	145	53	*	*	PUNCT
dpc-4910	145	54	*	*	NOUN
dpc-4910	145	55	,	,	PUNCT
dpc-4910	145	56	#	#	SYM
dpc-4910	145	57	#	#	SYM
dpc-4910	145	58	#	#	NOUN
dpc-4910	145	59	51.17	51.17	NUM
dpc-4910	145	60	±	±	NUM
dpc-4910	145	61	6.73	6.73	NUM
dpc-4910	145	62	*	*	PUNCT
dpc-4910	145	63	*	*	PUNCT
dpc-4910	145	64	*	*	PUNCT
dpc-4910	145	65	17.76±5.87	17.76±5.87	NUM
dpc-4910	145	66	nephrin	nephrin	X
dpc-4910	145	67	(	(	PUNCT
dpc-4910	145	68	ng	ng	PROPN
dpc-4910	145	69	/	/	SYM
dpc-4910	145	70	ml	ml	PROPN
dpc-4910	145	71	)	)	PUNCT
dpc-4910	145	72	28.21	28.21	NUM
dpc-4910	145	73	±	±	NUM
dpc-4910	145	74	7.04	7.04	NUM
dpc-4910	145	75	*	*	PUNCT
dpc-4910	145	76	*	*	PUNCT
dpc-4910	145	77	*	*	NOUN
dpc-4910	145	78	,	,	PUNCT
dpc-4910	145	79	#	#	SYM
dpc-4910	145	80	#	#	SYM
dpc-4910	145	81	#	#	NOUN
dpc-4910	145	82	29.59	29.59	NUM
dpc-4910	145	83	±	±	NUM
dpc-4910	145	84	5.03	5.03	NUM
dpc-4910	145	85	*	*	PUNCT
dpc-4910	145	86	*	*	PUNCT
dpc-4910	145	87	*	*	NOUN
dpc-4910	145	88	,	,	PUNCT
dpc-4910	145	89	#	#	SYM
dpc-4910	145	90	#	#	SYM
dpc-4910	145	91	#	#	NOUN
dpc-4910	145	92	39.74	39.74	NUM
dpc-4910	145	93	±	±	NUM
dpc-4910	145	94	7.33	7.33	NUM
dpc-4910	145	95	*	*	PUNCT
dpc-4910	145	96	*	*	PUNCT
dpc-4910	145	97	*	*	PUNCT
dpc-4910	145	98	13.54±2.83	13.54±2.83	NUM
dpc-4910	145	99	fbg	fbg	X
dpc-4910	145	100	(	(	PUNCT
dpc-4910	145	101	mg	mg	PROPN
dpc-4910	145	102	/	/	SYM
dpc-4910	145	103	dl	dl	PROPN
dpc-4910	145	104	)	)	PUNCT
dpc-4910	145	105	86.5	86.5	NUM
dpc-4910	145	106	(	(	PUNCT
dpc-4910	145	107	80	80	NUM
dpc-4910	145	108	-	-	SYM
dpc-4910	145	109	95	95	NUM
dpc-4910	145	110	)	)	PUNCT
dpc-4910	145	111	91.5	91.5	NUM
dpc-4910	145	112	(	(	PUNCT
dpc-4910	145	113	87	87	NUM
dpc-4910	145	114	-	-	SYM
dpc-4910	145	115	98.5	98.5	NUM
dpc-4910	145	116	)	)	PUNCT
dpc-4910	145	117	92.5	92.5	NUM
dpc-4910	145	118	(	(	PUNCT
dpc-4910	145	119	87.5	87.5	NUM
dpc-4910	145	120	-	-	SYM
dpc-4910	145	121	97	97	NUM
dpc-4910	145	122	)	)	PUNCT
dpc-4910	145	123	91.5	91.5	NUM
dpc-4910	145	124	(	(	PUNCT
dpc-4910	145	125	88	88	NUM
dpc-4910	145	126	-	-	SYM
dpc-4910	145	127	98	98	NUM
dpc-4910	145	128	)	)	PUNCT
dpc-4910	145	129	urea	urea	NOUN
dpc-4910	145	130	(	(	PUNCT
dpc-4910	145	131	mg	mg	PROPN
dpc-4910	145	132	/	/	SYM
dpc-4910	145	133	dl	dl	NOUN
dpc-4910	145	134	)	)	PUNCT
dpc-4910	145	135	30.68	30.68	NUM
dpc-4910	145	136	±8.35	±8.35	NOUN
dpc-4910	145	137	29.39	29.39	NUM
dpc-4910	145	138	±3.95	±3.95	NOUN
dpc-4910	145	139	30.21	30.21	NUM
dpc-4910	145	140	±6.35	±6.35	NOUN
dpc-4910	145	141	28.95	28.95	NUM
dpc-4910	145	142	±6.64	±6.64	NOUN
dpc-4910	145	143	creatinine	creatinine	NOUN
dpc-4910	145	144	(	(	PUNCT
dpc-4910	145	145	mg	mg	PROPN
dpc-4910	145	146	/	/	SYM
dpc-4910	145	147	dl	dl	NOUN
dpc-4910	145	148	)	)	PUNCT
dpc-4910	145	149	0.70	0.70	NUM
dpc-4910	145	150	(	(	PUNCT
dpc-4910	145	151	0.64	0.64	NUM
dpc-4910	145	152	-	-	PUNCT
dpc-4910	145	153	0.78	0.78	NUM
dpc-4910	145	154	)	)	PUNCT
dpc-4910	145	155	#	#	SYM
dpc-4910	145	156	#	#	NOUN
dpc-4910	145	157	0.79	0.79	NUM
dpc-4910	145	158	(	(	PUNCT
dpc-4910	145	159	0.74	0.74	NUM
dpc-4910	145	160	-	-	PUNCT
dpc-4910	145	161	0.89	0.89	NUM
dpc-4910	145	162	)	)	PUNCT
dpc-4910	145	163	0.88	0.88	NUM
dpc-4910	145	164	(	(	PUNCT
dpc-4910	145	165	0.75	0.75	NUM
dpc-4910	145	166	-	-	SYM
dpc-4910	145	167	0.98	0.98	NUM
dpc-4910	145	168	)	)	PUNCT
dpc-4910	145	169	*	*	PUNCT
dpc-4910	145	170	0.72	0.72	NUM
dpc-4910	145	171	(	(	PUNCT
dpc-4910	145	172	0.63	0.63	NUM
dpc-4910	145	173	0.83	0.83	NUM
dpc-4910	145	174	)	)	PUNCT
dpc-4910	145	175	sbp	sbp	NOUN
dpc-4910	145	176	(	(	PUNCT
dpc-4910	145	177	mm	mm	PROPN
dpc-4910	145	178	/	/	SYM
dpc-4910	145	179	hg	hg	NOUN
dpc-4910	145	180	)	)	PUNCT
dpc-4910	145	181	112.5	112.5	NUM
dpc-4910	145	182	(	(	PUNCT
dpc-4910	145	183	105	105	NUM
dpc-4910	145	184	-	-	SYM
dpc-4910	145	185	120	120	NUM
dpc-4910	145	186	)	)	PUNCT
dpc-4910	145	187	110	110	NUM
dpc-4910	145	188	(	(	PUNCT
dpc-4910	145	189	110	110	NUM
dpc-4910	145	190	-	-	SYM
dpc-4910	145	191	115	115	NUM
dpc-4910	145	192	)	)	PUNCT
dpc-4910	145	193	120	120	NUM
dpc-4910	145	194	(	(	PUNCT
dpc-4910	145	195	110	110	NUM
dpc-4910	145	196	-	-	SYM
dpc-4910	145	197	122.5	122.5	NUM
dpc-4910	145	198	)	)	PUNCT
dpc-4910	145	199	110	110	NUM
dpc-4910	145	200	(	(	PUNCT
dpc-4910	145	201	110	110	NUM
dpc-4910	145	202	-	-	SYM
dpc-4910	145	203	115	115	NUM
dpc-4910	145	204	)	)	PUNCT
dpc-4910	145	205	dbp	dbp	PROPN
dpc-4910	145	206	(	(	PUNCT
dpc-4910	145	207	mm	mm	PROPN
dpc-4910	145	208	/	/	SYM
dpc-4910	145	209	hg	hg	NOUN
dpc-4910	145	210	)	)	PUNCT
dpc-4910	145	211	75.0	75.0	NUM
dpc-4910	145	212	(	(	PUNCT
dpc-4910	145	213	70.0	70.0	NUM
dpc-4910	145	214	-	-	SYM
dpc-4910	145	215	80.0	80.0	NUM
dpc-4910	145	216	)	)	PUNCT
dpc-4910	145	217	75.0	75.0	NUM
dpc-4910	145	218	(	(	PUNCT
dpc-4910	145	219	70.0	70.0	NUM
dpc-4910	145	220	-	-	SYM
dpc-4910	145	221	80.0	80.0	NUM
dpc-4910	145	222	)	)	PUNCT
dpc-4910	145	223	80.0	80.0	NUM
dpc-4910	145	224	(	(	PUNCT
dpc-4910	145	225	75.0	75.0	NUM
dpc-4910	145	226	-	-	SYM
dpc-4910	145	227	85.0	85.0	NUM
dpc-4910	145	228	)	)	PUNCT
dpc-4910	145	229	72.5	72.5	NUM
dpc-4910	145	230	(	(	PUNCT
dpc-4910	145	231	70.0	70.0	NUM
dpc-4910	145	232	-	-	SYM
dpc-4910	145	233	80.0	80.0	NUM
dpc-4910	145	234	)	)	PUNCT
dpc-4910	145	235	hdl	hdl	PROPN
dpc-4910	145	236	-	-	PUNCT
dpc-4910	145	237	c	c	PROPN
dpc-4910	145	238	(	(	PUNCT
dpc-4910	145	239	mg	mg	PROPN
dpc-4910	145	240	/	/	SYM
dpc-4910	145	241	dl	dl	NOUN
dpc-4910	145	242	)	)	PUNCT
dpc-4910	145	243	35.55	35.55	NUM
dpc-4910	145	244	±12.03	±12.03	PROPN
dpc-4910	145	245	33.06	33.06	NUM
dpc-4910	145	246	±	±	NUM
dpc-4910	145	247	13.90	13.90	NUM
dpc-4910	145	248	*	*	SYM
dpc-4910	145	249	34.35	34.35	NUM
dpc-4910	145	250	±	±	NUM
dpc-4910	145	251	7.31	7.31	NUM
dpc-4910	145	252	*	*	PUNCT
dpc-4910	145	253	46.70	46.70	NUM
dpc-4910	145	254	±	±	NUM
dpc-4910	145	255	15.85	15.85	NUM
dpc-4910	145	256	tg	tg	PROPN
dpc-4910	145	257	(	(	PUNCT
dpc-4910	145	258	mg	mg	PROPN
dpc-4910	145	259	/	/	SYM
dpc-4910	145	260	dl	dl	PROPN
dpc-4910	145	261	)	)	PUNCT
dpc-4910	145	262	106.5	106.5	NUM
dpc-4910	145	263	(	(	PUNCT
dpc-4910	145	264	89154	89154	NUM
dpc-4910	145	265	)	)	PUNCT
dpc-4910	145	266	107.5	107.5	NUM
dpc-4910	145	267	(	(	PUNCT
dpc-4910	145	268	81	81	NUM
dpc-4910	145	269	-165	-165	PROPN
dpc-4910	145	270	)	)	PUNCT
dpc-4910	145	271	156.5	156.5	NUM
dpc-4910	145	272	(	(	PUNCT
dpc-4910	145	273	133.5	133.5	NUM
dpc-4910	145	274	-	-	SYM
dpc-4910	145	275	198	198	NUM
dpc-4910	145	276	)	)	PUNCT
dpc-4910	145	277	*	*	PUNCT
dpc-4910	145	278	*	*	NOUN
dpc-4910	145	279	92.5	92.5	NUM
dpc-4910	145	280	(	(	PUNCT
dpc-4910	145	281	75.5119.5	75.5119.5	NUM
dpc-4910	145	282	)	)	PUNCT
dpc-4910	145	283	homa	homa	NOUN
dpc-4910	145	284	-	-	PUNCT
dpc-4910	145	285	ir	ir	PROPN
dpc-4910	145	286	1.95	1.95	NUM
dpc-4910	145	287	±	±	NOUN
dpc-4910	145	288	0.29	0.29	NUM
dpc-4910	145	289	*	*	NUM
dpc-4910	145	290	2.08	2.08	NUM
dpc-4910	145	291	±	±	NUM
dpc-4910	145	292	0.35	0.35	NUM
dpc-4910	145	293	*	*	PUNCT
dpc-4910	145	294	2.15	2.15	NUM
dpc-4910	145	295	±	±	NOUN
dpc-4910	145	296	0.38	0.38	NUM
dpc-4910	145	297	*	*	NOUN
dpc-4910	145	298	1.29	1.29	NUM
dpc-4910	145	299	±	±	NUM
dpc-4910	145	300	0.15	0.15	NUM
dpc-4910	145	301	normo	normo	NOUN
dpc-4910	145	302	-	-	PUNCT
dpc-4910	145	303	albuminuria	albuminuria	PROPN
dpc-4910	145	304	(	(	PUNCT
dpc-4910	145	305	uacr≤30	uacr≤30	PROPN
dpc-4910	145	306	mg	mg	PROPN
dpc-4910	145	307	/	/	SYM
dpc-4910	145	308	gcr	gcr	NOUN
dpc-4910	145	309	)	)	PUNCT
dpc-4910	145	310	20	20	NUM
dpc-4910	145	311	(	(	PUNCT
dpc-4910	145	312	90.9	90.9	NUM
dpc-4910	145	313	%	%	NOUN
dpc-4910	145	314	)	)	PUNCT
dpc-4910	145	315	14	14	NUM
dpc-4910	145	316	(	(	PUNCT
dpc-4910	145	317	87.5	87.5	NUM
dpc-4910	145	318	%	%	NOUN
dpc-4910	145	319	)	)	PUNCT
dpc-4910	145	320	14	14	NUM
dpc-4910	145	321	(	(	PUNCT
dpc-4910	145	322	70	70	NUM
dpc-4910	145	323	%	%	NOUN
dpc-4910	145	324	)	)	PUNCT
dpc-4910	145	325	19	19	NUM
dpc-4910	145	326	(	(	PUNCT
dpc-4910	145	327	95	95	NUM
dpc-4910	145	328	%	%	NOUN
dpc-4910	145	329	)	)	PUNCT
dpc-4910	145	330	micro	micro	NOUN
dpc-4910	145	331	-	-	NOUN
dpc-4910	145	332	albuminuria	albuminuria	PROPN
dpc-4910	145	333	(	(	PUNCT
dpc-4910	145	334	uacr>30	uacr>30	NOUN
dpc-4910	145	335	-	-	PUNCT
dpc-4910	145	336	300	300	NUM
dpc-4910	145	337	mg	mg	PROPN
dpc-4910	145	338	/	/	SYM
dpc-4910	145	339	gcr	gcr	NOUN
dpc-4910	145	340	)	)	PUNCT
dpc-4910	145	341	2	2	NUM
dpc-4910	145	342	(	(	PUNCT
dpc-4910	145	343	9.1	9.1	NUM
dpc-4910	145	344	%	%	NOUN
dpc-4910	145	345	)	)	PUNCT
dpc-4910	145	346	2	2	NUM
dpc-4910	145	347	(	(	PUNCT
dpc-4910	145	348	%	%	NOUN
dpc-4910	145	349	12.5	12.5	NUM
dpc-4910	145	350	)	)	PUNCT
dpc-4910	145	351	6	6	NUM
dpc-4910	145	352	(	(	PUNCT
dpc-4910	145	353	30	30	NUM
dpc-4910	145	354	%	%	NOUN
dpc-4910	145	355	)	)	PUNCT
dpc-4910	145	356	1	1	NUM
dpc-4910	145	357	(	(	PUNCT
dpc-4910	145	358	5	5	NUM
dpc-4910	145	359	%	%	NOUN
dpc-4910	145	360	)	)	PUNCT
dpc-4910	145	361	data	datum	NOUN
dpc-4910	145	362	are	be	AUX
dpc-4910	145	363	given	give	VERB
dpc-4910	145	364	as	as	ADP
dpc-4910	145	365	mean	mean	PROPN
dpc-4910	145	366	±	±	NUM
dpc-4910	145	367	standard	standard	ADJ
dpc-4910	145	368	deviation	deviation	NOUN
dpc-4910	145	369	or	or	CCONJ
dpc-4910	145	370	median	median	NOUN
dpc-4910	145	371	(	(	PUNCT
dpc-4910	145	372	1st	1st	ADJ
dpc-4910	145	373	quartile	quartile	NOUN
dpc-4910	145	374	–	–	PUNCT
dpc-4910	145	375	3rd	3rd	ADJ
dpc-4910	145	376	quartile	quartile	NOUN
dpc-4910	145	377	)	)	PUNCT
dpc-4910	145	378	for	for	ADP
dpc-4910	145	379	continuous	continuous	ADJ
dpc-4910	145	380	variables	variable	NOUN
dpc-4910	145	381	according	accord	VERB
dpc-4910	145	382	to	to	ADP
dpc-4910	145	383	normality	normality	NOUN
dpc-4910	145	384	of	of	ADP
dpc-4910	145	385	distribution	distribution	NOUN
dpc-4910	145	386	and	and	CCONJ
dpc-4910	145	387	as	as	ADP
dpc-4910	145	388	frequency	frequency	NOUN
dpc-4910	145	389	(	(	PUNCT
dpc-4910	145	390	percentage	percentage	NOUN
dpc-4910	145	391	)	)	PUNCT
dpc-4910	145	392	for	for	ADP
dpc-4910	145	393	categorical	categorical	ADJ
dpc-4910	145	394	variable	variable	NOUN
dpc-4910	145	395	.	.	PUNCT
dpc-4910	146	1	bonferroni	bonferroni	PROPN
dpc-4910	146	2	adjusted	adjust	VERB
dpc-4910	146	3	p	p	NOUN
dpc-4910	146	4	values	value	NOUN
dpc-4910	146	5	were	be	AUX
dpc-4910	146	6	used	use	VERB
dpc-4910	146	7	.	.	PUNCT
dpc-4910	147	1	*	*	PUNCT
dpc-4910	147	2	p	p	X
dpc-4910	147	3	<	<	NOUN
dpc-4910	147	4	0.05	0.05	NUM
dpc-4910	147	5	,	,	PUNCT
dpc-4910	147	6	*	*	PUNCT
dpc-4910	147	7	*	*	PUNCT
dpc-4910	147	8	p	p	X
dpc-4910	147	9	<	<	X
dpc-4910	147	10	0.01	0.01	NUM
dpc-4910	147	11	,	,	PUNCT
dpc-4910	147	12	*	*	PUNCT
dpc-4910	147	13	*	*	PUNCT
dpc-4910	147	14	*	*	PUNCT
dpc-4910	147	15	p	p	X
dpc-4910	147	16	<	<	X
dpc-4910	147	17	0.001	0.001	NUM
dpc-4910	147	18	vs.	vs.	ADP
dpc-4910	147	19	control	control	NOUN
dpc-4910	147	20	;	;	PUNCT
dpc-4910	147	21	#	#	SYM
dpc-4910	147	22	#	#	SYM
dpc-4910	147	23	p	p	NOUN
dpc-4910	147	24	<	<	NOUN
dpc-4910	147	25	0.01	0.01	NUM
dpc-4910	147	26	,	,	PUNCT
dpc-4910	147	27	#	#	SYM
dpc-4910	147	28	#	#	SYM
dpc-4910	147	29	#	#	SYM
dpc-4910	147	30	p	p	NOUN
dpc-4910	147	31	<	<	NOUN
dpc-4910	147	32	0.001	0.001	NUM
dpc-4910	147	33	vs.	vs.	ADP
dpc-4910	147	34	severe	severe	ADJ
dpc-4910	147	35	psoriasis	psoriasis	NOUN
dpc-4910	147	36	group	group	NOUN
dpc-4910	147	37	.	.	PUNCT
dpc-4910	148	1	abbreviations	abbreviation	NOUN
dpc-4910	148	2	:	:	PUNCT
dpc-4910	148	3	bmi	bmi	PROPN
dpc-4910	148	4	=	=	SYM
dpc-4910	148	5	body	body	PROPN
dpc-4910	148	6	mass	mass	PROPN
dpc-4910	148	7	index	index	NOUN
dpc-4910	148	8	;	;	PUNCT
dpc-4910	148	9	bsa	bsa	PROPN
dpc-4910	148	10	=	=	PROPN
dpc-4910	148	11	body	body	PROPN
dpc-4910	148	12	surface	surface	NOUN
dpc-4910	148	13	area	area	NOUN
dpc-4910	148	14	;	;	PUNCT
dpc-4910	148	15	dbp	dbp	PROPN
dpc-4910	148	16	=	=	PROPN
dpc-4910	148	17	diastolic	diastolic	NOUN
dpc-4910	148	18	blood	blood	NOUN
dpc-4910	148	19	pressure	pressure	NOUN
dpc-4910	148	20	;	;	PUNCT
dpc-4910	148	21	fbg	fbg	NOUN
dpc-4910	148	22	=	=	PUNCT
dpc-4910	148	23	fasting	fast	VERB
dpc-4910	148	24	blood	blood	NOUN
dpc-4910	148	25	glucose	glucose	NOUN
dpc-4910	148	26	;	;	PUNCT
dpc-4910	148	27	hdl	hdl	PROPN
dpc-4910	148	28	-	-	PUNCT
dpc-4910	148	29	c	c	NOUN
dpc-4910	148	30	=	=	SYM
dpc-4910	148	31	high	high	ADJ
dpc-4910	148	32	-	-	PUNCT
dpc-4910	148	33	density	density	NOUN
dpc-4910	148	34	lipoprotein	lipoprotein	ADJ
dpc-4910	148	35	cholesterol	cholesterol	NOUN
dpc-4910	148	36	;	;	PUNCT
dpc-4910	148	37	homa	homa	NOUN
dpc-4910	148	38	-	-	PUNCT
dpc-4910	148	39	ir	ir	NOUN
dpc-4910	148	40	=	=	NOUN
dpc-4910	148	41	homeostasis	homeostasis	NOUN
dpc-4910	148	42	model	model	NOUN
dpc-4910	148	43	assessment	assessment	NOUN
dpc-4910	148	44	insulin	insulin	NOUN
dpc-4910	148	45	resistance	resistance	NOUN
dpc-4910	148	46	;	;	PUNCT
dpc-4910	148	47	sbp	sbp	NOUN
dpc-4910	148	48	=	=	SYM
dpc-4910	148	49	systolic	systolic	ADJ
dpc-4910	148	50	blood	blood	NOUN
dpc-4910	148	51	pressure	pressure	NOUN
dpc-4910	148	52	;	;	PUNCT
dpc-4910	148	53	pdx	pdx	PROPN
dpc-4910	148	54	=	=	PROPN
dpc-4910	148	55	podocalyxin	podocalyxin	PROPN
dpc-4910	148	56	;	;	PUNCT
dpc-4910	149	1	tg	tg	PROPN
dpc-4910	149	2	=	=	PUNCT
dpc-4910	149	3	triglyceride	triglyceride	ADJ
dpc-4910	149	4	;	;	PUNCT
dpc-4910	149	5	uacr	uacr	NOUN
dpc-4910	149	6	=	=	SYM
dpc-4910	149	7	albumin	albumin	ADJ
dpc-4910	149	8	-	-	PUNCT
dpc-4910	149	9	creatinine	creatinine	NOUN
dpc-4910	149	10	ratio	ratio	NOUN
dpc-4910	149	11	.	.	PUNCT
dpc-4910	150	1	cases	case	NOUN
dpc-4910	150	2	,	,	PUNCT
dpc-4910	150	3	albumin	albumin	ADJ
dpc-4910	150	4	leakage	leakage	NOUN
dpc-4910	150	5	,	,	PUNCT
dpc-4910	150	6	serum	serum	NOUN
dpc-4910	150	7	creatinine	creatinine	NOUN
dpc-4910	150	8	,	,	PUNCT
dpc-4910	150	9	and	and	CCONJ
dpc-4910	150	10	serum	serum	NOUN
dpc-4910	150	11	nitrogen	nitrogen	NOUN
dpc-4910	150	12	levels	level	NOUN
dpc-4910	150	13	may	may	AUX
dpc-4910	150	14	be	be	AUX
dpc-4910	150	15	normal	normal	ADJ
dpc-4910	150	16	in	in	ADP
dpc-4910	150	17	mild	mild	ADJ
dpc-4910	150	18	and	and	CCONJ
dpc-4910	150	19	moderate	moderate	ADJ
dpc-4910	150	20	psoriasis	psoriasis	NOUN
dpc-4910	150	21	cases	case	NOUN
dpc-4910	150	22	[	[	X
dpc-4910	150	23	6,12	6,12	NUM
dpc-4910	150	24	]	]	PUNCT
dpc-4910	150	25	.	.	PUNCT
dpc-4910	151	1	this	this	DET
dpc-4910	151	2	study	study	NOUN
dpc-4910	151	3	provides	provide	VERB
dpc-4910	151	4	new	new	ADJ
dpc-4910	151	5	data	datum	NOUN
dpc-4910	151	6	showing	show	VERB
dpc-4910	151	7	that	that	SCONJ
dpc-4910	151	8	the	the	DET
dpc-4910	151	9	urinary	urinary	ADJ
dpc-4910	151	10	levels	level	NOUN
dpc-4910	151	11	of	of	ADP
dpc-4910	151	12	the	the	DET
dpc-4910	151	13	podocyte	podocyte	NOUN
dpc-4910	151	14	degradation	degradation	NOUN
dpc-4910	151	15	proteins	protein	NOUN
dpc-4910	151	16	pdx	pdx	NOUN
dpc-4910	151	17	and	and	CCONJ
dpc-4910	151	18	nephrin	nephrin	NOUN
dpc-4910	151	19	are	be	AUX
dpc-4910	151	20	significantly	significantly	ADV
dpc-4910	151	21	increased	increase	VERB
dpc-4910	151	22	in	in	ADP
dpc-4910	151	23	patients	patient	NOUN
dpc-4910	151	24	with	with	ADP
dpc-4910	151	25	psoriasis	psoriasis	NOUN
dpc-4910	151	26	compared	compare	VERB
dpc-4910	151	27	to	to	ADP
dpc-4910	151	28	those	those	PRON
dpc-4910	151	29	in	in	ADP
dpc-4910	151	30	healthy	healthy	ADJ
dpc-4910	151	31	controls	control	NOUN
dpc-4910	151	32	.	.	PUNCT
dpc-4910	152	1	the	the	DET
dpc-4910	152	2	positive	positive	ADJ
dpc-4910	152	3	correlation	correlation	NOUN
dpc-4910	152	4	between	between	ADP
dpc-4910	152	5	uacr	uacr	PROPN
dpc-4910	152	6	,	,	PUNCT
dpc-4910	152	7	pdx	pdx	PROPN
dpc-4910	152	8	,	,	PUNCT
dpc-4910	152	9	and	and	CCONJ
dpc-4910	152	10	nephrin	nephrin	PROPN
dpc-4910	152	11	indicates	indicate	VERB
dpc-4910	152	12	that	that	SCONJ
dpc-4910	152	13	the	the	DET
dpc-4910	152	14	urinary	urinary	ADJ
dpc-4910	152	15	excretion	excretion	NOUN
dpc-4910	152	16	of	of	ADP
dpc-4910	152	17	podocyte	podocyte	NOUN
dpc-4910	152	18	degradation	degradation	NOUN
dpc-4910	152	19	proteins	protein	NOUN
dpc-4910	152	20	and	and	CCONJ
dpc-4910	152	21	albumin	albumin	NOUN
dpc-4910	152	22	are	be	AUX
dpc-4910	152	23	interrelated	interrelate	VERB
dpc-4910	152	24	.	.	PUNCT
dpc-4910	153	1	although	although	SCONJ
dpc-4910	153	2	microalbuminuria	microalbuminuria	PROPN
dpc-4910	153	3	is	be	AUX
dpc-4910	153	4	observed	observe	VERB
dpc-4910	153	5	in	in	ADP
dpc-4910	153	6	17.2	17.2	NUM
dpc-4910	153	7	%	%	NOUN
dpc-4910	153	8	of	of	ADP
dpc-4910	153	9	patients	patient	NOUN
dpc-4910	153	10	with	with	ADP
dpc-4910	153	11	psoriasis	psoriasis	NOUN
dpc-4910	153	12	,	,	PUNCT
dpc-4910	153	13	an	an	DET
dpc-4910	153	14	increase	increase	NOUN
dpc-4910	153	15	in	in	ADP
dpc-4910	153	16	urinary	urinary	ADJ
dpc-4910	153	17	pdx	pdx	PROPN
dpc-4910	153	18	and	and	CCONJ
dpc-4910	153	19	nephrin	nephrin	PROPN
dpc-4910	153	20	levels	level	NOUN
dpc-4910	153	21	is	be	AUX
dpc-4910	153	22	detected	detect	VERB
dpc-4910	153	23	in	in	ADP
dpc-4910	153	24	the	the	DET
dpc-4910	153	25	majority	majority	NOUN
dpc-4910	153	26	of	of	ADP
dpc-4910	153	27	patients	patient	NOUN
dpc-4910	153	28	with	with	ADP
dpc-4910	153	29	psoriasis	psoriasis	NOUN
dpc-4910	153	30	,	,	PUNCT
dpc-4910	153	31	suggesting	suggest	VERB
dpc-4910	153	32	that	that	SCONJ
dpc-4910	153	33	the	the	DET
dpc-4910	153	34	passage	passage	NOUN
dpc-4910	153	35	of	of	ADP
dpc-4910	153	36	podocyte	podocyte	NOUN
dpc-4910	153	37	destruction	destruction	NOUN
dpc-4910	153	38	proteins	protein	NOUN
dpc-4910	153	39	into	into	ADP
dpc-4910	153	40	the	the	DET
dpc-4910	153	41	urine	urine	NOUN
dpc-4910	153	42	begins	begin	VERB
dpc-4910	153	43	before	before	ADP
dpc-4910	153	44	albumin	albumin	NOUN
dpc-4910	153	45	.	.	PUNCT
dpc-4910	154	1	even	even	ADV
dpc-4910	154	2	if	if	SCONJ
dpc-4910	154	3	renal	renal	ADJ
dpc-4910	154	4	dysfunction	dysfunction	NOUN
dpc-4910	154	5	and	and	CCONJ
dpc-4910	154	6	podocyte	podocyte	NOUN
dpc-4910	154	7	damage	damage	NOUN
dpc-4910	154	8	6	6	NUM
dpc-4910	154	9	original	original	ADJ
dpc-4910	154	10	article	article	NOUN
dpc-4910	154	11	|	|	ADV
dpc-4910	154	12	dermatol	dermatol	ADJ
dpc-4910	154	13	pract	pract	NOUN
dpc-4910	154	14	concept	concept	NOUN
dpc-4910	154	15	.	.	PUNCT
dpc-4910	155	1	2025;15(2):4910	2025;15(2):4910	NUM
dpc-4910	155	2	0.64	0.64	NUM
dpc-4910	155	3	*	*	PUNCT
dpc-4910	155	4	*	*	PUNCT
dpc-4910	155	5	*	*	PUNCT
dpc-4910	155	6	0.61	0.61	NUM
dpc-4910	155	7	*	*	PUNCT
dpc-4910	155	8	*	*	PUNCT
dpc-4910	155	9	*	*	PUNCT
dpc-4910	156	1	0.51	0.51	NUM
dpc-4910	156	2	*	*	PUNCT
dpc-4910	156	3	*	*	PUNCT
dpc-4910	156	4	*	*	PUNCT
dpc-4910	156	5	0.09	0.09	NUM
dpc-4910	156	6	ns	ns	NUM
dpc-4910	156	7	0.20	0.20	NUM
dpc-4910	156	8	ns	ns	NUM
dpc-4910	156	9	0.01	0.01	NUM
dpc-4910	156	10	ns	ns	NUM
dpc-4910	156	11	0.15	0.15	NUM
dpc-4910	156	12	ns	ns	NUM
dpc-4910	156	13	0.08	0.08	NUM
dpc-4910	156	14	ns	ns	NUM
dpc-4910	156	15	0.16	0.16	NUM
dpc-4910	156	16	ns	ns	NUM
dpc-4910	156	17	–	–	PUNCT
dpc-4910	156	18	0.01	0.01	NUM
dpc-4910	156	19	ns	ns	NUM
dpc-4910	156	20	0.25	0.25	NUM
dpc-4910	156	21	ns	ns	NUM
dpc-4910	156	22	0.10	0.10	NUM
dpc-4910	156	23	ns	ns	NUM
dpc-4910	156	24	–	–	PUNCT
dpc-4910	156	25	0.15	0.15	NUM
dpc-4910	156	26	ns	ns	NUM
dpc-4910	156	27	0.25	0.25	NUM
dpc-4910	156	28	ns	ns	NUM
dpc-4910	156	29	–	–	PUNCT
dpc-4910	156	30	0.13	0.13	NUM
dpc-4910	156	31	ns	ns	NUM
dpc-4910	156	32	–	–	PUNCT
dpc-4910	156	33	0.06	0.06	NUM
dpc-4910	156	34	ns	ns	NUM
dpc-4910	156	35	–	–	PUNCT
dpc-4910	156	36	0.09	0.09	NUM
dpc-4910	156	37	ns	ns	NUM
dpc-4910	156	38	0.09	0.09	NUM
dpc-4910	156	39	ns	ns	NUM
dpc-4910	156	40	–	–	PUNCT
dpc-4910	156	41	0.07	0.07	NUM
dpc-4910	156	42	ns	ns	NUM
dpc-4910	156	43	0.17	0.17	NUM
dpc-4910	156	44	ns	ns	NUM
dpc-4910	156	45	–	–	PUNCT
dpc-4910	156	46	0.06	0.06	NUM
dpc-4910	156	47	ns	ns	NUM
dpc-4910	156	48	0.01	0.01	NUM
dpc-4910	156	49	ns	ns	NUM
dpc-4910	156	50	0.15	0.15	NUM
dpc-4910	156	51	ns	ns	NUM
dpc-4910	156	52	–	–	PUNCT
dpc-4910	156	53	0.04	0.04	NUM
dpc-4910	156	54	ns	ns	NUM
dpc-4910	156	55	0.22	0.22	NUM
dpc-4910	156	56	ns	ns	NUM
dpc-4910	156	57	0.19	0.19	NUM
dpc-4910	156	58	ns	ns	NUM
dpc-4910	156	59	0.21	0.21	NUM
dpc-4910	156	60	ns	ns	NUM
dpc-4910	156	61	–	–	PUNCT
dpc-4910	156	62	0.07	0.07	NUM
dpc-4910	156	63	ns	ns	NUM
dpc-4910	156	64	0.22	0.22	NUM
dpc-4910	156	65	ns	ns	NUM
dpc-4910	156	66	0.11	0.11	NUM
dpc-4910	156	67	ns	ns	NUM
dpc-4910	156	68	0.13	0.13	NUM
dpc-4910	156	69	ns	ns	NUM
dpc-4910	156	70	0.18	0.18	NUM
dpc-4910	156	71	ns	ns	NUM
dpc-4910	156	72	–	–	PUNCT
dpc-4910	156	73	0.06	0.06	NUM
dpc-4910	156	74	ns	ns	NUM
dpc-4910	156	75	–	–	PUNCT
dpc-4910	156	76	0.02	0.02	NUM
dpc-4910	156	77	ns	ns	NUM
dpc-4910	156	78	–	–	PUNCT
dpc-4910	156	79	0.22	0.22	NUM
dpc-4910	156	80	ns	ns	NUM
dpc-4910	156	81	–	–	PUNCT
dpc-4910	156	82	0.06	0.06	NUM
dpc-4910	156	83	ns	ns	NUM
dpc-4910	156	84	–	–	PUNCT
dpc-4910	156	85	0.16	0.16	NUM
dpc-4910	156	86	ns	ns	NUM
dpc-4910	156	87	0.03	0.03	NUM
dpc-4910	156	88	ns	ns	NUM
dpc-4910	156	89	0.12	0.12	NUM
dpc-4910	156	90	ns	ns	NUM
dpc-4910	156	91	0.17	0.17	NUM
dpc-4910	156	92	ns	ns	NUM
dpc-4910	156	93	0.02	0.02	NUM
dpc-4910	156	94	ns	ns	NUM
dpc-4910	156	95	–	–	PUNCT
dpc-4910	156	96	0.08	0.08	NUM
dpc-4910	156	97	ns	ns	NUM
dpc-4910	156	98	0.00	0.00	NUM
dpc-4910	156	99	ns	ns	NUM
dpc-4910	156	100	0.08	0.08	NUM
dpc-4910	156	101	ns	ns	NUM
dpc-4910	156	102	0.07	0.07	NUM
dpc-4910	156	103	ns	ns	NUM
dpc-4910	156	104	–	–	PUNCT
dpc-4910	156	105	0.14	0.14	NUM
dpc-4910	156	106	ns	ns	NUM
dpc-4910	156	107	–	–	PUNCT
dpc-4910	156	108	0.18	0.18	NUM
dpc-4910	156	109	ns	ns	NUM
dpc-4910	156	110	0.08	0.08	NUM
dpc-4910	156	111	ns	ns	NUM
dpc-4910	156	112	–	–	PUNCT
dpc-4910	156	113	0.06	0.06	NUM
dpc-4910	156	114	ns	ns	NUM
dpc-4910	156	115	–	–	PUNCT
dpc-4910	156	116	0.10	0.10	NUM
dpc-4910	156	117	ns	ns	NUM
dpc-4910	156	118	0.10	0.10	NUM
dpc-4910	156	119	ns	ns	NUM
dpc-4910	156	120	–	–	PUNCT
dpc-4910	156	121	0.28	0.28	NUM
dpc-4910	156	122	*	*	NUM
dpc-4910	156	123	0.28	0.28	NUM
dpc-4910	156	124	*	*	PUNCT
dpc-4910	156	125	–	–	PUNCT
dpc-4910	156	126	0.10	0.10	NUM
dpc-4910	156	127	ns	ns	NUM
dpc-4910	156	128	–	–	PUNCT
dpc-4910	156	129	0.17	0.17	NUM
dpc-4910	156	130	ns	ns	NUM
dpc-4910	156	131	0.06	0.06	NUM
dpc-4910	156	132	ns	ns	NUM
dpc-4910	156	133	0.09	0.09	NUM
dpc-4910	156	134	ns	ns	NUM
dpc-4910	156	135	0.12	0.12	NUM
dpc-4910	156	136	ns	ns	NUM
dpc-4910	156	137	–	–	PUNCT
dpc-4910	156	138	0.07	0.07	NUM
dpc-4910	156	139	ns	ns	NUM
dpc-4910	156	140	–	–	PUNCT
dpc-4910	156	141	0.03	0.03	NUM
dpc-4910	156	142	ns	ns	NUM
dpc-4910	156	143	0.14	0.14	NUM
dpc-4910	156	144	ns	ns	NUM
dpc-4910	156	145	0.15	0.15	NUM
dpc-4910	156	146	ns	ns	NOUN
dpc-4910	156	147	spearman	spearman	NOUN
dpc-4910	156	148	/	/	SYM
dpc-4910	156	149	corr	corr	PROPN
dpc-4910	156	150	creatinine	creatinine	NOUN
dpc-4910	156	151	tg	tg	PROPN
dpc-4910	156	152	dbp	dbp	PROPN
dpc-4910	156	153	glucose	glucose	NOUN
dpc-4910	156	154	bmi	bmi	PROPN
dpc-4910	156	155	urea	urea	PROPN
dpc-4910	156	156	hdl_c	hdl_c	PROPN
dpc-4910	156	157	age	age	NOUN
dpc-4910	156	158	sbp	sbp	PROPN
dpc-4910	156	159	nphn	nphn	PROPN
dpc-4910	156	160	uacr	uacr	PROPN
dpc-4910	156	161	pdx	pdx	PROPN
dpc-4910	156	162	–	–	PUNCT
dpc-4910	156	163	1.0	1.0	NUM
dpc-4910	156	164	–	–	SYM
dpc-4910	156	165	0.5	0.5	NUM
dpc-4910	156	166	0.0	0.0	NUM
dpc-4910	156	167	0.5	0.5	NUM
dpc-4910	156	168	1.0	1.0	NUM
dpc-4910	156	169	0.21	0.21	NUM
dpc-4910	156	170	ns	ns	NUM
dpc-4910	156	171	0.09	0.09	NUM
dpc-4910	156	172	ns	ns	NUM
dpc-4910	156	173	–	–	PUNCT
dpc-4910	156	174	0.01	0.01	NUM
dpc-4910	156	175	ns	ns	NUM
dpc-4910	156	176	0.13	0.13	NUM
dpc-4910	156	177	ns	ns	NUM
dpc-4910	156	178	0.23	0.23	NUM
dpc-4910	156	179	ns	ns	NUM
dpc-4910	156	180	–	–	PUNCT
dpc-4910	156	181	0.02	0.02	NUM
dpc-4910	156	182	ns	ns	NUM
dpc-4910	156	183	0.03	0.03	NUM
dpc-4910	156	184	ns	ns	NUM
dpc-4910	156	185	0.03	0.03	NUM
dpc-4910	156	186	ns	ns	NUM
dpc-4910	156	187	0.00	0.00	NUM
dpc-4910	156	188	ns	ns	NUM
dpc-4910	156	189	0.12	0.12	NUM
dpc-4910	156	190	ns	ns	NUM
dpc-4910	156	191	0.03	0.03	NUM
dpc-4910	156	192	ns	ns	NUM
dpc-4910	156	193	0.06	0.06	NUM
dpc-4910	156	194	ns	ns	NUM
dpc-4910	156	195	0.03	0.03	NUM
dpc-4910	156	196	ns	ns	NUM
dpc-4910	156	197	0.31	0.31	NUM
dpc-4910	156	198	*	*	PUNCT
dpc-4910	156	199	0.32	0.32	NUM
dpc-4910	156	200	*	*	PUNCT
dpc-4910	156	201	0.34	0.34	NUM
dpc-4910	156	202	*	*	PUNCT
dpc-4910	156	203	*	*	PUNCT
dpc-4910	156	204	ua	ua	PROPN
dpc-4910	156	205	cr	cr	PROPN
dpc-4910	156	206	nphn	nphn	PROPN
dpc-4910	156	207	sbp	sbp	PROPN
dpc-4910	156	208	age	age	NOUN
dpc-4910	156	209	hdl	hdl	PROPN
dpc-4910	156	210	_	_	PROPN
dpc-4910	156	211	c	c	PROPN
dpc-4910	156	212	ure	ure	VERB
dpc-4910	156	213	a	a	DET
dpc-4910	156	214	bm	bm	PROPN
dpc-4910	156	215	i	i	PRON
dpc-4910	156	216	gluc	gluc	VERB
dpc-4910	156	217	os	os	PROPN
dpc-4910	156	218	e	e	PROPN
dpc-4910	156	219	dbp	dbp	PROPN
dpc-4910	156	220	tg	tg	PROPN
dpc-4910	156	221	cre	cre	PROPN
dpc-4910	156	222	at	at	ADP
dpc-4910	156	223	ini	ini	PROPN
dpc-4910	156	224	ne	ne	PROPN
dpc-4910	156	225	hom	hom	NOUN
dpc-4910	156	226	a_i	a_i	PROPN
dpc-4910	156	227	r	r	NOUN
dpc-4910	156	228	ns	ns	NUM
dpc-4910	156	229	p>=	p>=	NOUN
dpc-4910	156	230	0.05	0.05	NUM
dpc-4910	156	231	;	;	PUNCT
dpc-4910	156	232	*	*	PUNCT
dpc-4910	156	233	p<0.05	p<0.05	NOUN
dpc-4910	156	234	;	;	PUNCT
dpc-4910	156	235	*	*	PUNCT
dpc-4910	156	236	*	*	PUNCT
dpc-4910	156	237	p<0.01	p<0.01	PROPN
dpc-4910	156	238	;	;	PUNCT
dpc-4910	156	239	and	and	CCONJ
dpc-4910	156	240	*	*	PUNCT
dpc-4910	156	241	*	*	PUNCT
dpc-4910	156	242	*	*	PUNCT
dpc-4910	156	243	p	p	X
dpc-4910	156	244	<	<	X
dpc-4910	156	245	0.001	0.001	NUM
dpc-4910	156	246	figure	figure	NOUN
dpc-4910	156	247	3	3	NUM
dpc-4910	156	248	.	.	PUNCT
dpc-4910	156	249	correlation	correlation	NOUN
dpc-4910	156	250	matrix	matrix	NOUN
dpc-4910	156	251	showing	show	VERB
dpc-4910	156	252	the	the	DET
dpc-4910	156	253	correlation	correlation	NOUN
dpc-4910	156	254	coefficients	coefficient	NOUN
dpc-4910	156	255	between	between	ADP
dpc-4910	156	256	podocalyxin	podocalyxin	NOUN
dpc-4910	156	257	(	(	PUNCT
dpc-4910	156	258	pdx	pdx	PROPN
dpc-4910	156	259	)	)	PUNCT
dpc-4910	156	260	,	,	PUNCT
dpc-4910	156	261	nephrin	nephrin	NOUN
dpc-4910	156	262	,	,	PUNCT
dpc-4910	156	263	and	and	CCONJ
dpc-4910	156	264	laboratory	laboratory	NOUN
dpc-4910	156	265	and	and	CCONJ
dpc-4910	156	266	demographic	demographic	ADJ
dpc-4910	156	267	variables	variable	NOUN
dpc-4910	156	268	as	as	ADP
dpc-4910	156	269	a	a	DET
dpc-4910	156	270	heat	heat	NOUN
dpc-4910	156	271	map	map	NOUN
dpc-4910	156	272	.	.	PUNCT
dpc-4910	157	1	a	a	DET
dpc-4910	157	2	correlation	correlation	NOUN
dpc-4910	157	3	coefficient	coefficient	NOUN
dpc-4910	157	4	of	of	ADP
dpc-4910	157	5	0	0	NUM
dpc-4910	157	6	indicates	indicate	VERB
dpc-4910	157	7	no	no	DET
dpc-4910	157	8	correlation	correlation	NOUN
dpc-4910	157	9	between	between	ADP
dpc-4910	157	10	variables	variable	NOUN
dpc-4910	157	11	,	,	PUNCT
dpc-4910	157	12	+1	+1	PROPN
dpc-4910	157	13	indicates	indicate	VERB
dpc-4910	157	14	a	a	DET
dpc-4910	157	15	positive	positive	ADJ
dpc-4910	157	16	correlation	correlation	NOUN
dpc-4910	157	17	,	,	PUNCT
dpc-4910	157	18	and	and	CCONJ
dpc-4910	157	19	-1	-1	X
dpc-4910	157	20	indicates	indicate	VERB
dpc-4910	157	21	a	a	DET
dpc-4910	157	22	negative	negative	ADJ
dpc-4910	157	23	correlation	correlation	NOUN
dpc-4910	157	24	.	.	PUNCT
dpc-4910	158	1	color	color	NOUN
dpc-4910	158	2	intensity	intensity	NOUN
dpc-4910	158	3	(	(	PUNCT
dpc-4910	158	4	red	red	ADJ
dpc-4910	158	5	,	,	PUNCT
dpc-4910	158	6	negative	negative	ADJ
dpc-4910	158	7	correlation	correlation	NOUN
dpc-4910	158	8	;	;	PUNCT
dpc-4910	158	9	blue	blue	ADJ
dpc-4910	158	10	,	,	PUNCT
dpc-4910	158	11	positive	positive	ADJ
dpc-4910	158	12	correlation	correlation	NOUN
dpc-4910	158	13	)	)	PUNCT
dpc-4910	158	14	.	.	PUNCT
dpc-4910	159	1	figure	figure	NOUN
dpc-4910	159	2	2	2	NUM
dpc-4910	159	3	.	.	PUNCT
dpc-4910	159	4	graphical	graphical	ADJ
dpc-4910	159	5	representation	representation	NOUN
dpc-4910	159	6	of	of	ADP
dpc-4910	159	7	changes	change	NOUN
dpc-4910	159	8	in	in	ADP
dpc-4910	159	9	podocalyxin	podocalyxin	NOUN
dpc-4910	159	10	(	(	PUNCT
dpc-4910	159	11	pdx	pdx	PROPN
dpc-4910	159	12	)	)	PUNCT
dpc-4910	159	13	and	and	CCONJ
dpc-4910	159	14	nephrin	nephrin	ADJ
dpc-4910	159	15	levels	level	NOUN
dpc-4910	159	16	according	accord	VERB
dpc-4910	159	17	to	to	ADP
dpc-4910	159	18	psoriasis	psoriasis	NOUN
dpc-4910	159	19	severity	severity	NOUN
dpc-4910	159	20	.	.	PUNCT
dpc-4910	160	1	*	*	PUNCT
dpc-4910	160	2	*	*	PUNCT
dpc-4910	160	3	*	*	PUNCT
dpc-4910	160	4	p<0.001	p<0.001	X
dpc-4910	160	5	vs.	vs.	ADP
dpc-4910	160	6	control	control	NOUN
dpc-4910	160	7	;	;	PUNCT
dpc-4910	160	8	#	#	SYM
dpc-4910	160	9	#	#	SYM
dpc-4910	160	10	#	#	NOUN
dpc-4910	160	11	p<0.001	p<0.001	NOUN
dpc-4910	160	12	vs.	vs.	ADP
dpc-4910	160	13	severe	severe	ADJ
dpc-4910	160	14	psoriasis	psoriasis	NOUN
dpc-4910	160	15	group	group	NOUN
dpc-4910	160	16	.	.	PUNCT
dpc-4910	161	1	begin	begin	VERB
dpc-4910	161	2	in	in	ADP
dpc-4910	161	3	mild	mild	ADJ
dpc-4910	161	4	and	and	CCONJ
dpc-4910	161	5	moderate	moderate	ADJ
dpc-4910	161	6	psoriasis	psoriasis	NOUN
dpc-4910	161	7	cases	case	NOUN
dpc-4910	161	8	,	,	PUNCT
dpc-4910	161	9	it	it	PRON
dpc-4910	161	10	is	be	AUX
dpc-4910	161	11	obvious	obvious	ADJ
dpc-4910	161	12	that	that	SCONJ
dpc-4910	161	13	a	a	DET
dpc-4910	161	14	certain	certain	ADJ
dpc-4910	161	15	amount	amount	NOUN
dpc-4910	161	16	of	of	ADP
dpc-4910	161	17	time	time	NOUN
dpc-4910	161	18	is	be	AUX
dpc-4910	161	19	needed	need	VERB
dpc-4910	161	20	for	for	ADP
dpc-4910	161	21	podocyte	podocyte	NOUN
dpc-4910	161	22	destruction	destruction	NOUN
dpc-4910	161	23	proteins	protein	NOUN
dpc-4910	161	24	to	to	PART
dpc-4910	161	25	become	become	VERB
dpc-4910	161	26	detectable	detectable	ADJ
dpc-4910	161	27	in	in	ADP
dpc-4910	161	28	the	the	DET
dpc-4910	161	29	urine	urine	NOUN
dpc-4910	161	30	.	.	PUNCT
dpc-4910	162	1	as	as	SCONJ
dpc-4910	162	2	disease	disease	NOUN
dpc-4910	162	3	severity	severity	NOUN
dpc-4910	162	4	affects	affect	VERB
dpc-4910	162	5	the	the	DET
dpc-4910	162	6	incidence	incidence	NOUN
dpc-4910	162	7	of	of	ADP
dpc-4910	162	8	long	long	ADJ
dpc-4910	162	9	-	-	PUNCT
dpc-4910	162	10	term	term	NOUN
dpc-4910	162	11	renal	renal	ADJ
dpc-4910	162	12	damage	damage	NOUN
dpc-4910	162	13	,	,	PUNCT
dpc-4910	162	14	we	we	PRON
dpc-4910	162	15	evaluated	evaluate	VERB
dpc-4910	162	16	the	the	DET
dpc-4910	162	17	changes	change	NOUN
dpc-4910	162	18	in	in	ADP
dpc-4910	162	19	urine	urine	NOUN
dpc-4910	162	20	pdx	pdx	PROPN
dpc-4910	162	21	and	and	CCONJ
dpc-4910	162	22	nephrin	nephrin	PROPN
dpc-4910	162	23	levels	level	NOUN
dpc-4910	162	24	in	in	ADP
dpc-4910	162	25	the	the	DET
dpc-4910	162	26	mild	mild	ADJ
dpc-4910	162	27	,	,	PUNCT
dpc-4910	162	28	moderate	moderate	ADJ
dpc-4910	162	29	,	,	PUNCT
dpc-4910	162	30	and	and	CCONJ
dpc-4910	162	31	severe	severe	ADJ
dpc-4910	162	32	groups	group	NOUN
dpc-4910	162	33	.	.	PUNCT
dpc-4910	163	1	urinary	urinary	ADJ
dpc-4910	163	2	pdx	pdx	PROPN
dpc-4910	163	3	and	and	CCONJ
dpc-4910	163	4	nephrin	nephrin	PROPN
dpc-4910	163	5	levels	level	NOUN
dpc-4910	163	6	were	be	AUX
dpc-4910	163	7	significantly	significantly	ADV
dpc-4910	163	8	higher	high	ADJ
dpc-4910	163	9	in	in	ADP
dpc-4910	163	10	all	all	DET
dpc-4910	163	11	groups	group	NOUN
dpc-4910	163	12	than	than	ADP
dpc-4910	163	13	in	in	ADP
dpc-4910	163	14	healthy	healthy	ADJ
dpc-4910	163	15	controls	control	NOUN
dpc-4910	163	16	.	.	PUNCT
dpc-4910	164	1	the	the	DET
dpc-4910	164	2	similarity	similarity	NOUN
dpc-4910	164	3	in	in	ADP
dpc-4910	164	4	urinary	urinary	ADJ
dpc-4910	164	5	podocyte	podocyte	NOUN
dpc-4910	164	6	degradation	degradation	NOUN
dpc-4910	164	7	product	product	NOUN
dpc-4910	164	8	levels	level	NOUN
dpc-4910	164	9	in	in	ADP
dpc-4910	164	10	the	the	DET
dpc-4910	164	11	mild	mild	ADJ
dpc-4910	164	12	and	and	CCONJ
dpc-4910	164	13	moderate	moderate	ADJ
dpc-4910	164	14	groups	group	NOUN
dpc-4910	164	15	suggests	suggest	VERB
dpc-4910	164	16	that	that	SCONJ
dpc-4910	164	17	an	an	DET
dpc-4910	164	18	increase	increase	NOUN
dpc-4910	164	19	in	in	ADP
dpc-4910	164	20	disease	disease	NOUN
dpc-4910	164	21	severity	severity	NOUN
dpc-4910	164	22	does	do	AUX
dpc-4910	164	23	not	not	PART
dpc-4910	164	24	cause	cause	VERB
dpc-4910	164	25	a	a	DET
dpc-4910	164	26	gradual	gradual	ADJ
dpc-4910	164	27	increase	increase	NOUN
dpc-4910	164	28	in	in	ADP
dpc-4910	164	29	glomerular	glomerular	ADJ
dpc-4910	164	30	damage	damage	NOUN
dpc-4910	164	31	.	.	PUNCT
dpc-4910	165	1	the	the	DET
dpc-4910	165	2	pdx	pdx	PROPN
dpc-4910	165	3	and	and	CCONJ
dpc-4910	165	4	nephrin	nephrin	PROPN
dpc-4910	165	5	levels	level	NOUN
dpc-4910	165	6	in	in	ADP
dpc-4910	165	7	both	both	DET
dpc-4910	165	8	groups	group	NOUN
dpc-4910	165	9	may	may	AUX
dpc-4910	165	10	be	be	AUX
dpc-4910	165	11	similar	similar	ADJ
dpc-4910	165	12	because	because	SCONJ
dpc-4910	165	13	the	the	DET
dpc-4910	165	14	original	original	ADJ
dpc-4910	165	15	article	article	NOUN
dpc-4910	165	16	|	|	ADV
dpc-4910	165	17	dermatol	dermatol	ADJ
dpc-4910	165	18	pract	pract	NOUN
dpc-4910	165	19	concept	concept	NOUN
dpc-4910	165	20	.	.	PUNCT
dpc-4910	166	1	2025;15(2):4910	2025;15(2):4910	NUM
dpc-4910	166	2	7	7	NUM
dpc-4910	166	3	references	reference	NOUN
dpc-4910	166	4	1	1	NUM
dpc-4910	166	5	.	.	PUNCT
dpc-4910	166	6	parisi	parisi	PROPN
dpc-4910	166	7	r	r	PROPN
dpc-4910	166	8	,	,	PUNCT
dpc-4910	166	9	symmons	symmon	NOUN
dpc-4910	166	10	dp	dp	PROPN
dpc-4910	166	11	,	,	PUNCT
dpc-4910	166	12	griffiths	griffiths	PROPN
dpc-4910	166	13	ce	ce	PROPN
dpc-4910	166	14	,	,	PUNCT
dpc-4910	166	15	ashcroft	ashcroft	PROPN
dpc-4910	166	16	dm	dm	PROPN
dpc-4910	166	17	;	;	PUNCT
dpc-4910	166	18	identification	identification	NOUN
dpc-4910	166	19	and	and	CCONJ
dpc-4910	166	20	management	management	NOUN
dpc-4910	166	21	of	of	ADP
dpc-4910	166	22	psoriasis	psoriasis	NOUN
dpc-4910	166	23	and	and	CCONJ
dpc-4910	166	24	associated	associate	VERB
dpc-4910	166	25	comorbidity	comorbidity	NOUN
dpc-4910	166	26	(	(	PUNCT
dpc-4910	166	27	impact	impact	NOUN
dpc-4910	166	28	)	)	PUNCT
dpc-4910	166	29	project	project	NOUN
dpc-4910	166	30	team	team	NOUN
dpc-4910	166	31	.	.	PUNCT
dpc-4910	167	1	global	global	ADJ
dpc-4910	167	2	epidemiology	epidemiology	NOUN
dpc-4910	167	3	of	of	ADP
dpc-4910	167	4	psoriasis	psoriasis	NOUN
dpc-4910	167	5	:	:	PUNCT
dpc-4910	167	6	a	a	DET
dpc-4910	167	7	systematic	systematic	ADJ
dpc-4910	167	8	review	review	NOUN
dpc-4910	167	9	of	of	ADP
dpc-4910	167	10	incidence	incidence	NOUN
dpc-4910	167	11	and	and	CCONJ
dpc-4910	167	12	prevalence	prevalence	NOUN
dpc-4910	167	13	.	.	PUNCT
dpc-4910	168	1	j	j	PROPN
dpc-4910	168	2	invest	invest	VERB
dpc-4910	168	3	dermatol	dermatol	NOUN
dpc-4910	168	4	.	.	PUNCT
dpc-4910	169	1	2013;133(2	2013;133(2	NUM
dpc-4910	169	2	):	):	PUNCT
dpc-4910	170	1	377–385	377–385	NUM
dpc-4910	170	2	.	.	PUNCT
dpc-4910	171	1	doi	doi	NOUN
dpc-4910	171	2	:	:	PUNCT
dpc-4910	171	3	10.1038	10.1038	NUM
dpc-4910	171	4	/	/	SYM
dpc-4910	171	5	jid.2012.339	jid.2012.339	PROPN
dpc-4910	171	6	.	.	PUNCT
dpc-4910	172	1	pmid	pmid	NOUN
dpc-4910	172	2	:	:	PUNCT
dpc-4910	172	3	23014338	23014338	NUM
dpc-4910	172	4	.	.	PUNCT
dpc-4910	173	1	2	2	X
dpc-4910	173	2	.	.	X
dpc-4910	173	3	chi	chi	PROPN
dpc-4910	173	4	cc	cc	PROPN
dpc-4910	173	5	,	,	PUNCT
dpc-4910	173	6	wang	wang	PROPN
dpc-4910	173	7	j	j	PROPN
dpc-4910	173	8	,	,	PUNCT
dpc-4910	173	9	chen	chen	PROPN
dpc-4910	173	10	yf	yf	PROPN
dpc-4910	173	11	,	,	PUNCT
dpc-4910	173	12	wang	wang	PROPN
dpc-4910	173	13	sh	sh	PROPN
dpc-4910	173	14	,	,	PUNCT
dpc-4910	173	15	chen	chen	PROPN
dpc-4910	173	16	fl	fl	PROPN
dpc-4910	173	17	,	,	PUNCT
dpc-4910	173	18	tung	tung	PROPN
dpc-4910	173	19	th	th	PROPN
dpc-4910	173	20	.	.	PUNCT
dpc-4910	174	1	risk	risk	NOUN
dpc-4910	174	2	of	of	ADP
dpc-4910	174	3	incident	incident	NOUN
dpc-4910	174	4	chronic	chronic	ADJ
dpc-4910	174	5	kidney	kidney	NOUN
dpc-4910	174	6	disease	disease	NOUN
dpc-4910	174	7	and	and	CCONJ
dpc-4910	174	8	end	end	NOUN
dpc-4910	174	9	-	-	PUNCT
dpc-4910	174	10	stage	stage	NOUN
dpc-4910	174	11	renal	renal	ADJ
dpc-4910	174	12	disease	disease	NOUN
dpc-4910	174	13	in	in	ADP
dpc-4910	174	14	patients	patient	NOUN
dpc-4910	174	15	with	with	ADP
dpc-4910	174	16	psoriasis	psoriasis	NOUN
dpc-4910	174	17	:	:	PUNCT
dpc-4910	174	18	a	a	DET
dpc-4910	174	19	nationwide	nationwide	ADJ
dpc-4910	174	20	population	population	NOUN
dpc-4910	174	21	-	-	PUNCT
dpc-4910	174	22	based	base	VERB
dpc-4910	174	23	cohort	cohort	NOUN
dpc-4910	174	24	study	study	NOUN
dpc-4910	174	25	.	.	PUNCT
dpc-4910	175	1	j	j	PROPN
dpc-4910	175	2	dermatol	dermatol	NOUN
dpc-4910	175	3	sci	sci	PROPN
dpc-4910	175	4	.	.	PUNCT
dpc-4910	176	1	2015;78(3):232–238	2015;78(3):232–238	NUM
dpc-4910	176	2	.	.	PUNCT
dpc-4910	176	3	doi	doi	PROPN
dpc-4910	176	4	:	:	PUNCT
dpc-4910	176	5	10.1016	10.1016	NUM
dpc-4910	176	6	/	/	SYM
dpc-4910	176	7	j.jdermsci	j.jdermsci	PROPN
dpc-4910	176	8	.2015.03.012	.2015.03.012	PROPN
dpc-4910	176	9	.	.	PUNCT
dpc-4910	177	1	pmid	pmid	NOUN
dpc-4910	177	2	:	:	PUNCT
dpc-4910	177	3	25862150	25862150	NUM
dpc-4910	177	4	.	.	PUNCT
dpc-4910	178	1	3	3	X
dpc-4910	178	2	.	.	X
dpc-4910	178	3	chiu	chiu	PROPN
dpc-4910	178	4	hy	hy	PROPN
dpc-4910	178	5	,	,	PUNCT
dpc-4910	178	6	huang	huang	PROPN
dpc-4910	178	7	hl	hl	PROPN
dpc-4910	178	8	,	,	PUNCT
dpc-4910	178	9	li	li	PROPN
dpc-4910	178	10	ch	ch	PROPN
dpc-4910	178	11	,	,	PUNCT
dpc-4910	178	12	et	et	PROPN
dpc-4910	178	13	al	al	PROPN
dpc-4910	178	14	.	.	PROPN
dpc-4910	178	15	increased	increase	VERB
dpc-4910	178	16	risk	risk	NOUN
dpc-4910	178	17	of	of	ADP
dpc-4910	178	18	glomerulonephritis	glomerulonephritis	NOUN
dpc-4910	178	19	and	and	CCONJ
dpc-4910	178	20	chronic	chronic	ADJ
dpc-4910	178	21	kidney	kidney	NOUN
dpc-4910	178	22	disease	disease	NOUN
dpc-4910	178	23	in	in	ADP
dpc-4910	178	24	relation	relation	NOUN
dpc-4910	178	25	to	to	ADP
dpc-4910	178	26	the	the	DET
dpc-4910	178	27	severity	severity	NOUN
dpc-4910	178	28	of	of	ADP
dpc-4910	178	29	psoriasis	psoriasis	NOUN
dpc-4910	178	30	,	,	PUNCT
dpc-4910	178	31	concomitant	concomitant	ADJ
dpc-4910	178	32	medication	medication	NOUN
dpc-4910	178	33	,	,	PUNCT
dpc-4910	178	34	and	and	CCONJ
dpc-4910	178	35	comorbidity	comorbidity	NOUN
dpc-4910	178	36	:	:	PUNCT
dpc-4910	178	37	a	a	DET
dpc-4910	178	38	nationwide	nationwide	ADJ
dpc-4910	178	39	population	population	NOUN
dpc-4910	178	40	-	-	PUNCT
dpc-4910	178	41	based	base	VERB
dpc-4910	178	42	cohort	cohort	NOUN
dpc-4910	178	43	study	study	NOUN
dpc-4910	178	44	.	.	PUNCT
dpc-4910	179	1	br	br	PROPN
dpc-4910	179	2	j	j	PROPN
dpc-4910	179	3	dermatol	dermatol	NOUN
dpc-4910	179	4	.	.	PUNCT
dpc-4910	180	1	2015;173(1	2015;173(1	NUM
dpc-4910	180	2	):	):	PUNCT
dpc-4910	180	3	146–154	146–154	NUM
dpc-4910	180	4	.	.	PUNCT
dpc-4910	180	5	doi	doi	NOUN
dpc-4910	180	6	:	:	PUNCT
dpc-4910	180	7	10.1111	10.1111	NUM
dpc-4910	180	8	/	/	SYM
dpc-4910	180	9	bjd.13599	bjd.13599	PROPN
dpc-4910	180	10	.	.	PUNCT
dpc-4910	181	1	pmid	pmid	NOUN
dpc-4910	181	2	:	:	PUNCT
dpc-4910	181	3	25511692	25511692	NUM
dpc-4910	181	4	.	.	PUNCT
dpc-4910	182	1	4	4	X
dpc-4910	182	2	.	.	X
dpc-4910	182	3	svedbom	svedbom	VERB
dpc-4910	182	4	a	a	PRON
dpc-4910	182	5	,	,	PUNCT
dpc-4910	182	6	dalén	dalén	PROPN
dpc-4910	182	7	j	j	PROPN
dpc-4910	182	8	,	,	PUNCT
dpc-4910	182	9	mamolo	mamolo	PROPN
dpc-4910	182	10	c	c	NOUN
dpc-4910	182	11	,	,	PUNCT
dpc-4910	182	12	et	et	PROPN
dpc-4910	182	13	al	al	PROPN
dpc-4910	182	14	.	.	PROPN
dpc-4910	182	15	increased	increase	VERB
dpc-4910	182	16	cause	cause	VERB
dpc-4910	182	17	specific	specific	ADJ
dpc-4910	182	18	mortality	mortality	NOUN
dpc-4910	182	19	in	in	ADP
dpc-4910	182	20	patients	patient	NOUN
dpc-4910	182	21	with	with	ADP
dpc-4910	182	22	mild	mild	ADJ
dpc-4910	182	23	and	and	CCONJ
dpc-4910	182	24	severe	severe	ADJ
dpc-4910	182	25	psoriasis	psoriasis	NOUN
dpc-4910	182	26	:	:	PUNCT
dpc-4910	182	27	a	a	DET
dpc-4910	182	28	population	population	NOUN
dpc-4910	182	29	-	-	PUNCT
dpc-4910	182	30	based	base	VERB
dpc-4910	182	31	swedish	swedish	ADJ
dpc-4910	182	32	register	register	PROPN
dpc-4910	182	33	study	study	NOUN
dpc-4910	182	34	.	.	PUNCT
dpc-4910	183	1	acta	acta	PROPN
dpc-4910	183	2	derm	derm	PROPN
dpc-4910	183	3	venereol	venereol	NOUN
dpc-4910	183	4	.	.	PUNCT
dpc-4910	184	1	2015;95(7):809–815	2015;95(7):809–815	X
dpc-4910	184	2	.	.	PUNCT
dpc-4910	185	1	doi	doi	NOUN
dpc-4910	185	2	:	:	PUNCT
dpc-4910	185	3	10.2340/00015555	10.2340/00015555	NUM
dpc-4910	185	4	-	-	SYM
dpc-4910	185	5	2095	2095	NUM
dpc-4910	185	6	.	.	PUNCT
dpc-4910	186	1	pmid	pmid	NOUN
dpc-4910	186	2	:	:	PUNCT
dpc-4910	186	3	25766866	25766866	NUM
dpc-4910	186	4	.	.	PUNCT
dpc-4910	187	1	5	5	X
dpc-4910	187	2	.	.	X
dpc-4910	187	3	jabbar	jabbar	PROPN
dpc-4910	187	4	-	-	PUNCT
dpc-4910	187	5	lopez	lopez	PROPN
dpc-4910	187	6	zk	zk	PROPN
dpc-4910	187	7	,	,	PUNCT
dpc-4910	187	8	weatherhead	weatherhead	PROPN
dpc-4910	187	9	sc	sc	PROPN
dpc-4910	187	10	,	,	PUNCT
dpc-4910	187	11	reynolds	reynolds	PROPN
dpc-4910	187	12	nj	nj	PROPN
dpc-4910	187	13	.	.	PUNCT
dpc-4910	187	14	kidney	kidney	PROPN
dpc-4910	187	15	disease	disease	NOUN
dpc-4910	187	16	in	in	ADP
dpc-4910	187	17	moderate	moderate	ADJ
dpc-4910	187	18	-	-	PUNCT
dpc-4910	187	19	to	to	ADP
dpc-4910	187	20	-	-	PUNCT
dpc-4910	187	21	severe	severe	ADJ
dpc-4910	187	22	psoriasis	psoriasis	NOUN
dpc-4910	187	23	:	:	PUNCT
dpc-4910	187	24	a	a	DET
dpc-4910	187	25	critical	critical	ADJ
dpc-4910	187	26	appraisal	appraisal	NOUN
dpc-4910	187	27	.	.	PUNCT
dpc-4910	188	1	br	br	PROPN
dpc-4910	188	2	j	j	PROPN
dpc-4910	188	3	dermatol	dermatol	NOUN
dpc-4910	188	4	.	.	PUNCT
dpc-4910	189	1	2016;174(2):267–270	2016;174(2):267–270	X
dpc-4910	189	2	.	.	PUNCT
dpc-4910	189	3	doi	doi	NOUN
dpc-4910	189	4	:	:	PUNCT
dpc-4910	189	5	10.1111	10.1111	NUM
dpc-4910	189	6	/	/	SYM
dpc-4910	189	7	bjd.14302	bjd.14302	NOUN
dpc-4910	189	8	.	.	PUNCT
dpc-4910	190	1	pmid	pmid	NOUN
dpc-4910	190	2	:	:	PUNCT
dpc-4910	190	3	26871922	26871922	NUM
dpc-4910	190	4	.	.	PUNCT
dpc-4910	191	1	6	6	NUM
dpc-4910	191	2	.	.	X
dpc-4910	191	3	wan	wan	PROPN
dpc-4910	191	4	j	j	PROPN
dpc-4910	191	5	,	,	PUNCT
dpc-4910	191	6	wang	wang	PROPN
dpc-4910	191	7	s	s	PROPN
dpc-4910	191	8	,	,	PUNCT
dpc-4910	191	9	haynes	haynes	PROPN
dpc-4910	191	10	k	k	PROPN
dpc-4910	191	11	,	,	PUNCT
dpc-4910	191	12	denburg	denburg	PROPN
dpc-4910	191	13	mr	mr	PROPN
dpc-4910	191	14	,	,	PUNCT
dpc-4910	191	15	shin	shin	PROPN
dpc-4910	191	16	db	db	PROPN
dpc-4910	191	17	,	,	PUNCT
dpc-4910	191	18	gelfand	gelfand	PROPN
dpc-4910	191	19	jm	jm	PROPN
dpc-4910	191	20	.	.	PROPN
dpc-4910	191	21	risk	risk	NOUN
dpc-4910	191	22	of	of	ADP
dpc-4910	191	23	moderate	moderate	ADJ
dpc-4910	191	24	to	to	ADP
dpc-4910	191	25	advanced	advanced	ADJ
dpc-4910	191	26	kidney	kidney	NOUN
dpc-4910	191	27	disease	disease	NOUN
dpc-4910	191	28	in	in	ADP
dpc-4910	191	29	patients	patient	NOUN
dpc-4910	191	30	with	with	ADP
dpc-4910	191	31	psoriasis	psoriasis	NOUN
dpc-4910	191	32	:	:	PUNCT
dpc-4910	191	33	population	population	NOUN
dpc-4910	191	34	based	base	VERB
dpc-4910	191	35	cohort	cohort	NOUN
dpc-4910	191	36	study	study	NOUN
dpc-4910	191	37	.	.	PUNCT
dpc-4910	192	1	bmj	bmj	PROPN
dpc-4910	192	2	.	.	PUNCT
dpc-4910	193	1	2013;347	2013;347	NUM
dpc-4910	193	2	:	:	PUNCT
dpc-4910	194	1	f5961	f5961	PROPN
dpc-4910	194	2	.	.	PUNCT
dpc-4910	194	3	doi	doi	PROPN
dpc-4910	194	4	:	:	PUNCT
dpc-4910	194	5	10.1136	10.1136	NUM
dpc-4910	194	6	/	/	SYM
dpc-4910	194	7	bmj.f5961	bmj.f5961	PROPN
dpc-4910	194	8	.	.	PUNCT
dpc-4910	195	1	pmid	pmid	NOUN
dpc-4910	195	2	:	:	PUNCT
dpc-4910	195	3	24129480	24129480	NUM
dpc-4910	195	4	.	.	PUNCT
dpc-4910	196	1	7	7	X
dpc-4910	196	2	.	.	X
dpc-4910	196	3	ren	ren	PROPN
dpc-4910	196	4	f	f	PROPN
dpc-4910	196	5	,	,	PUNCT
dpc-4910	196	6	zhang	zhang	PROPN
dpc-4910	196	7	m	m	PROPN
dpc-4910	196	8	,	,	PUNCT
dpc-4910	196	9	zhang	zhang	PROPN
dpc-4910	196	10	c	c	AUX
dpc-4910	196	11	,	,	PUNCT
dpc-4910	196	12	sang	sing	VERB
dpc-4910	196	13	h.	h.	PROPN
dpc-4910	196	14	psoriasis	psoriasis	NOUN
dpc-4910	196	15	-	-	PUNCT
dpc-4910	196	16	like	like	ADJ
dpc-4910	196	17	inflammation	inflammation	NOUN
dpc-4910	196	18	induced	induce	VERB
dpc-4910	196	19	renal	renal	ADJ
dpc-4910	196	20	dysfunction	dysfunction	NOUN
dpc-4910	196	21	through	through	ADP
dpc-4910	196	22	the	the	DET
dpc-4910	196	23	tlr	tlr	PROPN
dpc-4910	196	24	/	/	SYM
dpc-4910	196	25	nf	nf	ADJ
dpc-4910	196	26	-	-	PUNCT
dpc-4910	196	27	κb	κb	PROPN
dpc-4910	196	28	signal	signal	NOUN
dpc-4910	196	29	pathway	pathway	NOUN
dpc-4910	196	30	.	.	PUNCT
dpc-4910	197	1	biomed	biome	VERB
dpc-4910	197	2	res	re	NOUN
dpc-4910	197	3	int	int	NOUN
dpc-4910	197	4	.	.	PUNCT
dpc-4910	198	1	2020;2020:3535264	2020;2020:3535264	NUM
dpc-4910	198	2	.	.	PUNCT
dpc-4910	199	1	doi	doi	NOUN
dpc-4910	199	2	:	:	PUNCT
dpc-4910	199	3	10.1155/2020/3535264	10.1155/2020/3535264	NUM
dpc-4910	199	4	.	.	PUNCT
dpc-4910	200	1	pmid	pmid	NOUN
dpc-4910	200	2	:	:	PUNCT
dpc-4910	200	3	32090080	32090080	NUM
dpc-4910	200	4	.	.	PUNCT
dpc-4910	201	1	8	8	X
dpc-4910	201	2	.	.	PUNCT
dpc-4910	202	1	kerjaschki	kerjaschki	PROPN
dpc-4910	202	2	d	d	PROPN
dpc-4910	202	3	,	,	PUNCT
dpc-4910	202	4	sharkey	sharkey	PROPN
dpc-4910	202	5	dj	dj	PROPN
dpc-4910	202	6	,	,	PUNCT
dpc-4910	202	7	farquhar	farquhar	PROPN
dpc-4910	202	8	mg	mg	PROPN
dpc-4910	202	9	.	.	PUNCT
dpc-4910	202	10	identification	identification	NOUN
dpc-4910	202	11	and	and	CCONJ
dpc-4910	202	12	characterization	characterization	NOUN
dpc-4910	202	13	of	of	ADP
dpc-4910	202	14	podocalyxin	podocalyxin	NOUN
dpc-4910	202	15	--	--	PUNCT
dpc-4910	202	16	the	the	DET
dpc-4910	202	17	major	major	ADJ
dpc-4910	202	18	sialoprotein	sialoprotein	NOUN
dpc-4910	202	19	of	of	ADP
dpc-4910	202	20	the	the	DET
dpc-4910	202	21	renal	renal	ADJ
dpc-4910	202	22	glomerular	glomerular	ADJ
dpc-4910	202	23	epithelial	epithelial	ADJ
dpc-4910	202	24	cell	cell	NOUN
dpc-4910	202	25	.	.	PUNCT
dpc-4910	203	1	j	j	PROPN
dpc-4910	203	2	cell	cell	NOUN
dpc-4910	203	3	biol	biol	PROPN
dpc-4910	203	4	.	.	PUNCT
dpc-4910	204	1	1984;98(4	1984;98(4	NUM
dpc-4910	204	2	):	):	PUNCT
dpc-4910	204	3	1591–1596	1591–1596	NUM
dpc-4910	204	4	.	.	PUNCT
dpc-4910	205	1	doi	doi	NOUN
dpc-4910	205	2	:	:	PUNCT
dpc-4910	205	3	10.1083	10.1083	NUM
dpc-4910	205	4	/	/	SYM
dpc-4910	205	5	jcb.98.4.1591	jcb.98.4.1591	NOUN
dpc-4910	205	6	.	.	PUNCT
dpc-4910	206	1	pmid	pmid	NOUN
dpc-4910	206	2	:	:	PUNCT
dpc-4910	206	3	6371025	6371025	NUM
dpc-4910	206	4	.	.	PUNCT
dpc-4910	207	1	9	9	X
dpc-4910	207	2	.	.	X
dpc-4910	207	3	satchell	satchell	PROPN
dpc-4910	207	4	sc	sc	PROPN
dpc-4910	207	5	,	,	PUNCT
dpc-4910	207	6	braet	braet	PROPN
dpc-4910	207	7	f.	f.	PROPN
dpc-4910	207	8	glomerular	glomerular	ADJ
dpc-4910	207	9	endothelial	endothelial	ADJ
dpc-4910	207	10	cell	cell	NOUN
dpc-4910	207	11	fenestrations	fenestration	NOUN
dpc-4910	207	12	:	:	PUNCT
dpc-4910	207	13	an	an	DET
dpc-4910	207	14	integral	integral	ADJ
dpc-4910	207	15	component	component	NOUN
dpc-4910	207	16	of	of	ADP
dpc-4910	207	17	the	the	DET
dpc-4910	207	18	glomerular	glomerular	ADJ
dpc-4910	207	19	filtration	filtration	NOUN
dpc-4910	207	20	barrier	barrier	NOUN
dpc-4910	207	21	.	.	PUNCT
dpc-4910	208	1	am	be	AUX
dpc-4910	208	2	j	j	PROPN
dpc-4910	208	3	physiol	physiol	PROPN
dpc-4910	208	4	renal	renal	PROPN
dpc-4910	208	5	physiol	physiol	PROPN
dpc-4910	208	6	.	.	PUNCT
dpc-4910	209	1	2009;296(5):f947–956	2009;296(5):f947–956	NUM
dpc-4910	209	2	.	.	PUNCT
dpc-4910	210	1	doi	doi	PROPN
dpc-4910	210	2	:	:	PUNCT
dpc-4910	210	3	10.1152	10.1152	NUM
dpc-4910	210	4	/ajprenal.90601.2008	/ajprenal.90601.2008	NOUN
dpc-4910	210	5	.	.	PUNCT
dpc-4910	211	1	pmid	pmid	NOUN
dpc-4910	211	2	:	:	PUNCT
dpc-4910	211	3	19129259	19129259	NUM
dpc-4910	211	4	.	.	PUNCT
dpc-4910	212	1	10	10	NUM
dpc-4910	212	2	.	.	PUNCT
dpc-4910	212	3	skoberne	skoberne	VERB
dpc-4910	212	4	a	a	DET
dpc-4910	212	5	,	,	PUNCT
dpc-4910	212	6	konieczny	konieczny	NOUN
dpc-4910	212	7	a	a	PRON
dpc-4910	212	8	,	,	PUNCT
dpc-4910	212	9	schiffer	schiffer	PROPN
dpc-4910	212	10	m.	m.	NOUN
dpc-4910	212	11	glomerular	glomerular	ADJ
dpc-4910	212	12	epithelial	epithelial	ADJ
dpc-4910	212	13	cells	cell	NOUN
dpc-4910	212	14	in	in	ADP
dpc-4910	212	15	the	the	DET
dpc-4910	212	16	urine	urine	NOUN
dpc-4910	212	17	:	:	PUNCT
dpc-4910	212	18	what	what	PRON
dpc-4910	212	19	has	have	VERB
dpc-4910	212	20	to	to	PART
dpc-4910	212	21	be	be	AUX
dpc-4910	212	22	done	do	VERB
dpc-4910	212	23	to	to	PART
dpc-4910	212	24	make	make	VERB
dpc-4910	212	25	them	they	PRON
dpc-4910	212	26	worthwhile	worthwhile	ADJ
dpc-4910	212	27	?	?	PUNCT
dpc-4910	213	1	am	be	AUX
dpc-4910	213	2	j	j	PROPN
dpc-4910	213	3	physiol	physiol	PROPN
dpc-4910	213	4	renal	renal	PROPN
dpc-4910	213	5	physiol	physiol	PROPN
dpc-4910	213	6	.	.	PUNCT
dpc-4910	214	1	2009;296(2):f230–241	2009;296(2):f230–241	X
dpc-4910	214	2	.	.	PUNCT
dpc-4910	215	1	doi	doi	NOUN
dpc-4910	215	2	:	:	PUNCT
dpc-4910	215	3	10.1152	10.1152	NUM
dpc-4910	215	4	/ajprenal.90507.2008	/ajprenal.90507.2008	NOUN
dpc-4910	215	5	.	.	PUNCT
dpc-4910	216	1	pmid	pmid	NOUN
dpc-4910	216	2	:	:	PUNCT
dpc-4910	216	3	18842819	18842819	NUM
dpc-4910	216	4	.	.	PUNCT
dpc-4910	217	1	11	11	NUM
dpc-4910	217	2	.	.	PUNCT
dpc-4910	218	1	jha	jha	PROPN
dpc-4910	218	2	jc	jc	PROPN
dpc-4910	218	3	,	,	PUNCT
dpc-4910	218	4	thallas	thalla	NOUN
dpc-4910	218	5	-	-	PUNCT
dpc-4910	218	6	bonke	bonke	PROPN
dpc-4910	218	7	v	v	NOUN
dpc-4910	218	8	,	,	PUNCT
dpc-4910	218	9	banal	banal	ADJ
dpc-4910	218	10	c	c	NOUN
dpc-4910	218	11	,	,	PUNCT
dpc-4910	218	12	et	et	PROPN
dpc-4910	218	13	al	al	PROPN
dpc-4910	218	14	.	.	PUNCT
dpc-4910	218	15	podocyte	podocyte	NOUN
dpc-4910	218	16	-	-	PUNCT
dpc-4910	218	17	specific	specific	ADJ
dpc-4910	218	18	nox4	nox4	NOUN
dpc-4910	218	19	deletion	deletion	NOUN
dpc-4910	218	20	affords	afford	NOUN
dpc-4910	218	21	renoprotection	renoprotection	NOUN
dpc-4910	218	22	in	in	ADP
dpc-4910	218	23	a	a	DET
dpc-4910	218	24	mouse	mouse	NOUN
dpc-4910	218	25	model	model	NOUN
dpc-4910	218	26	of	of	ADP
dpc-4910	218	27	diabetic	diabetic	ADJ
dpc-4910	218	28	nephropathy	nephropathy	NOUN
dpc-4910	218	29	.	.	PUNCT
dpc-4910	219	1	diabetologia	diabetologia	NOUN
dpc-4910	219	2	.	.	PUNCT
dpc-4910	220	1	2016;59(2):379–389	2016;59(2):379–389	X
dpc-4910	220	2	.	.	PUNCT
dpc-4910	221	1	doi	doi	NOUN
dpc-4910	221	2	:	:	PUNCT
dpc-4910	221	3	10.1007	10.1007	NUM
dpc-4910	221	4	/s00125	/s00125	ADJ
dpc-4910	221	5	-	-	PUNCT
dpc-4910	221	6	015	015	NUM
dpc-4910	221	7	-	-	PUNCT
dpc-4910	221	8	3796	3796	NUM
dpc-4910	221	9	-	-	SYM
dpc-4910	221	10	0	0	NUM
dpc-4910	221	11	.	.	PUNCT
dpc-4910	222	1	pmid	pmid	NOUN
dpc-4910	222	2	:	:	PUNCT
dpc-4910	222	3	26508318	26508318	NUM
dpc-4910	222	4	.	.	PUNCT
dpc-4910	223	1	12	12	NUM
dpc-4910	223	2	.	.	PUNCT
dpc-4910	224	1	ren	ren	PROPN
dpc-4910	224	2	f	f	PROPN
dpc-4910	224	3	,	,	PUNCT
dpc-4910	224	4	zhang	zhang	PROPN
dpc-4910	224	5	m	m	PROPN
dpc-4910	224	6	,	,	PUNCT
dpc-4910	224	7	hao	hao	PROPN
dpc-4910	224	8	l	l	PROPN
dpc-4910	224	9	,	,	PUNCT
dpc-4910	224	10	sang	sing	VERB
dpc-4910	224	11	h.	h.	PROPN
dpc-4910	224	12	kidney	kidney	PROPN
dpc-4910	224	13	involvement	involvement	NOUN
dpc-4910	224	14	in	in	ADP
dpc-4910	224	15	psoriasis	psoriasis	NOUN
dpc-4910	224	16	:	:	PUNCT
dpc-4910	224	17	a	a	DET
dpc-4910	224	18	case	case	NOUN
dpc-4910	224	19	-	-	PUNCT
dpc-4910	224	20	control	control	NOUN
dpc-4910	224	21	study	study	NOUN
dpc-4910	224	22	from	from	ADP
dpc-4910	224	23	china	china	PROPN
dpc-4910	224	24	.	.	PUNCT
dpc-4910	225	1	int	int	PROPN
dpc-4910	225	2	urol	urol	ADJ
dpc-4910	225	3	nephrol	nephrol	NOUN
dpc-4910	225	4	.	.	PUNCT
dpc-4910	226	1	2017;49(11):1999–2003	2017;49(11):1999–2003	NOUN
dpc-4910	226	2	.	.	PUNCT
dpc-4910	227	1	doi	doi	NOUN
dpc-4910	227	2	:	:	PUNCT
dpc-4910	227	3	10.1007	10.1007	NUM
dpc-4910	227	4	/	/	SYM
dpc-4910	227	5	s11255	s11255	NOUN
dpc-4910	227	6	-	-	PUNCT
dpc-4910	227	7	017	017	NUM
dpc-4910	227	8	-	-	PUNCT
dpc-4910	227	9	1692	1692	NUM
dpc-4910	227	10	-	-	PUNCT
dpc-4910	227	11	x.	x.	NOUN
dpc-4910	227	12	pmid	pmid	PROPN
dpc-4910	227	13	:	:	PUNCT
dpc-4910	227	14	28939941	28939941	NUM
dpc-4910	227	15	.	.	PUNCT
dpc-4910	228	1	13	13	NUM
dpc-4910	228	2	.	.	PUNCT
dpc-4910	228	3	boehncke	boehncke	PROPN
dpc-4910	228	4	wh	wh	PROPN
dpc-4910	228	5	,	,	PUNCT
dpc-4910	228	6	schön	schön	PROPN
dpc-4910	228	7	mp	mp	PROPN
dpc-4910	228	8	.	.	PROPN
dpc-4910	228	9	psoriasis	psoriasis	NOUN
dpc-4910	228	10	.	.	PUNCT
dpc-4910	229	1	lancet	lancet	NOUN
dpc-4910	229	2	.	.	PUNCT
dpc-4910	230	1	2015;386(9997	2015;386(9997	NUM
dpc-4910	230	2	):	):	PUNCT
dpc-4910	231	1	983–994	983–994	NUM
dpc-4910	231	2	.	.	PUNCT
dpc-4910	232	1	doi	doi	NOUN
dpc-4910	232	2	:	:	PUNCT
dpc-4910	232	3	10.1016	10.1016	NUM
dpc-4910	232	4	/	/	SYM
dpc-4910	232	5	s0140	s0140	PROPN
dpc-4910	232	6	-	-	PUNCT
dpc-4910	232	7	6736(14)61909	6736(14)61909	NUM
dpc-4910	232	8	-	-	SYM
dpc-4910	232	9	7	7	NUM
dpc-4910	232	10	.	.	PUNCT
dpc-4910	233	1	pmid	pmid	NOUN
dpc-4910	233	2	:	:	PUNCT
dpc-4910	233	3	2602	2602	NUM
dpc-4910	233	4	5581	5581	NUM
dpc-4910	233	5	.	.	PUNCT
dpc-4910	234	1	14	14	NUM
dpc-4910	234	2	.	.	PUNCT
dpc-4910	235	1	canadian	canadian	ADJ
dpc-4910	235	2	psoriasis	psoriasis	NOUN
dpc-4910	235	3	guidelines	guideline	NOUN
dpc-4910	235	4	committee	committee	NOUN
dpc-4910	235	5	.	.	PUNCT
dpc-4910	236	1	canadian	canadian	ADJ
dpc-4910	236	2	guidelines	guideline	NOUN
dpc-4910	236	3	for	for	ADP
dpc-4910	236	4	the	the	DET
dpc-4910	236	5	management	management	NOUN
dpc-4910	236	6	of	of	ADP
dpc-4910	236	7	plaque	plaque	NOUN
dpc-4910	236	8	psoriasis	psoriasis	NOUN
dpc-4910	236	9	.	.	PUNCT
dpc-4910	237	1	ottawa	ottawa	PROPN
dpc-4910	237	2	,	,	PUNCT
dpc-4910	237	3	on	on	ADP
dpc-4910	237	4	:	:	PUNCT
dpc-4910	237	5	canadian	canadian	ADJ
dpc-4910	237	6	dermatology	dermatology	NOUN
dpc-4910	237	7	association	association	NOUN
dpc-4910	237	8	;	;	PUNCT
dpc-4910	237	9	2009	2009	NUM
dpc-4910	237	10	.	.	PUNCT
dpc-4910	238	1	transition	transition	NOUN
dpc-4910	238	2	from	from	ADP
dpc-4910	238	3	the	the	DET
dpc-4910	238	4	mild	mild	NOUN
dpc-4910	238	5	to	to	ADP
dpc-4910	238	6	moderate	moderate	ADJ
dpc-4910	238	7	group	group	NOUN
dpc-4910	238	8	occurred	occur	VERB
dpc-4910	238	9	,	,	PUNCT
dpc-4910	238	10	or	or	CCONJ
dpc-4910	238	11	the	the	DET
dpc-4910	238	12	process	process	NOUN
dpc-4910	238	13	of	of	ADP
dpc-4910	238	14	being	be	AUX
dpc-4910	238	15	in	in	ADP
dpc-4910	238	16	the	the	DET
dpc-4910	238	17	moderate	moderate	ADJ
dpc-4910	238	18	group	group	NOUN
dpc-4910	238	19	was	be	AUX
dpc-4910	238	20	at	at	ADP
dpc-4910	238	21	an	an	DET
dpc-4910	238	22	early	early	ADJ
dpc-4910	238	23	stage	stage	NOUN
dpc-4910	238	24	.	.	PUNCT
dpc-4910	239	1	the	the	DET
dpc-4910	239	2	significantly	significantly	ADV
dpc-4910	239	3	higher	high	ADJ
dpc-4910	239	4	albuminuria	albuminuria	NOUN
dpc-4910	239	5	,	,	PUNCT
dpc-4910	239	6	urine	urine	NOUN
dpc-4910	239	7	pdx	pdx	NOUN
dpc-4910	239	8	,	,	PUNCT
dpc-4910	239	9	and	and	CCONJ
dpc-4910	239	10	nephrin	nephrin	ADJ
dpc-4910	239	11	levels	level	NOUN
dpc-4910	239	12	in	in	ADP
dpc-4910	239	13	patients	patient	NOUN
dpc-4910	239	14	with	with	ADP
dpc-4910	239	15	severe	severe	ADJ
dpc-4910	239	16	psoriasis	psoriasis	NOUN
dpc-4910	239	17	than	than	ADP
dpc-4910	239	18	in	in	ADP
dpc-4910	239	19	those	those	PRON
dpc-4910	239	20	with	with	ADP
dpc-4910	239	21	mild	mild	ADJ
dpc-4910	239	22	and	and	CCONJ
dpc-4910	239	23	moderate	moderate	ADJ
dpc-4910	239	24	psoriasis	psoriasis	NOUN
dpc-4910	239	25	suggest	suggest	VERB
dpc-4910	239	26	exponential	exponential	ADJ
dpc-4910	239	27	renal	renal	ADJ
dpc-4910	239	28	damage	damage	NOUN
dpc-4910	239	29	.	.	PUNCT
dpc-4910	240	1	the	the	DET
dpc-4910	240	2	rapid	rapid	ADJ
dpc-4910	240	3	increase	increase	NOUN
dpc-4910	240	4	in	in	ADP
dpc-4910	240	5	podocyte	podocyte	NOUN
dpc-4910	240	6	damage	damage	NOUN
dpc-4910	240	7	in	in	ADP
dpc-4910	240	8	the	the	DET
dpc-4910	240	9	mild	mild	ADJ
dpc-4910	240	10	and	and	CCONJ
dpc-4910	240	11	moderate	moderate	ADJ
dpc-4910	240	12	groups	group	NOUN
dpc-4910	240	13	after	after	ADP
dpc-4910	240	14	switching	switch	VERB
dpc-4910	240	15	to	to	ADP
dpc-4910	240	16	the	the	DET
dpc-4910	240	17	severe	severe	ADJ
dpc-4910	240	18	group	group	NOUN
dpc-4910	240	19	may	may	AUX
dpc-4910	240	20	be	be	AUX
dpc-4910	240	21	due	due	ADJ
dpc-4910	240	22	to	to	ADP
dpc-4910	240	23	an	an	DET
dpc-4910	240	24	increase	increase	NOUN
dpc-4910	240	25	in	in	ADP
dpc-4910	240	26	inflammatory	inflammatory	ADJ
dpc-4910	240	27	reactions	reaction	NOUN
dpc-4910	240	28	owing	owe	VERB
dpc-4910	240	29	to	to	ADP
dpc-4910	240	30	bsa	bsa	PROPN
dpc-4910	240	31	expansion	expansion	NOUN
dpc-4910	240	32	.	.	PUNCT
dpc-4910	241	1	the	the	DET
dpc-4910	241	2	chronic	chronic	ADJ
dpc-4910	241	3	inflammatory	inflammatory	ADJ
dpc-4910	241	4	features	feature	NOUN
dpc-4910	241	5	of	of	ADP
dpc-4910	241	6	psoriasis	psoriasis	NOUN
dpc-4910	241	7	may	may	AUX
dpc-4910	241	8	lead	lead	VERB
dpc-4910	241	9	to	to	ADP
dpc-4910	241	10	an	an	DET
dpc-4910	241	11	increase	increase	NOUN
dpc-4910	241	12	in	in	ADP
dpc-4910	241	13	podocyte	podocyte	NOUN
dpc-4910	241	14	damage	damage	NOUN
dpc-4910	241	15	due	due	ADP
dpc-4910	241	16	to	to	ADP
dpc-4910	241	17	the	the	DET
dpc-4910	241	18	activation	activation	NOUN
dpc-4910	241	19	of	of	ADP
dpc-4910	241	20	nuclear	nuclear	ADJ
dpc-4910	241	21	factor	factor	NOUN
dpc-4910	241	22	kappa	kappa	PROPN
dpc-4910	241	23	-	-	PROPN
dpc-4910	241	24	b	b	PROPN
dpc-4910	241	25	,	,	PUNCT
dpc-4910	241	26	which	which	PRON
dpc-4910	241	27	is	be	AUX
dpc-4910	241	28	the	the	DET
dpc-4910	241	29	main	main	ADJ
dpc-4910	241	30	inflammatory	inflammatory	ADJ
dpc-4910	241	31	pathway	pathway	NOUN
dpc-4910	241	32	in	in	ADP
dpc-4910	241	33	the	the	DET
dpc-4910	241	34	glomeruli	glomeruli	NOUN
dpc-4910	241	35	,	,	PUNCT
dpc-4910	241	36	in	in	ADP
dpc-4910	241	37	cases	case	NOUN
dpc-4910	241	38	of	of	ADP
dpc-4910	241	39	severe	severe	ADJ
dpc-4910	241	40	psoriasis	psoriasis	NOUN
dpc-4910	242	1	[	[	X
dpc-4910	242	2	6,7	6,7	NUM
dpc-4910	242	3	]	]	PUNCT
dpc-4910	242	4	.	.	PUNCT
dpc-4910	243	1	clinically	clinically	ADV
dpc-4910	243	2	evident	evident	ADJ
dpc-4910	243	3	nephrotoxic	nephrotoxic	ADJ
dpc-4910	243	4	treatments	treatment	NOUN
dpc-4910	243	5	and	and	CCONJ
dpc-4910	243	6	osteoarthritis	osteoarthritis	NOUN
dpc-4910	243	7	may	may	AUX
dpc-4910	243	8	also	also	ADV
dpc-4910	243	9	be	be	AUX
dpc-4910	243	10	responsible	responsible	ADJ
dpc-4910	243	11	for	for	ADP
dpc-4910	243	12	the	the	DET
dpc-4910	243	13	exponential	exponential	ADJ
dpc-4910	243	14	increase	increase	NOUN
dpc-4910	243	15	in	in	ADP
dpc-4910	243	16	urine	urine	NOUN
dpc-4910	243	17	pdx	pdx	PROPN
dpc-4910	243	18	and	and	CCONJ
dpc-4910	243	19	nephrin	nephrin	PROPN
dpc-4910	243	20	levels	level	NOUN
dpc-4910	243	21	in	in	ADP
dpc-4910	243	22	patients	patient	NOUN
dpc-4910	243	23	with	with	ADP
dpc-4910	243	24	severe	severe	ADJ
dpc-4910	243	25	psoriasis	psoriasis	NOUN
dpc-4910	243	26	.	.	PUNCT
dpc-4910	244	1	after	after	ADP
dpc-4910	244	2	adjusting	adjust	VERB
dpc-4910	244	3	for	for	ADP
dpc-4910	244	4	possible	possible	ADJ
dpc-4910	244	5	confounding	confound	VERB
dpc-4910	244	6	factors	factor	NOUN
dpc-4910	244	7	,	,	PUNCT
dpc-4910	244	8	such	such	ADJ
dpc-4910	244	9	as	as	ADP
dpc-4910	244	10	age	age	NOUN
dpc-4910	244	11	,	,	PUNCT
dpc-4910	244	12	bmi	bmi	NOUN
dpc-4910	244	13	,	,	PUNCT
dpc-4910	244	14	and	and	CCONJ
dpc-4910	244	15	sex	sex	NOUN
dpc-4910	244	16	,	,	PUNCT
dpc-4910	244	17	pdx	pdx	PROPN
dpc-4910	244	18	and	and	CCONJ
dpc-4910	244	19	nephrin	nephrin	PROPN
dpc-4910	244	20	were	be	AUX
dpc-4910	244	21	independent	independent	ADJ
dpc-4910	244	22	risk	risk	NOUN
dpc-4910	244	23	factors	factor	NOUN
dpc-4910	244	24	for	for	ADP
dpc-4910	244	25	microalbuminuria	microalbuminuria	NOUN
dpc-4910	244	26	occurring	occur	VERB
dpc-4910	244	27	in	in	ADP
dpc-4910	244	28	psoriasis	psoriasis	NOUN
dpc-4910	244	29	,	,	PUNCT
dpc-4910	244	30	indicating	indicate	VERB
dpc-4910	244	31	that	that	SCONJ
dpc-4910	244	32	disease	disease	NOUN
dpc-4910	244	33	severity	severity	NOUN
dpc-4910	244	34	is	be	AUX
dpc-4910	244	35	an	an	DET
dpc-4910	244	36	important	important	ADJ
dpc-4910	244	37	determinant	determinant	NOUN
dpc-4910	244	38	of	of	ADP
dpc-4910	244	39	podocyte	podocyte	NOUN
dpc-4910	244	40	damage	damage	NOUN
dpc-4910	244	41	,	,	PUNCT
dpc-4910	244	42	independent	independent	ADJ
dpc-4910	244	43	of	of	ADP
dpc-4910	244	44	other	other	ADJ
dpc-4910	244	45	confounders	confounder	NOUN
dpc-4910	244	46	.	.	PUNCT
dpc-4910	245	1	the	the	DET
dpc-4910	245	2	cumulative	cumulative	ADJ
dpc-4910	245	3	effect	effect	NOUN
dpc-4910	245	4	of	of	ADP
dpc-4910	245	5	multiple	multiple	ADJ
dpc-4910	245	6	etiological	etiological	ADJ
dpc-4910	245	7	factors	factor	NOUN
dpc-4910	245	8	that	that	PRON
dpc-4910	245	9	determine	determine	VERB
dpc-4910	245	10	the	the	DET
dpc-4910	245	11	occurrence	occurrence	NOUN
dpc-4910	245	12	and	and	CCONJ
dpc-4910	245	13	progression	progression	NOUN
dpc-4910	245	14	of	of	ADP
dpc-4910	245	15	psoriasis	psoriasis	NOUN
dpc-4910	245	16	may	may	AUX
dpc-4910	245	17	cause	cause	VERB
dpc-4910	245	18	glomerular	glomerular	ADJ
dpc-4910	245	19	damage	damage	NOUN
dpc-4910	245	20	in	in	ADP
dpc-4910	245	21	patients	patient	NOUN
dpc-4910	245	22	with	with	ADP
dpc-4910	245	23	psoriasis	psoriasis	NOUN
dpc-4910	245	24	.	.	PUNCT
dpc-4910	246	1	the	the	DET
dpc-4910	246	2	high	high	ADJ
dpc-4910	246	3	triglyceride	triglyceride	ADJ
dpc-4910	246	4	levels	level	NOUN
dpc-4910	246	5	,	,	PUNCT
dpc-4910	246	6	increased	increase	VERB
dpc-4910	246	7	insulin	insulin	NOUN
dpc-4910	246	8	resistance	resistance	NOUN
dpc-4910	246	9	,	,	PUNCT
dpc-4910	246	10	and	and	CCONJ
dpc-4910	246	11	high	high	ADJ
dpc-4910	246	12	glucose	glucose	NOUN
dpc-4910	246	13	levels	level	NOUN
dpc-4910	246	14	observed	observe	VERB
dpc-4910	246	15	in	in	ADP
dpc-4910	246	16	the	the	DET
dpc-4910	246	17	psoriasis	psoriasis	NOUN
dpc-4910	246	18	group	group	NOUN
dpc-4910	246	19	may	may	AUX
dpc-4910	246	20	have	have	AUX
dpc-4910	246	21	contributed	contribute	VERB
dpc-4910	246	22	to	to	ADP
dpc-4910	246	23	podocyte	podocyte	NOUN
dpc-4910	246	24	damage	damage	NOUN
dpc-4910	246	25	.	.	PUNCT
dpc-4910	247	1	similarly	similarly	ADV
dpc-4910	247	2	,	,	PUNCT
dpc-4910	247	3	the	the	DET
dpc-4910	247	4	positive	positive	ADJ
dpc-4910	247	5	correlation	correlation	NOUN
dpc-4910	247	6	between	between	ADP
dpc-4910	247	7	systolic	systolic	ADJ
dpc-4910	247	8	blood	blood	NOUN
dpc-4910	247	9	pressure	pressure	NOUN
dpc-4910	247	10	,	,	PUNCT
dpc-4910	247	11	pdx	pdx	PROPN
dpc-4910	247	12	,	,	PUNCT
dpc-4910	247	13	and	and	CCONJ
dpc-4910	247	14	nephrin	nephrin	PROPN
dpc-4910	247	15	levels	level	NOUN
dpc-4910	247	16	supports	support	VERB
dpc-4910	247	17	the	the	DET
dpc-4910	247	18	hypothesis	hypothesis	NOUN
dpc-4910	247	19	that	that	SCONJ
dpc-4910	247	20	systemic	systemic	ADJ
dpc-4910	247	21	comorbidities	comorbiditie	NOUN
dpc-4910	247	22	associated	associate	VERB
dpc-4910	247	23	with	with	ADP
dpc-4910	247	24	the	the	DET
dpc-4910	247	25	disease	disease	NOUN
dpc-4910	247	26	also	also	ADV
dpc-4910	247	27	contribute	contribute	VERB
dpc-4910	247	28	to	to	ADP
dpc-4910	247	29	podocyte	podocyte	NOUN
dpc-4910	247	30	damage	damage	NOUN
dpc-4910	247	31	.	.	PUNCT
dpc-4910	248	1	the	the	DET
dpc-4910	248	2	reported	report	VERB
dpc-4910	248	3	increase	increase	NOUN
dpc-4910	248	4	in	in	ADP
dpc-4910	248	5	podocyte	podocyte	NOUN
dpc-4910	248	6	damage	damage	NOUN
dpc-4910	248	7	in	in	ADP
dpc-4910	248	8	patients	patient	NOUN
dpc-4910	248	9	with	with	ADP
dpc-4910	248	10	preeclampsia	preeclampsia	NOUN
dpc-4910	248	11	is	be	AUX
dpc-4910	248	12	evidence	evidence	NOUN
dpc-4910	248	13	that	that	SCONJ
dpc-4910	248	14	blood	blood	NOUN
dpc-4910	248	15	pressure	pressure	NOUN
dpc-4910	248	16	and	and	CCONJ
dpc-4910	248	17	podocyte	podocyte	NOUN
dpc-4910	248	18	damage	damage	NOUN
dpc-4910	248	19	are	be	AUX
dpc-4910	248	20	related	relate	VERB
dpc-4910	248	21	[	[	PUNCT
dpc-4910	248	22	18	18	NUM
dpc-4910	248	23	]	]	PUNCT
dpc-4910	248	24	.	.	PUNCT
dpc-4910	249	1	similarly	similarly	ADV
dpc-4910	249	2	,	,	PUNCT
dpc-4910	249	3	in	in	ADP
dpc-4910	249	4	the	the	DET
dpc-4910	249	5	psoriasis	psoriasis	NOUN
dpc-4910	249	6	group	group	NOUN
dpc-4910	249	7	,	,	PUNCT
dpc-4910	249	8	hyperinsulinemia	hyperinsulinemia	NOUN
dpc-4910	249	9	may	may	AUX
dpc-4910	249	10	mediate	mediate	VERB
dpc-4910	249	11	glomerular	glomerular	ADJ
dpc-4910	249	12	hypertrophy	hypertrophy	NOUN
dpc-4910	249	13	and	and	CCONJ
dpc-4910	249	14	podocyte	podocyte	NOUN
dpc-4910	249	15	damage	damage	NOUN
dpc-4910	249	16	by	by	ADP
dpc-4910	249	17	increasing	increase	VERB
dpc-4910	249	18	blood	blood	NOUN
dpc-4910	249	19	pressure	pressure	NOUN
dpc-4910	249	20	[	[	X
dpc-4910	249	21	19	19	NUM
dpc-4910	249	22	,	,	PUNCT
dpc-4910	249	23	20	20	NUM
dpc-4910	249	24	]	]	PUNCT
dpc-4910	249	25	.	.	PUNCT
dpc-4910	250	1	in	in	ADP
dpc-4910	250	2	the	the	DET
dpc-4910	250	3	psoriasis	psoriasis	NOUN
dpc-4910	250	4	group	group	NOUN
dpc-4910	250	5	,	,	PUNCT
dpc-4910	250	6	high	high	ADJ
dpc-4910	250	7	triglyceride	triglyceride	ADJ
dpc-4910	250	8	levels	level	NOUN
dpc-4910	250	9	may	may	AUX
dpc-4910	250	10	cause	cause	VERB
dpc-4910	250	11	podocyte	podocyte	NOUN
dpc-4910	250	12	damage	damage	NOUN
dpc-4910	250	13	by	by	ADP
dpc-4910	250	14	stimulating	stimulate	VERB
dpc-4910	250	15	oxidative	oxidative	ADJ
dpc-4910	250	16	stress	stress	NOUN
dpc-4910	250	17	and	and	CCONJ
dpc-4910	250	18	fibrinogenic	fibrinogenic	ADJ
dpc-4910	250	19	activity	activity	NOUN
dpc-4910	250	20	[	[	X
dpc-4910	250	21	20	20	NUM
dpc-4910	250	22	-	-	SYM
dpc-4910	250	23	22	22	NUM
dpc-4910	250	24	]	]	PUNCT
dpc-4910	250	25	.	.	PUNCT
dpc-4910	251	1	although	although	SCONJ
dpc-4910	251	2	the	the	DET
dpc-4910	251	3	relatively	relatively	ADV
dpc-4910	251	4	small	small	ADJ
dpc-4910	251	5	number	number	NOUN
dpc-4910	251	6	of	of	ADP
dpc-4910	251	7	participants	participant	NOUN
dpc-4910	251	8	is	be	AUX
dpc-4910	251	9	a	a	DET
dpc-4910	251	10	significant	significant	ADJ
dpc-4910	251	11	limitation	limitation	NOUN
dpc-4910	251	12	,	,	PUNCT
dpc-4910	251	13	this	this	DET
dpc-4910	251	14	study	study	NOUN
dpc-4910	251	15	shows	show	VERB
dpc-4910	251	16	that	that	SCONJ
dpc-4910	251	17	podocyte	podocyte	NOUN
dpc-4910	251	18	damage	damage	NOUN
dpc-4910	251	19	in	in	ADP
dpc-4910	251	20	patients	patient	NOUN
dpc-4910	251	21	with	with	ADP
dpc-4910	251	22	psoriasis	psoriasis	NOUN
dpc-4910	251	23	begins	begin	VERB
dpc-4910	251	24	in	in	ADP
dpc-4910	251	25	the	the	DET
dpc-4910	251	26	early	early	ADJ
dpc-4910	251	27	stage	stage	NOUN
dpc-4910	251	28	of	of	ADP
dpc-4910	251	29	the	the	DET
dpc-4910	251	30	disease	disease	NOUN
dpc-4910	251	31	and	and	CCONJ
dpc-4910	251	32	increases	increase	NOUN
dpc-4910	251	33	significantly	significantly	ADV
dpc-4910	251	34	in	in	ADP
dpc-4910	251	35	the	the	DET
dpc-4910	251	36	severe	severe	ADJ
dpc-4910	251	37	disease	disease	NOUN
dpc-4910	251	38	stage	stage	NOUN
dpc-4910	251	39	.	.	PUNCT
dpc-4910	252	1	urinary	urinary	ADJ
dpc-4910	252	2	pdx	pdx	PROPN
dpc-4910	252	3	and	and	CCONJ
dpc-4910	252	4	nephrin	nephrin	PROPN
dpc-4910	252	5	levels	level	NOUN
dpc-4910	252	6	were	be	AUX
dpc-4910	252	7	positively	positively	ADV
dpc-4910	252	8	correlated	correlate	VERB
dpc-4910	252	9	with	with	ADP
dpc-4910	252	10	uacr	uacr	NOUN
dpc-4910	252	11	and	and	CCONJ
dpc-4910	252	12	could	could	AUX
dpc-4910	252	13	be	be	AUX
dpc-4910	252	14	detected	detect	VERB
dpc-4910	252	15	in	in	ADP
dpc-4910	252	16	urine	urine	NOUN
dpc-4910	252	17	before	before	ADP
dpc-4910	252	18	or	or	CCONJ
dpc-4910	252	19	simultaneously	simultaneously	ADV
dpc-4910	252	20	with	with	ADP
dpc-4910	252	21	microalbuminuria	microalbuminuria	NOUN
dpc-4910	252	22	.	.	PUNCT
dpc-4910	253	1	although	although	SCONJ
dpc-4910	253	2	renal	renal	ADJ
dpc-4910	253	3	damage	damage	NOUN
dpc-4910	253	4	is	be	AUX
dpc-4910	253	5	common	common	ADJ
dpc-4910	253	6	in	in	ADP
dpc-4910	253	7	severe	severe	ADJ
dpc-4910	253	8	psoriasis	psoriasis	NOUN
dpc-4910	253	9	,	,	PUNCT
dpc-4910	253	10	renal	renal	ADJ
dpc-4910	253	11	dysfunction	dysfunction	NOUN
dpc-4910	253	12	in	in	ADP
dpc-4910	253	13	mild	mild	ADJ
dpc-4910	253	14	and	and	CCONJ
dpc-4910	253	15	moderate	moderate	ADJ
dpc-4910	253	16	cases	case	NOUN
dpc-4910	253	17	may	may	AUX
dpc-4910	253	18	not	not	PART
dpc-4910	253	19	be	be	AUX
dpc-4910	253	20	detected	detect	VERB
dpc-4910	253	21	using	use	VERB
dpc-4910	253	22	classical	classical	ADJ
dpc-4910	253	23	blood	blood	NOUN
dpc-4910	253	24	and	and	CCONJ
dpc-4910	253	25	urine	urine	NOUN
dpc-4910	253	26	analysis	analysis	NOUN
dpc-4910	253	27	.	.	PUNCT
dpc-4910	254	1	for	for	ADP
dpc-4910	254	2	this	this	DET
dpc-4910	254	3	reason	reason	NOUN
dpc-4910	254	4	,	,	PUNCT
dpc-4910	254	5	analyzing	analyze	VERB
dpc-4910	254	6	urine	urine	NOUN
dpc-4910	254	7	pdx	pdx	PROPN
dpc-4910	254	8	and	and	CCONJ
dpc-4910	254	9	nephrin	nephrin	ADJ
dpc-4910	254	10	levels	level	NOUN
dpc-4910	254	11	of	of	ADP
dpc-4910	254	12	patients	patient	NOUN
dpc-4910	254	13	with	with	ADP
dpc-4910	254	14	psoriasis	psoriasis	NOUN
dpc-4910	254	15	in	in	ADP
dpc-4910	254	16	addition	addition	NOUN
dpc-4910	254	17	to	to	ADP
dpc-4910	254	18	conventional	conventional	ADJ
dpc-4910	254	19	analyses	analysis	NOUN
dpc-4910	254	20	such	such	ADJ
dpc-4910	254	21	as	as	ADP
dpc-4910	254	22	microalbuminuria	microalbuminuria	NOUN
dpc-4910	254	23	,	,	PUNCT
dpc-4910	254	24	serum	serum	NOUN
dpc-4910	254	25	creatinine	creatinine	NOUN
dpc-4910	254	26	,	,	PUNCT
dpc-4910	254	27	and	and	CCONJ
dpc-4910	254	28	blood	blood	NOUN
dpc-4910	254	29	urea	urea	NOUN
dpc-4910	254	30	nitrogen	nitrogen	NOUN
dpc-4910	254	31	can	can	AUX
dpc-4910	254	32	provide	provide	VERB
dpc-4910	254	33	an	an	DET
dpc-4910	254	34	early	early	ADJ
dpc-4910	254	35	diagnosis	diagnosis	NOUN
dpc-4910	254	36	of	of	ADP
dpc-4910	254	37	renal	renal	ADJ
dpc-4910	254	38	dysfunction	dysfunction	NOUN
dpc-4910	254	39	,	,	PUNCT
dpc-4910	254	40	making	make	VERB
dpc-4910	254	41	it	it	PRON
dpc-4910	254	42	possible	possible	ADJ
dpc-4910	254	43	to	to	PART
dpc-4910	254	44	take	take	VERB
dpc-4910	254	45	the	the	DET
dpc-4910	254	46	necessary	necessary	ADJ
dpc-4910	254	47	precautions	precaution	NOUN
dpc-4910	254	48	.	.	PUNCT
dpc-4910	255	1	8	8	NUM
dpc-4910	255	2	original	original	ADJ
dpc-4910	255	3	article	article	NOUN
dpc-4910	255	4	|	|	ADV
dpc-4910	255	5	dermatol	dermatol	ADJ
dpc-4910	255	6	pract	pract	NOUN
dpc-4910	255	7	concept	concept	NOUN
dpc-4910	255	8	.	.	PUNCT
dpc-4910	256	1	2025;15(2):4910	2025;15(2):4910	NUM
dpc-4910	256	2	2014;31(2):77–81	2014;31(2):77–81	NUM
dpc-4910	256	3	.	.	PUNCT
dpc-4910	257	1	doi	doi	NOUN
dpc-4910	257	2	:	:	PUNCT
dpc-4910	257	3	10.5114	10.5114	NUM
dpc-4910	257	4	/	/	SYM
dpc-4910	257	5	pdia.2014.40810	pdia.2014.40810	NOUN
dpc-4910	257	6	.	.	PUNCT
dpc-4910	258	1	pmid	pmid	NOUN
dpc-4910	258	2	:	:	PUNCT
dpc-4910	258	3	24790518	24790518	NUM
dpc-4910	258	4	.	.	PUNCT
dpc-4910	259	1	20	20	NUM
dpc-4910	259	2	.	.	PUNCT
dpc-4910	259	3	naldi	naldi	PROPN
dpc-4910	259	4	l	l	PROPN
dpc-4910	259	5	,	,	PUNCT
dpc-4910	259	6	gambardella	gambardella	VERB
dpc-4910	259	7	a	a	PRON
dpc-4910	259	8	,	,	PUNCT
dpc-4910	259	9	svensson	svensson	PROPN
dpc-4910	259	10	å	å	PROPN
dpc-4910	259	11	,	,	PUNCT
dpc-4910	259	12	et	et	PROPN
dpc-4910	259	13	al	al	PROPN
dpc-4910	259	14	.	.	PUNCT
dpc-4910	260	1	prevalence	prevalence	NOUN
dpc-4910	260	2	of	of	ADP
dpc-4910	260	3	metabolic	metabolic	NOUN
dpc-4910	260	4	syndrome	syndrome	NOUN
dpc-4910	260	5	and	and	CCONJ
dpc-4910	260	6	related	related	ADJ
dpc-4910	260	7	comorbidities	comorbiditie	NOUN
dpc-4910	260	8	in	in	ADP
dpc-4910	260	9	patients	patient	NOUN
dpc-4910	260	10	with	with	ADP
dpc-4910	260	11	psoriasis	psoriasis	NOUN
dpc-4910	260	12	:	:	PUNCT
dpc-4910	260	13	a	a	DET
dpc-4910	260	14	cross	cross	ADJ
dpc-4910	260	15	-	-	ADJ
dpc-4910	260	16	sectional	sectional	ADJ
dpc-4910	260	17	study	study	NOUN
dpc-4910	260	18	from	from	ADP
dpc-4910	260	19	the	the	DET
dpc-4910	260	20	italian	italian	ADJ
dpc-4910	260	21	psocare	psocare	ADJ
dpc-4910	260	22	project	project	NOUN
dpc-4910	260	23	.	.	PUNCT
dpc-4910	261	1	br	br	PROPN
dpc-4910	261	2	j	j	PROPN
dpc-4910	261	3	dermatol	dermatol	NOUN
dpc-4910	261	4	.	.	PUNCT
dpc-4910	262	1	2013;169(6):1273–1279	2013;169(6):1273–1279	NUM
dpc-4910	262	2	.	.	PUNCT
dpc-4910	263	1	doi	doi	NOUN
dpc-4910	263	2	:	:	PUNCT
dpc-4910	263	3	10.1111	10.1111	NUM
dpc-4910	263	4	/	/	SYM
dpc-4910	263	5	bjd.12567	bjd.12567	NOUN
dpc-4910	263	6	.	.	PUNCT
dpc-4910	264	1	pmid	pmid	NOUN
dpc-4910	264	2	:	:	PUNCT
dpc-4910	264	3	23905877	23905877	NUM
dpc-4910	264	4	.	.	PUNCT
dpc-4910	265	1	21	21	NUM
dpc-4910	265	2	.	.	PUNCT
dpc-4910	265	3	neimann	neimann	PROPN
dpc-4910	265	4	al	al	PROPN
dpc-4910	265	5	,	,	PUNCT
dpc-4910	265	6	shin	shin	PROPN
dpc-4910	265	7	db	db	PROPN
dpc-4910	265	8	,	,	PUNCT
dpc-4910	265	9	kiseljak	kiseljak	PROPN
dpc-4910	265	10	-	-	PUNCT
dpc-4910	265	11	vassiliades	vassiliade	NOUN
dpc-4910	265	12	k	k	NOUN
dpc-4910	265	13	,	,	PUNCT
dpc-4910	265	14	noe	noe	PROPN
dpc-4910	265	15	mh	mh	PROPN
dpc-4910	265	16	,	,	PUNCT
dpc-4910	265	17	dozmorov	dozmorov	PROPN
dpc-4910	265	18	i	i	PROPN
dpc-4910	265	19	,	,	PUNCT
dpc-4910	265	20	gelfand	gelfand	PROPN
dpc-4910	265	21	jm	jm	PROPN
dpc-4910	265	22	.	.	PROPN
dpc-4910	265	23	psoriasis	psoriasis	NOUN
dpc-4910	265	24	is	be	AUX
dpc-4910	265	25	associated	associate	VERB
dpc-4910	265	26	with	with	ADP
dpc-4910	265	27	independent	independent	ADJ
dpc-4910	265	28	risk	risk	NOUN
dpc-4910	265	29	of	of	ADP
dpc-4910	265	30	diabetes	diabetes	NOUN
dpc-4910	265	31	mellitus	mellitus	NOUN
dpc-4910	265	32	.	.	PUNCT
dpc-4910	266	1	results	result	NOUN
dpc-4910	266	2	from	from	ADP
dpc-4910	266	3	the	the	DET
dpc-4910	266	4	national	national	ADJ
dpc-4910	266	5	psoriasis	psoriasis	NOUN
dpc-4910	266	6	foundation	foundation	NOUN
dpc-4910	266	7	case	case	NOUN
dpc-4910	266	8	-	-	PUNCT
dpc-4910	266	9	control	control	NOUN
dpc-4910	266	10	study	study	NOUN
dpc-4910	266	11	.	.	PUNCT
dpc-4910	267	1	j	j	PROPN
dpc-4910	267	2	am	be	AUX
dpc-4910	267	3	acad	acad	ADJ
dpc-4910	267	4	dermatol	dermatol	NOUN
dpc-4910	267	5	.	.	PUNCT
dpc-4910	268	1	2011;65(1):98–103	2011;65(1):98–103	NUM
dpc-4910	268	2	.	.	PUNCT
dpc-4910	269	1	e1–3	e1–3	ADJ
dpc-4910	269	2	.	.	PUNCT
dpc-4910	270	1	doi	doi	NOUN
dpc-4910	270	2	:	:	PUNCT
dpc-4910	270	3	10.1016	10.1016	NUM
dpc-4910	270	4	/	/	SYM
dpc-4910	270	5	j.jaad.2010.12.022	j.jaad.2010.12.022	PROPN
dpc-4910	270	6	.	.	PUNCT
dpc-4910	271	1	pmid	pmid	NOUN
dpc-4910	271	2	:	:	PUNCT
dpc-4910	271	3	21300407	21300407	NUM
dpc-4910	271	4	.	.	PUNCT
dpc-4910	272	1	22	22	NUM
dpc-4910	272	2	.	.	PUNCT
dpc-4910	273	1	sommer	sommer	PROPN
dpc-4910	273	2	dm	dm	PROPN
dpc-4910	273	3	,	,	PUNCT
dpc-4910	273	4	jenisch	jenisch	PROPN
dpc-4910	273	5	l	l	PROPN
dpc-4910	273	6	,	,	PUNCT
dpc-4910	273	7	suchan	suchan	PROPN
dpc-4910	273	8	m	m	PROPN
dpc-4910	273	9	,	,	PUNCT
dpc-4910	273	10	christophers	christophers	PROPN
dpc-4910	273	11	e	e	PROPN
dpc-4910	273	12	,	,	PUNCT
dpc-4910	273	13	weichenmeier	weichenmeier	PROPN
dpc-4910	273	14	i.	i.	PROPN
dpc-4910	273	15	increased	increase	VERB
dpc-4910	273	16	prevalence	prevalence	NOUN
dpc-4910	273	17	of	of	ADP
dpc-4910	273	18	the	the	DET
dpc-4910	273	19	metabolic	metabolic	NOUN
dpc-4910	273	20	syndrome	syndrome	NOUN
dpc-4910	273	21	in	in	ADP
dpc-4910	273	22	patients	patient	NOUN
dpc-4910	273	23	with	with	ADP
dpc-4910	273	24	moderate	moderate	ADJ
dpc-4910	273	25	to	to	ADP
dpc-4910	273	26	severe	severe	ADJ
dpc-4910	273	27	psoriasis	psoriasis	NOUN
dpc-4910	273	28	.	.	PUNCT
dpc-4910	274	1	arch	arch	ADJ
dpc-4910	274	2	dermatol	dermatol	NOUN
dpc-4910	274	3	res	re	NOUN
dpc-4910	274	4	.	.	PUNCT
dpc-4910	275	1	2006;298(7):321–328	2006;298(7):321–328	X
dpc-4910	275	2	.	.	PUNCT
dpc-4910	275	3	doi	doi	NOUN
dpc-4910	275	4	:	:	PUNCT
dpc-4910	275	5	10.1007	10.1007	NUM
dpc-4910	275	6	/	/	SYM
dpc-4910	275	7	s00403	s00403	NOUN
dpc-4910	275	8	-	-	PUNCT
dpc-4910	275	9	006	006	NUM
dpc-4910	275	10	-	-	PUNCT
dpc-4910	275	11	0691	0691	NUM
dpc-4910	275	12	-	-	PUNCT
dpc-4910	275	13	z.	z.	NOUN
dpc-4910	275	14	pmid	pmid	PROPN
dpc-4910	275	15	:	:	PUNCT
dpc-4910	275	16	17006528	17006528	NUM
dpc-4910	275	17	.	.	PUNCT
dpc-4910	276	1	15	15	NUM
dpc-4910	276	2	.	.	PUNCT
dpc-4910	276	3	griffiths	griffiths	PROPN
dpc-4910	276	4	ce	ce	PROPN
dpc-4910	276	5	,	,	PUNCT
dpc-4910	276	6	barker	barker	PROPN
dpc-4910	277	1	jn	jn	PROPN
dpc-4910	277	2	.	.	PROPN
dpc-4910	278	1	pathogenesis	pathogenesis	PROPN
dpc-4910	278	2	and	and	CCONJ
dpc-4910	278	3	clinical	clinical	ADJ
dpc-4910	278	4	features	feature	NOUN
dpc-4910	278	5	of	of	ADP
dpc-4910	278	6	psoriasis	psoriasis	NOUN
dpc-4910	278	7	.	.	PUNCT
dpc-4910	279	1	lancet	lancet	NOUN
dpc-4910	279	2	.	.	PUNCT
dpc-4910	280	1	2007;370(9583):263–271	2007;370(9583):263–271	X
dpc-4910	280	2	.	.	X
dpc-4910	280	3	doi	doi	NOUN
dpc-4910	280	4	:	:	PUNCT
dpc-4910	280	5	10.1016	10.1016	NUM
dpc-4910	280	6	/	/	SYM
dpc-4910	280	7	s0140	s0140	ADJ
dpc-4910	280	8	-6736(07)61128	-6736(07)61128	NOUN
dpc-4910	280	9	-	-	PUNCT
dpc-4910	280	10	3	3	NUM
dpc-4910	280	11	.	.	PUNCT
dpc-4910	281	1	pmid	pmid	NOUN
dpc-4910	281	2	:	:	PUNCT
dpc-4910	281	3	17658397	17658397	NUM
dpc-4910	281	4	.	.	PUNCT
dpc-4910	282	1	16	16	NUM
dpc-4910	282	2	.	.	PUNCT
dpc-4910	283	1	matthews	matthews	PROPN
dpc-4910	283	2	dr	dr	PROPN
dpc-4910	283	3	,	,	PUNCT
dpc-4910	283	4	hosker	hosker	NOUN
dpc-4910	283	5	jp	jp	PROPN
dpc-4910	283	6	,	,	PUNCT
dpc-4910	283	7	rudenski	rudenski	NOUN
dpc-4910	283	8	as	as	ADP
dpc-4910	283	9	,	,	PUNCT
dpc-4910	283	10	naylor	naylor	PROPN
dpc-4910	283	11	ba	ba	PROPN
dpc-4910	283	12	,	,	PUNCT
dpc-4910	283	13	treacher	treacher	PROPN
dpc-4910	283	14	df	df	PROPN
dpc-4910	283	15	,	,	PUNCT
dpc-4910	283	16	turner	turner	PROPN
dpc-4910	283	17	rc	rc	PROPN
dpc-4910	283	18	.	.	PUNCT
dpc-4910	283	19	homeostasis	homeostasis	NOUN
dpc-4910	283	20	model	model	NOUN
dpc-4910	283	21	assessment	assessment	NOUN
dpc-4910	283	22	:	:	PUNCT
dpc-4910	283	23	insulin	insulin	NOUN
dpc-4910	283	24	resistance	resistance	NOUN
dpc-4910	283	25	and	and	CCONJ
dpc-4910	283	26	beta	beta	NOUN
dpc-4910	283	27	-	-	PUNCT
dpc-4910	283	28	cell	cell	NOUN
dpc-4910	283	29	function	function	NOUN
dpc-4910	283	30	from	from	ADP
dpc-4910	283	31	fasting	fast	VERB
dpc-4910	283	32	plasma	plasma	NOUN
dpc-4910	283	33	glucose	glucose	NOUN
dpc-4910	283	34	and	and	CCONJ
dpc-4910	283	35	insulin	insulin	NOUN
dpc-4910	283	36	concentrations	concentration	NOUN
dpc-4910	283	37	in	in	ADP
dpc-4910	283	38	man	man	NOUN
dpc-4910	283	39	.	.	PUNCT
dpc-4910	284	1	diabetologia	diabetologia	NOUN
dpc-4910	284	2	.	.	PUNCT
dpc-4910	285	1	1985;28(7):412–419	1985;28(7):412–419	X
dpc-4910	285	2	.	.	PUNCT
dpc-4910	286	1	doi	doi	NOUN
dpc-4910	286	2	:	:	PUNCT
dpc-4910	286	3	10.1007	10.1007	NUM
dpc-4910	286	4	/	/	SYM
dpc-4910	286	5	bf00280883	bf00280883	NOUN
dpc-4910	286	6	.	.	PUNCT
dpc-4910	287	1	pmid	pmid	NOUN
dpc-4910	287	2	:	:	PUNCT
dpc-4910	287	3	3899825	3899825	NUM
dpc-4910	287	4	.	.	PUNCT
dpc-4910	288	1	17	17	NUM
dpc-4910	288	2	.	.	PUNCT
dpc-4910	288	3	olivoto	olivoto	PROPN
dpc-4910	288	4	t	t	PROPN
dpc-4910	288	5	,	,	PUNCT
dpc-4910	288	6	lucio	lucio	PROPN
dpc-4910	288	7	ad	ad	PROPN
dpc-4910	288	8	.	.	PUNCT
dpc-4910	289	1	metan	metan	PROPN
dpc-4910	289	2	:	:	PUNCT
dpc-4910	289	3	an	an	DET
dpc-4910	289	4	r	r	NOUN
dpc-4910	289	5	package	package	NOUN
dpc-4910	289	6	for	for	ADP
dpc-4910	289	7	multienvironment	multienvironment	ADJ
dpc-4910	289	8	trial	trial	NOUN
dpc-4910	289	9	analysis	analysis	NOUN
dpc-4910	289	10	.	.	PUNCT
dpc-4910	290	1	methods	method	NOUN
dpc-4910	290	2	ecol	ecol	PROPN
dpc-4910	290	3	evol	evol	NOUN
dpc-4910	290	4	.	.	PUNCT
dpc-4910	291	1	2020;11(6):783–789	2020;11(6):783–789	X
dpc-4910	291	2	.	.	PUNCT
dpc-4910	292	1	doi	doi	NOUN
dpc-4910	292	2	:	:	PUNCT
dpc-4910	292	3	10.1111/2041	10.1111/2041	NUM
dpc-4910	292	4	-	-	SYM
dpc-4910	292	5	210x.13384	210x.13384	NUM
dpc-4910	292	6	.	.	PROPN
dpc-4910	292	7	18	18	NUM
dpc-4910	292	8	.	.	PUNCT
dpc-4910	293	1	wang	wang	PROPN
dpc-4910	293	2	y	y	PROPN
dpc-4910	293	3	,	,	PUNCT
dpc-4910	293	4	zhao	zhao	PROPN
dpc-4910	293	5	s	s	PROPN
dpc-4910	293	6	,	,	PUNCT
dpc-4910	293	7	loyd	loyd	PROPN
dpc-4910	293	8	s	s	PROPN
dpc-4910	293	9	,	,	PUNCT
dpc-4910	293	10	groome	groome	ADJ
dpc-4910	293	11	lj	lj	PROPN
dpc-4910	293	12	.	.	PROPN
dpc-4910	293	13	increased	increase	VERB
dpc-4910	293	14	urinary	urinary	ADJ
dpc-4910	293	15	excretion	excretion	NOUN
dpc-4910	293	16	of	of	ADP
dpc-4910	293	17	nephrin	nephrin	NOUN
dpc-4910	293	18	,	,	PUNCT
dpc-4910	293	19	podocalyxin	podocalyxin	NOUN
dpc-4910	293	20	,	,	PUNCT
dpc-4910	293	21	and	and	CCONJ
dpc-4910	293	22	βig	βig	NOUN
dpc-4910	293	23	-	-	PUNCT
dpc-4910	293	24	h3	h3	NOUN
dpc-4910	293	25	in	in	ADP
dpc-4910	293	26	women	woman	NOUN
dpc-4910	293	27	with	with	ADP
dpc-4910	293	28	preeclampsia	preeclampsia	NOUN
dpc-4910	293	29	.	.	PUNCT
dpc-4910	294	1	am	be	AUX
dpc-4910	294	2	j	j	PROPN
dpc-4910	294	3	physiol	physiol	PROPN
dpc-4910	294	4	renal	renal	PROPN
dpc-4910	294	5	physiol	physiol	PROPN
dpc-4910	294	6	.	.	PUNCT
dpc-4910	295	1	2012;302(9):f1084	2012;302(9):f1084	NUM
dpc-4910	295	2	-	-	SYM
dpc-4910	295	3	9	9	NUM
dpc-4910	295	4	.	.	PUNCT
dpc-4910	295	5	doi	doi	NOUN
dpc-4910	295	6	:	:	PUNCT
dpc-4910	295	7	10.1152	10.1152	NUM
dpc-4910	295	8	/	/	SYM
dpc-4910	295	9	ajprenal.00597.2011	ajprenal.00597.2011	PROPN
dpc-4910	295	10	.	.	PUNCT
dpc-4910	296	1	pmid	pmid	NOUN
dpc-4910	296	2	:	:	PUNCT
dpc-4910	296	3	22301621	22301621	NUM
dpc-4910	296	4	.	.	PUNCT
dpc-4910	297	1	19	19	NUM
dpc-4910	297	2	.	.	PUNCT
dpc-4910	297	3	bergler	bergler	NOUN
dpc-4910	297	4	-	-	PUNCT
dpc-4910	297	5	czop	czop	PROPN
dpc-4910	297	6	b	b	NOUN
dpc-4910	297	7	,	,	PUNCT
dpc-4910	297	8	brzezińska	brzezińska	NOUN
dpc-4910	297	9	-	-	PUNCT
dpc-4910	297	10	wcisło	wcisło	NOUN
dpc-4910	297	11	l.	l.	PROPN
dpc-4910	297	12	serum	serum	PROPN
dpc-4910	297	13	markers	marker	NOUN
dpc-4910	297	14	of	of	ADP
dpc-4910	297	15	insulin	insulin	NOUN
dpc-4910	297	16	resistance	resistance	NOUN
dpc-4910	297	17	in	in	ADP
dpc-4910	297	18	psoriasis	psoriasis	NOUN
dpc-4910	297	19	.	.	PUNCT
dpc-4910	298	1	postepy	postepy	ADJ
dpc-4910	298	2	dermatol	dermatol	NOUN
dpc-4910	298	3	alergol	alergol	NOUN
dpc-4910	298	4	.	.	PUNCT